{
  "graph": {
    "label": "Epigenetics-2.0-Hs",
    "directed": true,
    "nodes": [
      {
        "id": "p(HGNC:PRMT9)",
        "label": "p(HGNC:PRMT9)",
        "metadata": {
          "bel_function_type": "proteinAbundance",
          "coordinate": [
            0.7923611111111111,
            0.12252252252252253,
            0.0
          ],
          "createdBy": null,
          "nodeId": null,
          "bel.function": "proteinAbundance"
        }
      },
      {
        "id": "p(HGNC:CARM1)",
        "label": "p(HGNC:CARM1)",
        "metadata": {
          "bel_function_type": "proteinAbundance",
          "coordinate": [
            0.8319444444444444,
            0.11171171171171172,
            0.0
          ],
          "createdBy": null,
          "nodeId": null,
          "bel.function": "proteinAbundance"
        }
      },
      {
        "id": "p(HGNC:PRMT6)",
        "label": "p(HGNC:PRMT6)",
        "metadata": {
          "bel_function_type": "proteinAbundance",
          "coordinate": [
            0.7340277777777778,
            0.13513513513513514,
            0.0
          ],
          "createdBy": null,
          "nodeId": null,
          "bel.function": "proteinAbundance"
        }
      },
      {
        "id": "p(HGNC:PRMT5)",
        "label": "p(HGNC:PRMT5)",
        "metadata": {
          "bel_function_type": "proteinAbundance",
          "coordinate": [
            0.6784722222222223,
            0.14684684684684685,
            0.0
          ],
          "createdBy": null,
          "nodeId": null,
          "bel.function": "proteinAbundance"
        }
      },
      {
        "id": "bp(GOBP:\"peptidyl-arginine methylation\")",
        "label": "bp(GOBP:\"peptidyl-arginine methylation\")",
        "metadata": {
          "bel_function_type": "biologicalProcess",
          "coordinate": [
            0.7312500000000001,
            0.04864864864864865,
            0.0
          ],
          "createdBy": null,
          "nodeId": null,
          "bel.function": "biologicalProcess"
        }
      },
      {
        "id": "p(HGNC:GLI1)",
        "label": "p(HGNC:GLI1)",
        "metadata": {
          "bel_function_type": "proteinAbundance",
          "coordinate": [
            0.3902777777777778,
            0.7306306306306306,
            0.0
          ],
          "createdBy": "selventa",
          "nodeId": "524b3517d3fbfd4c3405198d",
          "bel.function": "proteinAbundance"
        }
      },
      {
        "id": "p(SFAM:\"WNT Family\")",
        "label": "p(SFAM:\"WNT Family\")",
        "metadata": {
          "bel_function_type": "proteinAbundance",
          "coordinate": [
            1.3880656637813171,
            0.3475860481085456,
            0.0
          ],
          "createdBy": "selventa",
          "nodeId": "524b3517d3fbfd4c34051990",
          "bel.function": "proteinAbundance"
        }
      },
      {
        "id": "p(HGNC:VEGFA)",
        "label": "p(HGNC:VEGFA)",
        "metadata": {
          "bel_function_type": "proteinAbundance",
          "coordinate": [
            1.1551983414107942,
            0.5940409879314668,
            0.0
          ],
          "createdBy": "selventa",
          "nodeId": "524b3517d3fbfd4c34051992",
          "bel.function": "proteinAbundance"
        }
      },
      {
        "id": "tscript(p(HGNC:GLI1))",
        "label": "tscript(p(HGNC:GLI1))",
        "metadata": {
          "bel_function_type": "transcriptionalActivity",
          "coordinate": [
            0.46875,
            0.6009009009009009,
            0.0
          ],
          "createdBy": "selventa",
          "nodeId": "524b3517d3fbfd4c34051993",
          "bel.function": "transcriptionalActivity"
        }
      },
      {
        "id": "p(HGNC:CDKN2A)",
        "label": "p(HGNC:CDKN2A)",
        "metadata": {
          "bel_function_type": "proteinAbundance",
          "coordinate": [
            0.9604166666666667,
            0.5531531531531532,
            0.0
          ],
          "createdBy": "shaman.qn",
          "nodeId": "5529224a89e3620d90b1b3bf",
          "bel.function": "proteinAbundance"
        }
      },
      {
        "id": "tscript(p(HGNC:E2F4))",
        "label": "tscript(p(HGNC:E2F4))",
        "metadata": {
          "bel_function_type": "transcriptionalActivity",
          "coordinate": [
            0.3875,
            0.5657657657657658,
            0.0
          ],
          "createdBy": "selventa",
          "nodeId": "524b3517d3fbfd4c34051996",
          "bel.function": "transcriptionalActivity"
        }
      },
      {
        "id": "a(CHEBI:\"EC 3.5.1.98 (histone deacetylase) inhibitor\")",
        "label": "a(CHEBI:\"EC 3.5.1.98 (histone deacetylase) inhibitor\")",
        "metadata": {
          "bel_function_type": "abundance",
          "coordinate": [
            0.47430555555555554,
            0.3954954954954955,
            0.0
          ],
          "createdBy": "selventa",
          "nodeId": "524b3517d3fbfd4c34051998",
          "bel.function": "abundance"
        }
      },
      {
        "id": "tscript(p(HGNC:CTNNB1))",
        "label": "tscript(p(HGNC:CTNNB1))",
        "metadata": {
          "bel_function_type": "transcriptionalActivity",
          "coordinate": [
            0.09722222222222222,
            0.6738738738738738,
            0.0
          ],
          "createdBy": "selventa",
          "nodeId": "524b3517d3fbfd4c34051999",
          "bel.function": "transcriptionalActivity"
        }
      },
      {
        "id": "p(HGNC:WNT5A)",
        "label": "p(HGNC:WNT5A)",
        "metadata": {
          "bel_function_type": "proteinAbundance",
          "coordinate": [
            1.3718475801601988,
            0.2448629238692215,
            0.0
          ],
          "createdBy": "selventa",
          "nodeId": "524b3517d3fbfd4c3405199a",
          "bel.function": "proteinAbundance"
        }
      },
      {
        "id": "cat(p(HGNC:CHFR))",
        "label": "cat(p(HGNC:CHFR))",
        "metadata": {
          "bel_function_type": "catalyticActivity",
          "coordinate": [
            0.30416666666666664,
            0.1945945945945946,
            0.0
          ],
          "createdBy": "selventa",
          "nodeId": "524b3517d3fbfd4c3405199c",
          "bel.function": "catalyticActivity"
        }
      },
      {
        "id": "p(HGNC:E2F4)",
        "label": "p(HGNC:E2F4)",
        "metadata": {
          "bel_function_type": "proteinAbundance",
          "coordinate": [
            0.44375000000000003,
            0.7036036036036036,
            0.0
          ],
          "createdBy": "selventa",
          "nodeId": "524b3517d3fbfd4c3405199d",
          "bel.function": "proteinAbundance"
        }
      },
      {
        "id": "p(HGNC:PLK1)",
        "label": "p(HGNC:PLK1)",
        "metadata": {
          "bel_function_type": "proteinAbundance",
          "coordinate": [
            0.2138888888888889,
            0.14864864864864866,
            0.0
          ],
          "createdBy": "selventa",
          "nodeId": "524b3517d3fbfd4c3405199e",
          "bel.function": "proteinAbundance"
        }
      },
      {
        "id": "p(HGNC:CHFR)",
        "label": "p(HGNC:CHFR)",
        "metadata": {
          "bel_function_type": "proteinAbundance",
          "coordinate": [
            0.2392361111111111,
            0.24864864864864866,
            0.0
          ],
          "createdBy": "selventa",
          "nodeId": "524b3517d3fbfd4c3405199f",
          "bel.function": "proteinAbundance"
        }
      },
      {
        "id": "p(HGNC:RASSF1)",
        "label": "p(HGNC:RASSF1)",
        "metadata": {
          "bel_function_type": "proteinAbundance",
          "coordinate": [
            0.14444444444444446,
            0.7234234234234234,
            0.0
          ],
          "createdBy": "selventa",
          "nodeId": "524b3517d3fbfd4c340519a0",
          "bel.function": "proteinAbundance"
        }
      },
      {
        "id": "p(HGNC:DKK1)",
        "label": "p(HGNC:DKK1)",
        "metadata": {
          "bel_function_type": "proteinAbundance",
          "coordinate": [
            1.3403654178368518,
            0.30674432401339263,
            0.0
          ],
          "createdBy": "selventa",
          "nodeId": "524b3517d3fbfd4c340519a1",
          "bel.function": "proteinAbundance"
        }
      },
      {
        "id": "p(HGNC:DNMT1)",
        "label": "p(HGNC:DNMT1)",
        "metadata": {
          "bel_function_type": "proteinAbundance",
          "coordinate": [
            1.1024305555555556,
            0.6225225225225225,
            0.0
          ],
          "createdBy": "selventa",
          "nodeId": "524b3517d3fbfd4c340519a2",
          "bel.function": "proteinAbundance"
        }
      },
      {
        "id": "p(HGNC:CCND1)",
        "label": "p(HGNC:CCND1)",
        "metadata": {
          "bel_function_type": "proteinAbundance",
          "coordinate": [
            0.225,
            0.636936936936937,
            0.0
          ],
          "createdBy": "selventa",
          "nodeId": "524b3517d3fbfd4c340519a4",
          "bel.function": "proteinAbundance"
        }
      },
      {
        "id": "p(HGNC:EGR1)",
        "label": "p(HGNC:EGR1)",
        "metadata": {
          "bel_function_type": "proteinAbundance",
          "coordinate": [
            0.36944444444444446,
            0.6387387387387388,
            0.0
          ],
          "createdBy": "selventa",
          "nodeId": "524b3517d3fbfd4c340519a6",
          "bel.function": "proteinAbundance"
        }
      },
      {
        "id": "tscript(p(HGNC:EGR1))",
        "label": "tscript(p(HGNC:EGR1))",
        "metadata": {
          "bel_function_type": "transcriptionalActivity",
          "coordinate": [
            0.4458333333333333,
            0.527927927927928,
            0.0
          ],
          "createdBy": "selventa",
          "nodeId": "524b3517d3fbfd4c340519a7",
          "bel.function": "transcriptionalActivity"
        }
      },
      {
        "id": "p(HGNC:CTNNB1)",
        "label": "p(HGNC:CTNNB1)",
        "metadata": {
          "bel_function_type": "proteinAbundance",
          "coordinate": [
            0.0,
            0.7162162162162162,
            0.0
          ],
          "createdBy": "selventa",
          "nodeId": "524b3517d3fbfd4c340519a8",
          "bel.function": "proteinAbundance"
        }
      },
      {
        "id": "p(HGNC:CCNB1)",
        "label": "p(HGNC:CCNB1)",
        "metadata": {
          "bel_function_type": "proteinAbundance",
          "coordinate": [
            0.4069444444444445,
            0.31981981981981983,
            0.0
          ],
          "createdBy": "selventa",
          "nodeId": "524b3517d3fbfd4c340519a9",
          "bel.function": "proteinAbundance"
        }
      },
      {
        "id": "p(HGNC:RB1)",
        "label": "p(HGNC:RB1)",
        "metadata": {
          "bel_function_type": "proteinAbundance",
          "coordinate": [
            1.0498563658012943,
            0.6516003520269579,
            0.0
          ],
          "createdBy": "selventa",
          "nodeId": "524b3517d3fbfd4c340519aa",
          "bel.function": "proteinAbundance"
        }
      },
      {
        "id": "complex(GOCC:\"PRC1 complex\")",
        "label": "complex(GOCC:\"PRC1 complex\")",
        "metadata": {
          "bel_function_type": "complexAbundance",
          "coordinate": [
            1.284375,
            0.3216216216216216,
            0.0
          ],
          "createdBy": "selventa",
          "nodeId": "524b3517d3fbfd4c340519ad",
          "bel.function": "complexAbundance"
        }
      },
      {
        "id": "p(SFAM:\"HDAC Family\")",
        "label": "p(SFAM:\"HDAC Family\")",
        "metadata": {
          "bel_function_type": "proteinAbundance",
          "coordinate": [
            0.5784722222222222,
            0.6675675675675676,
            0.0
          ],
          "createdBy": "selventa",
          "nodeId": "524b3517d3fbfd4c340519ae",
          "bel.function": "proteinAbundance"
        }
      },
      {
        "id": "kin(p(HGNC:CDK1))",
        "label": "kin(p(HGNC:CDK1))",
        "metadata": {
          "bel_function_type": "kinaseActivity",
          "coordinate": [
            0.2025484698138044,
            0.3055001326010717,
            0.0
          ],
          "createdBy": "alejandroferreiromorales.cr",
          "nodeId": "547651ae89e3620868759713",
          "bel.function": "kinaseActivity"
        }
      },
      {
        "id": "g(HGNC:GATA4)",
        "label": "g(HGNC:GATA4)",
        "metadata": {
          "bel_function_type": "geneAbundance",
          "coordinate": [
            0.9055555555555556,
            0.5315315315315315,
            0.0
          ],
          "createdBy": "swapna30",
          "nodeId": "547edebb89e36213f01591fb",
          "bel.function": "geneAbundance"
        }
      },
      {
        "id": "path(MESHD:\"Pulmonary Disease, Chronic Obstructive\")",
        "label": "path(MESHD:\"Pulmonary Disease, Chronic Obstructive\")",
        "metadata": {
          "bel_function_type": "pathology",
          "coordinate": [
            0.8118055555555556,
            0.47297297297297297,
            0.0
          ],
          "createdBy": "ganna.androsova",
          "nodeId": "5538c38589e362097c004aef",
          "bel.function": "pathology"
        }
      },
      {
        "id": "bp(GOBP:\"DNA methylation\")",
        "label": "bp(GOBP:\"DNA methylation\")",
        "metadata": {
          "bel_function_type": "biologicalProcess",
          "coordinate": [
            0.9763888888888889,
            0.45765765765765765,
            0.0
          ],
          "createdBy": "swapna30",
          "nodeId": "547ee11d89e36213f015981b",
          "bel.function": "biologicalProcess"
        }
      },
      {
        "id": "a(SCHEM:\"Smoke, cigarette\")",
        "label": "a(SCHEM:\"Smoke, cigarette\")",
        "metadata": {
          "bel_function_type": "abundance",
          "coordinate": [
            0.7302083333333332,
            0.445045045045045,
            0.0
          ],
          "createdBy": "swapna30",
          "nodeId": "547eeb5589e3620d84a19a94",
          "bel.function": "abundance"
        }
      },
      {
        "id": "g(HGNC:AHRR)",
        "label": "g(HGNC:AHRR)",
        "metadata": {
          "bel_function_type": "geneAbundance",
          "coordinate": [
            0.7673695929425675,
            0.3887136418436894,
            0.0
          ],
          "createdBy": "swapna30",
          "nodeId": "547eeb5589e3620d84a19a96",
          "bel.function": "geneAbundance"
        }
      },
      {
        "id": "bp(GOBP:\"histone modification\")",
        "label": "bp(GOBP:\"histone modification\")",
        "metadata": {
          "bel_function_type": "biologicalProcess",
          "coordinate": [
            0.8152777777777778,
            0.22432432432432434,
            0.0
          ],
          "createdBy": "swapna30",
          "nodeId": "547eeed489e3620d84a1ba53",
          "bel.function": "biologicalProcess"
        }
      },
      {
        "id": "complex(GOCC:\"ESC/E(Z) complex\")",
        "label": "complex(GOCC:\"ESC/E(Z) complex\")",
        "metadata": {
          "bel_function_type": "complexAbundance",
          "coordinate": [
            1.1600694444444444,
            0.3675675675675676,
            0.0
          ],
          "createdBy": "susana.martinez.arbas",
          "nodeId": "5500895289e3621814f3c6a0",
          "bel.function": "complexAbundance"
        }
      },
      {
        "id": "p(HGNC:EED)",
        "label": "p(HGNC:EED)",
        "metadata": {
          "bel_function_type": "proteinAbundance",
          "coordinate": [
            1.1276081778790552,
            0.42859166823413947,
            0.0
          ],
          "createdBy": "susana.martinez.arbas",
          "nodeId": "550085d489e3621814f3b75c",
          "bel.function": "proteinAbundance"
        }
      },
      {
        "id": "p(HGNC:EZH2)",
        "label": "p(HGNC:EZH2)",
        "metadata": {
          "bel_function_type": "proteinAbundance",
          "coordinate": [
            1.0687499999999999,
            0.2756756756756757,
            0.0
          ],
          "createdBy": "susana.martinez.arbas",
          "nodeId": "5500868789e3621814f3bbbb",
          "bel.function": "proteinAbundance"
        }
      },
      {
        "id": "p(HGNC:SUZ12)",
        "label": "p(HGNC:SUZ12)",
        "metadata": {
          "bel_function_type": "proteinAbundance",
          "coordinate": [
            1.1929399660735773,
            0.3069132816187944,
            0.0
          ],
          "createdBy": "susana.martinez.arbas",
          "nodeId": "5502e64d89e36209cc4e1bcc",
          "bel.function": "proteinAbundance"
        }
      },
      {
        "id": "a(CHEBI:\"hydrogen peroxide\")",
        "label": "a(CHEBI:\"hydrogen peroxide\")",
        "metadata": {
          "bel_function_type": "abundance",
          "coordinate": [
            0.75,
            0.845945945945946,
            0.0
          ],
          "createdBy": "pirxtrurl",
          "nodeId": "550743f089e3620b944ee668",
          "bel.function": "abundance"
        }
      },
      {
        "id": "g(HGNC:F2RL3)",
        "label": "g(HGNC:F2RL3)",
        "metadata": {
          "bel_function_type": "geneAbundance",
          "coordinate": [
            0.8541666666666666,
            0.6225225225225225,
            0.0
          ],
          "createdBy": "susana.martinez.arbas",
          "nodeId": "55114c8889e3620b9c5b2621",
          "bel.function": "geneAbundance"
        }
      },
      {
        "id": "bp(GOBP:\"hypomethylation of CpG island\")",
        "label": "bp(GOBP:\"hypomethylation of CpG island\")",
        "metadata": {
          "bel_function_type": "biologicalProcess",
          "coordinate": [
            0.9451388888888889,
            0.7441441441441441,
            0.0
          ],
          "createdBy": "susana.martinez.arbas",
          "nodeId": "55114c8889e3620b9c5b2623",
          "bel.function": "biologicalProcess"
        }
      },
      {
        "id": "p(HGNC:HDAC1)",
        "label": "p(HGNC:HDAC1)",
        "metadata": {
          "bel_function_type": "proteinAbundance",
          "coordinate": [
            0.6184027777777777,
            0.5720720720720721,
            0.0
          ],
          "createdBy": "susana.martinez.arbas",
          "nodeId": "551fd8e889e36205507d4773",
          "bel.function": "proteinAbundance"
        }
      },
      {
        "id": "bp(GOBP:\"histone methylation\")",
        "label": "bp(GOBP:\"histone methylation\")",
        "metadata": {
          "bel_function_type": "biologicalProcess",
          "coordinate": [
            0.9333333333333332,
            0.3117117117117117,
            0.0
          ],
          "createdBy": "susana.martinez.arbas",
          "nodeId": "5522e68189e36208f8fe7b15",
          "bel.function": "biologicalProcess"
        }
      },
      {
        "id": "bp(GOBP:\"histone acetylation\")",
        "label": "bp(GOBP:\"histone acetylation\")",
        "metadata": {
          "bel_function_type": "biologicalProcess",
          "coordinate": [
            0.8972222222222223,
            0.09099099099099099,
            0.0
          ],
          "createdBy": "dheeraj.bobbili",
          "nodeId": "5529391989e3620d90bef8a1",
          "bel.function": "biologicalProcess"
        }
      },
      {
        "id": "bp(GOBP:\"response to oxidative stress\")",
        "label": "bp(GOBP:\"response to oxidative stress\")",
        "metadata": {
          "bel_function_type": "biologicalProcess",
          "coordinate": [
            1.253472222222222,
            0.5621621621621622,
            0.0
          ],
          "createdBy": "aishwarya.alex",
          "nodeId": "5525548589e36205c48cf0bf",
          "bel.function": "biologicalProcess"
        }
      },
      {
        "id": "cat(p(HGNC:DNMT1))",
        "label": "cat(p(HGNC:DNMT1))",
        "metadata": {
          "bel_function_type": "catalyticActivity",
          "coordinate": [
            1.1381944444444445,
            0.518018018018018,
            0.0
          ],
          "createdBy": "aishwarya.alex",
          "nodeId": "5525548589e36205c48cf0c1",
          "bel.function": "catalyticActivity"
        }
      },
      {
        "id": "g(HGNC:SERPINA1)",
        "label": "g(HGNC:SERPINA1)",
        "metadata": {
          "bel_function_type": "geneAbundance",
          "coordinate": [
            0.8888888888888888,
            0.6378378378378379,
            0.0
          ],
          "createdBy": "susana.martinez.arbas",
          "nodeId": "55257b0b89e36205c49dc26a",
          "bel.function": "geneAbundance"
        }
      },
      {
        "id": "g(HGNC:FUT7)",
        "label": "g(HGNC:FUT7)",
        "metadata": {
          "bel_function_type": "geneAbundance",
          "coordinate": [
            0.9125,
            0.6135135135135136,
            0.0
          ],
          "createdBy": "susana.martinez.arbas",
          "nodeId": "55257cb989e36205c49e417f",
          "bel.function": "geneAbundance"
        }
      },
      {
        "id": "p(HGNC:DEFB1)",
        "label": "p(HGNC:DEFB1)",
        "metadata": {
          "bel_function_type": "proteinAbundance",
          "coordinate": [
            0.6610997054610691,
            0.6213593377505203,
            0.0
          ],
          "createdBy": "susana.martinez.arbas",
          "nodeId": "5525872089e36205c4a24f82",
          "bel.function": "proteinAbundance"
        }
      },
      {
        "id": "bp(GOBP:\"cellular response to DNA damage stimulus\")",
        "label": "bp(GOBP:\"cellular response to DNA damage stimulus\")",
        "metadata": {
          "bel_function_type": "biologicalProcess",
          "coordinate": [
            0.7068104152145777,
            0.7303317861348521,
            0.0
          ],
          "createdBy": "susana.martinez.arbas",
          "nodeId": "5526fe9189e36201cca7ccf5",
          "bel.function": "biologicalProcess"
        }
      },
      {
        "id": "deg(p(HGNC:HDAC2))",
        "label": "deg(p(HGNC:HDAC2))",
        "metadata": {
          "bel_function_type": "degradation",
          "coordinate": [
            0.7152777777777778,
            0.5423423423423424,
            0.0
          ],
          "createdBy": "susana.martinez.arbas",
          "nodeId": "55284ccb89e362084468e3d2",
          "bel.function": "degradation"
        }
      },
      {
        "id": "a(CHEBI:corticosteroid)",
        "label": "a(CHEBI:corticosteroid)",
        "metadata": {
          "bel_function_type": "abundance",
          "coordinate": [
            0.8517361111111111,
            0.01711711711711712,
            0.0
          ],
          "createdBy": "aishwarya.alex",
          "nodeId": "552910a689e3620d90a89187",
          "bel.function": "abundance"
        }
      },
      {
        "id": "bp(GOBP:\"inflammatory response\")",
        "label": "bp(GOBP:\"inflammatory response\")",
        "metadata": {
          "bel_function_type": "biologicalProcess",
          "coordinate": [
            0.7960993967429726,
            0.00015295098295771759,
            0.0
          ],
          "createdBy": "aishwarya.alex",
          "nodeId": "552910a689e3620d90a892b7",
          "bel.function": "biologicalProcess"
        }
      },
      {
        "id": "bp(GOBP:\"chromatin remodeling\")",
        "label": "bp(GOBP:\"chromatin remodeling\")",
        "metadata": {
          "bel_function_type": "biologicalProcess",
          "coordinate": [
            0.9074848199354154,
            0.033450779020745565,
            0.0
          ],
          "createdBy": "aishwarya.alex",
          "nodeId": "55291c3489e3620d90ae0c24",
          "bel.function": "biologicalProcess"
        }
      },
      {
        "id": "p(HGNC:HDAC2)",
        "label": "p(HGNC:HDAC2)",
        "metadata": {
          "bel_function_type": "proteinAbundance",
          "coordinate": [
            0.6954861111111111,
            0.6576576576576577,
            0.0
          ],
          "createdBy": "dheeraj.bobbili",
          "nodeId": "552931c889e3620d90b9f271",
          "bel.function": "proteinAbundance"
        }
      },
      {
        "id": "r(HGNC:HDAC5)",
        "label": "r(HGNC:HDAC5)",
        "metadata": {
          "bel_function_type": "rnaAbundance",
          "coordinate": [
            0.71875,
            0.6126126126126127,
            0.0
          ],
          "createdBy": "dheeraj.bobbili",
          "nodeId": "552932a889e3620d90ba4492",
          "bel.function": "rnaAbundance"
        }
      },
      {
        "id": "r(HGNC:HDAC8)",
        "label": "r(HGNC:HDAC8)",
        "metadata": {
          "bel_function_type": "rnaAbundance",
          "coordinate": [
            0.7763888888888889,
            0.6657657657657657,
            0.0
          ],
          "createdBy": "dheeraj.bobbili",
          "nodeId": "5529332a89e3620d90ba825c",
          "bel.function": "rnaAbundance"
        }
      },
      {
        "id": "cat(p(SFAM:\"HDAC Family\"))",
        "label": "cat(p(SFAM:\"HDAC Family\"))",
        "metadata": {
          "bel_function_type": "catalyticActivity",
          "coordinate": [
            0.5680555555555555,
            0.46396396396396394,
            0.0
          ],
          "createdBy": "dheeraj.bobbili",
          "nodeId": "5529355989e3620d90bb874f",
          "bel.function": "catalyticActivity"
        }
      },
      {
        "id": "p(HGNC:HDAC3)",
        "label": "p(HGNC:HDAC3)",
        "metadata": {
          "bel_function_type": "proteinAbundance",
          "coordinate": [
            0.5961805555555556,
            0.5297297297297298,
            0.0
          ],
          "createdBy": "susana.martinez.arbas",
          "nodeId": "55293bd689e3620d90c11893",
          "bel.function": "proteinAbundance"
        }
      },
      {
        "id": "p(HGNC:GDF11)",
        "label": "p(HGNC:GDF11)",
        "metadata": {
          "bel_function_type": "proteinAbundance",
          "coordinate": [
            0.5529915511140674,
            0.4811693791050551,
            0.0
          ],
          "createdBy": "susana.martinez.arbas",
          "nodeId": "55293dac89e3620d90c1d3a9",
          "bel.function": "proteinAbundance"
        }
      },
      {
        "id": "p(HGNC:KMT2A)",
        "label": "p(HGNC:KMT2A)",
        "metadata": {
          "bel_function_type": "proteinAbundance",
          "coordinate": [
            1.0145833333333334,
            0.29099099099099096,
            0.0
          ],
          "createdBy": "susana.martinez.arbas",
          "nodeId": "552ad49389e3620a30dd9013",
          "bel.function": "proteinAbundance"
        }
      },
      {
        "id": "r(HGNC:KMT2A)",
        "label": "r(HGNC:KMT2A)",
        "metadata": {
          "bel_function_type": "rnaAbundance",
          "coordinate": [
            0.9326388888888889,
            0.3855855855855856,
            0.0
          ],
          "createdBy": "susana.martinez.arbas",
          "nodeId": "552ad59189e3620a30dd999c",
          "bel.function": "rnaAbundance"
        }
      },
      {
        "id": "r(HGNC:HDAC10)",
        "label": "r(HGNC:HDAC10)",
        "metadata": {
          "bel_function_type": "rnaAbundance",
          "coordinate": [
            0.7673611111111112,
            0.6207207207207207,
            0.0
          ],
          "createdBy": "susana.martinez.arbas",
          "nodeId": "552ad73989e3620a30dda6fb",
          "bel.function": "rnaAbundance"
        }
      },
      {
        "id": "r(HGNC:CARM1)",
        "label": "r(HGNC:CARM1)",
        "metadata": {
          "bel_function_type": "rnaAbundance",
          "coordinate": [
            0.8548611111111111,
            0.2855855855855856,
            0.0
          ],
          "createdBy": "shaman.qn",
          "nodeId": "552c260c89e36208d47c9db0",
          "bel.function": "rnaAbundance"
        }
      },
      {
        "id": "r(HGNC:PRMT5)",
        "label": "r(HGNC:PRMT5)",
        "metadata": {
          "bel_function_type": "rnaAbundance",
          "coordinate": [
            0.7298611111111111,
            0.3099099099099099,
            0.0
          ],
          "createdBy": "shaman.qn",
          "nodeId": "552c28c889e36208d47d3ca8",
          "bel.function": "rnaAbundance"
        }
      },
      {
        "id": "r(HGNC:PRMT6)",
        "label": "r(HGNC:PRMT6)",
        "metadata": {
          "bel_function_type": "rnaAbundance",
          "coordinate": [
            0.7722222222222223,
            0.2981981981981982,
            0.0
          ],
          "createdBy": "shaman.qn",
          "nodeId": "552c2a9189e36208d47d7438",
          "bel.function": "rnaAbundance"
        }
      },
      {
        "id": "r(HGNC:PRMT9)",
        "label": "r(HGNC:PRMT9)",
        "metadata": {
          "bel_function_type": "rnaAbundance",
          "coordinate": [
            0.8166666666666668,
            0.2891891891891892,
            0.0
          ],
          "createdBy": "shaman.qn",
          "nodeId": "552c2c3d89e36208d47dfb07",
          "bel.function": "rnaAbundance"
        }
      },
      {
        "id": "a(CHEBI:\"N(omega),N'(omega)-dimethyl-L-arginine\")",
        "label": "a(CHEBI:\"N(omega),N'(omega)-dimethyl-L-arginine\")",
        "metadata": {
          "bel_function_type": "abundance",
          "coordinate": [
            0.725,
            0.22072072072072071,
            0.0
          ],
          "createdBy": "pranjul.shah_1",
          "nodeId": "552c307589e36208d47f9944",
          "bel.function": "abundance"
        }
      },
      {
        "id": "a(SCHEM:\"Diesel exhaust particles\")",
        "label": "a(SCHEM:\"Diesel exhaust particles\")",
        "metadata": {
          "bel_function_type": "abundance",
          "coordinate": [
            0.9131944444444445,
            0.45765765765765765,
            0.0
          ],
          "createdBy": "pranjul.shah_1",
          "nodeId": "552c363489e36208d4857c30",
          "bel.function": "abundance"
        }
      },
      {
        "id": "p(HGNC:HDAC5)",
        "label": "p(HGNC:HDAC5)",
        "metadata": {
          "bel_function_type": "proteinAbundance",
          "coordinate": [
            0.63125,
            0.7342342342342342,
            0.0
          ],
          "createdBy": null,
          "nodeId": null,
          "bel.function": "proteinAbundance"
        }
      },
      {
        "id": "p(HGNC:HDAC8)",
        "label": "p(HGNC:HDAC8)",
        "metadata": {
          "bel_function_type": "proteinAbundance",
          "coordinate": [
            0.6777777777777777,
            0.7720720720720721,
            0.0
          ],
          "createdBy": null,
          "nodeId": null,
          "bel.function": "proteinAbundance"
        }
      },
      {
        "id": "p(HGNC:HDAC10)",
        "label": "p(HGNC:HDAC10)",
        "metadata": {
          "bel_function_type": "proteinAbundance",
          "coordinate": [
            0.6743055555555556,
            0.7207207207207208,
            0.0
          ],
          "createdBy": null,
          "nodeId": null,
          "bel.function": "proteinAbundance"
        }
      },
      {
        "id": "bp(GPBP:\"histone deacetylation\")",
        "label": "bp(GPBP:\"histone deacetylation\")",
        "metadata": {
          "bel_function_type": "biologicalProcess",
          "coordinate": [
            0.6715277777777778,
            0.31981981981981983,
            0.0
          ],
          "createdBy": null,
          "nodeId": null,
          "bel.function": "biologicalProcess"
        }
      }
    ],
    "edges": [
      {
        "source": "p(HGNC:PRMT9)",
        "target": "bp(GOBP:\"peptidyl-arginine methylation\")",
        "relation": "directlyIncreases",
        "directed": true,
        "label": "p(HGNC:PRMT9) directlyIncreases bp(GOBP:\"peptidyl-arginine methylation\")",
        "metadata": {
          "edgeId": null,
          "createdBy": null,
          "casual": null,
          "evidences": [
            {
              "bel_statement": "p(HGNC:PRMT9) directlyIncreases bp(GOBP:\"peptidyl-arginine methylation\")",
              "citation": {
                "type": "PubMed",
                "id": "25807439",
                "name": "Eur Rev Med Pharmacol Sci. 2015;19(5):844-56."
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "PRMTs can specifically\nmethylate protein-incorporated arginine residues\nto generate protein-incorporated monomethy-\nlarginine (MMA), symmetric dimethylarginine\n(SDMA), or asymmetric dimethylarginine",
              "metadata": {
                "id": "",
                "created_by": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:CARM1)",
        "target": "bp(GOBP:\"peptidyl-arginine methylation\")",
        "relation": "directlyIncreases",
        "directed": true,
        "label": "p(HGNC:CARM1) directlyIncreases bp(GOBP:\"peptidyl-arginine methylation\")",
        "metadata": {
          "edgeId": null,
          "createdBy": null,
          "casual": null,
          "evidences": [
            {
              "bel_statement": "p(HGNC:CARM1) directlyIncreases bp(GOBP:\"peptidyl-arginine methylation\")",
              "citation": {
                "type": "PubMed",
                "id": "25807439",
                "name": "Eur Rev Med Pharmacol Sci. 2015;19(5):844-56."
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "PRMTs can specifically methylate protein-incorporated arginine residues to generate protein incorporated monomethylarginine (MMA), symmetric dimethylarginine (SDMA), or asymmetric dimethylarginine",
              "metadata": {
                "id": "",
                "created_by": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:PRMT6)",
        "target": "bp(GOBP:\"peptidyl-arginine methylation\")",
        "relation": "directlyIncreases",
        "directed": true,
        "label": "p(HGNC:PRMT6) directlyIncreases bp(GOBP:\"peptidyl-arginine methylation\")",
        "metadata": {
          "edgeId": null,
          "createdBy": null,
          "casual": null,
          "evidences": [
            {
              "bel_statement": "p(HGNC:PRMT6) directlyIncreases bp(GOBP:\"peptidyl-arginine methylation\")",
              "citation": {
                "type": "PubMed",
                "id": "25807439",
                "name": "Eur Rev Med Pharmacol Sci. 2015;19(5):844-56."
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "PRMTs can specifically methylate protein-incorporated arginine residues to generate protein incorporated monomethylarginine (MMA), symmetric dimethylarginine (SDMA), or asymmetric dimethylarginine",
              "metadata": {
                "id": "",
                "created_by": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:PRMT5)",
        "target": "bp(GOBP:\"peptidyl-arginine methylation\")",
        "relation": "directlyIncreases",
        "directed": true,
        "label": "p(HGNC:PRMT5) directlyIncreases bp(GOBP:\"peptidyl-arginine methylation\")",
        "metadata": {
          "edgeId": null,
          "createdBy": null,
          "casual": null,
          "evidences": [
            {
              "bel_statement": "p(HGNC:PRMT5) directlyIncreases bp(GOBP:\"peptidyl-arginine methylation\")",
              "citation": {
                "type": "PubMed",
                "id": "25807439",
                "name": "Eur Rev Med Pharmacol Sci. 2015;19(5):844-56."
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "PRMTs can specifically methylate protein-incorporated arginine residues to generate protein incorporated monomethylarginine (MMA), symmetric dimethylarginine (SDMA), or asymmetric dimethylarginine",
              "metadata": {
                "id": "",
                "created_by": ""
              }
            }
          ]
        }
      },
      {
        "source": "bp(GOBP:\"peptidyl-arginine methylation\")",
        "target": "a(CHEBI:\"N(omega),N'(omega)-dimethyl-L-arginine\")",
        "relation": "increases",
        "directed": true,
        "label": "bp(GOBP:\"peptidyl-arginine methylation\") increases a(CHEBI:\"N(omega),N'(omega)-dimethyl-L-arginine\")",
        "metadata": {
          "edgeId": null,
          "createdBy": null,
          "casual": null,
          "evidences": [
            {
              "bel_statement": "bp(GOBP:\"peptidyl-arginine methylation\") increases a(CHEBI:\"N(omega),N'(omega)-dimethyl-L-arginine\")",
              "citation": {
                "type": "PubMed",
                "id": "25807439",
                "name": "Eur Rev Med Pharmacol Sci. 2015;19(5):844-56."
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "PRMTs can specifically methylate protein-incorporated arginine residues to generate protein incorporated monomethylarginine (MMA), symmetric dimethylarginine (SDMA), or asymmetric dimethylarginine",
              "metadata": {
                "id": "",
                "created_by": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:GLI1)",
        "target": "tscript(p(HGNC:GLI1))",
        "relation": "actsIn",
        "directed": true,
        "label": "p(HGNC:GLI1) actsIn tscript(p(HGNC:GLI1))",
        "metadata": {
          "edgeId": "524b3517d3fbfd4c3405196c",
          "createdBy": "selventa",
          "casual": false,
          "evidences": [
            {
              "bel_statement": "p(HGNC:GLI1) actsIn tscript(p(HGNC:GLI1))",
              "citation": {
                "type": "PubMed",
                "id": "14611647",
                "name": "Biochem J 2004 Mar 1 378(Pt 2) 353-62"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Mouse",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Sufu (Suppressor of fused) is a negative regulator of the Hedgehog signal-transduction pathway, interacting directly with the Gli family of transcription factors.",
              "metadata": {
                "id": "524b3521d3fbfd4c3406210a",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:GLI1) actsIn tscript(p(HGNC:GLI1))",
              "citation": {
                "type": "PubMed",
                "id": "19575820",
                "name": "Mol Cancer 2009 8 44"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "##from text## While SMOH inhibition by cyclopamine did not affect GLI reporter gene activity in accordance with a previous study that showed GLI1 activation is ligand independent in A549 cells [18], a significant decrease in activity was observed by inhibition of PI3K with LY294002 (Fig. 5B).",
              "metadata": {
                "id": "524b3521d3fbfd4c34062121",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:GLI1) actsIn tscript(p(HGNC:GLI1))",
              "citation": {
                "type": "PubMed",
                "id": "12183437",
                "name": "Cancer Res 2002 Aug 15 62(16) 4773-80"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": "Keratinocytes"
              },
              "summary_text": "Expression of the Shh target glioma transcription factor-1 (Gli1) in primary keratinocytes and other cell lines caused a significant elevation of FOXM1 mRNA level and transcriptional activity, indicating that FOXM1 is a downstream target of Gli1.",
              "metadata": {
                "id": "524b3521d3fbfd4c34062218",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:GLI1) actsIn tscript(p(HGNC:GLI1))",
              "citation": {
                "type": "PubMed",
                "id": "11719506",
                "name": "J Biol Chem 2002 Feb 15 277(7) 5548-55"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "GLI1 consensusDNA-binding sequences were identified in the 5' regions of cyclin D2,IGFBP-6, osteopontin, and plakoglobin, suggesting that these genes representimmediate downstream targets. Gel shift analysis confirmed the ability of theGLI1 protein to bind these sequences. Up-regulation of cyclin D2 anddown-regulation of plakoglobin were demonstrated in GLI1-amplified compared withnon-amplified human rhabdomyosarcoma cells.",
              "metadata": {
                "id": "524b3521d3fbfd4c340621ec",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:GLI1) actsIn tscript(p(HGNC:GLI1))",
              "citation": {
                "type": "PubMed",
                "id": "16484682",
                "name": "Am J Respir Cell Mol Biol 2006 Jul 35(1) 3-9"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "from full text - Figure 1 ",
              "metadata": {
                "id": "524b3521d3fbfd4c34061f8e",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:GLI1) actsIn tscript(p(HGNC:GLI1))",
              "citation": {
                "type": "PubMed",
                "id": "17392427",
                "name": "Proc Natl Acad Sci U S A 2007 Apr 3 104(14) 5895-900"
              },
              "experiment_context": {
                "disease": "carcinoma of melanocyte",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "# from full text # with GLI1 mRNA expression being the only reliable marker of pathway activity and PTCH1 being also a GLI1 target (8).",
              "metadata": {
                "id": "524b3521d3fbfd4c340620d5",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:GLI1) actsIn tscript(p(HGNC:GLI1))",
              "citation": {
                "type": "PubMed",
                "id": "15645142",
                "name": "Int J Oncol 2005 Feb 26(2) 545-9"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Sonic hedgehog (SHH), Desert hedgehog (DHH) and Indian hedgehog (IHH) bind to Patched family receptors (PTCH1 and PTCH2) to transduce signals to GLI1, GLI2 and GLI3. GLI family transcription factors then activate transcription of Hedgehog target genes, such as FOXE1 and FOXM1 encoding Forkhead-box transcription factors.",
              "metadata": {
                "id": "524b3521d3fbfd4c3406203b",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:GLI1) actsIn tscript(p(HGNC:GLI1))",
              "citation": {
                "type": "PubMed",
                "id": "12907651",
                "name": "Cancer Res 2003 Aug 1 63(15) 4692-7"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Modified assertion",
              "metadata": {
                "id": "524b3521d3fbfd4c34062023",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:GLI1) actsIn tscript(p(HGNC:GLI1))",
              "citation": {
                "type": "PubMed",
                "id": "14555646",
                "name": "J Biol Chem 2004 Jan 9 279(2) 1197-205"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Modified assertion",
              "metadata": {
                "id": "524b3521d3fbfd4c34061f1c",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:GLI1) actsIn tscript(p(HGNC:GLI1))",
              "citation": {
                "type": "PubMed",
                "id": "17196391",
                "name": "Curr Biol 2007 Jan 23 17(2) 165-72"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": "Stem Cells"
              },
              "summary_text": "Analyses of a panel of fresh brain tumors (Fig. 1AFigure 1, Fig. S1A) demonstrated the ubiquitous and varied expression of HH-GLI pathway components including GLI1, SHH and PTCH1, confirming the general presence of an active pathway (Fig. 1AFigure 1, Figs. S1B, C, S2), as GLI1 transcription is the only reliable marker of pathway activity. .....Here we demonstrate that human gliomas and their cancer stem cells require HH-GLI pathway activity for proliferation, survival, self-renewal and tumorigenicity. ",
              "metadata": {
                "id": "524b3521d3fbfd4c34062258",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:GLI1) actsIn tscript(p(HGNC:GLI1))",
              "citation": {
                "type": "PubMed",
                "id": "10075717",
                "name": "J Biol Chem 1999 Mar 19 274(12) 8143-52"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Mouse",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "GLI3 directly binds to the Gli1 promoter and induces Gli1 transcription in response to Shh.",
              "metadata": {
                "id": "524b3521d3fbfd4c34061fa7",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:GLI1) actsIn tscript(p(HGNC:GLI1))",
              "citation": {
                "type": "PubMed",
                "id": "17353198",
                "name": "J Biol Chem 2007 May 11 282(19) 14048-55"
              },
              "experiment_context": {
                "disease": "pancreatic ductal carcinoma",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Oncogenic KRAS transformation of human pancreatic ductal epithelial cells increases GLI transcriptional activity, an effect that is inhibited by the MEK-specific inhibitors U0126 and PD98059, but not by the PI3K-specific inhibitor wortmannin.",
              "metadata": {
                "id": "524b3521d3fbfd4c34061fd9",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:GLI1) actsIn tscript(p(HGNC:GLI1))",
              "citation": {
                "type": "PubMed",
                "id": "16434164",
                "name": "Genomics 2006 May 87(5) 616-32"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Table 1 Gene expression profiles of human epidermal cells in response to GLI1 and GLI2deltaN ",
              "metadata": {
                "id": "524b3521d3fbfd4c340622a6",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:GLI1) actsIn tscript(p(HGNC:GLI1))",
              "citation": {
                "type": "PubMed",
                "id": "17353198",
                "name": "J Biol Chem 2007 May 11 282(19) 14048-55"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Oncogenic KRAS transformation of human pancreatic ductal epithelial cells increases GLI transcriptional activity, an effect that is inhibited by the MEK-specific inhibitors U0126 and PD98059, but not by the PI3K-specific inhibitor wortmannin.",
              "metadata": {
                "id": "524b3521d3fbfd4c34062102",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:GLI1) actsIn tscript(p(HGNC:GLI1))",
              "citation": {
                "type": "PubMed",
                "id": "16054035",
                "name": "Dev Cell 2005 Aug 9(2) 293-303"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Mouse",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "By genetically altering levels of Gli activator and repressor functions in mice, we have demonstrated that both Gli functions are involved in the transcriptional control of N-myc and Cyclin D2 during embryonic hair follicle development",
              "metadata": {
                "id": "524b3521d3fbfd4c34061fc0",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:GLI1) actsIn tscript(p(HGNC:GLI1))",
              "citation": {
                "type": "PubMed",
                "id": "18756266",
                "name": "EMBO J 2008 Oct 8 27(19) 2616-27"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Specifically, we identify miR-125b and miR-326 as suppressors of the pathway activator Smoothened together with miR-324-5p, which also targets the downstream transcription factor Gli1. Downregulation of these miRNAs allows high levels of Hh-dependent gene expression leading to tumour cell proliferation.",
              "metadata": {
                "id": "524b3521d3fbfd4c34061fb8",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:GLI1) actsIn tscript(p(HGNC:GLI1))",
              "citation": {
                "type": "PubMed",
                "id": "16880536",
                "name": "Mol Cell Biol 2006 Aug 26(16) 6283-98"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": "Keratinocytes"
              },
              "summary_text": "This is supported by the observation that both HH/GLI and EGFR signaling have previously been implicated in proliferative control and growth of human keratinocytes and anagen hair follicles, respectively, and by our own data presented in this study showing enhanced induction of CCND1 expression by concomitant GLI1 and EGF signaling (16, 28, 58, 67, 72, 94, 95). Furthermore, we have previously shown that GLI1 and GLI2 promote G1-phase-to-S-phase progression in serum-containing medium, while they fail to do so under starving conditions, suggesting that additional mitogenic stimuli are required to allow GLI proteins to exert their proliferative activity (75, 77)",
              "metadata": {
                "id": "524b3521d3fbfd4c34061ef9",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:GLI1) actsIn tscript(p(HGNC:GLI1))",
              "citation": {
                "type": "PubMed",
                "id": "11960000",
                "name": "Proc Natl Acad Sci U S A 2002 Apr 16 99(8) 5442-7"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Mouse",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Here we report that the mouse homolog of Su(fu) [mSu(fu)] specifically interacts with SAP18, a component of the mSin3 and histone deacetylase complex. In addition, we demonstrate that mSu(fu) functionally cooperates with SAP18 to repress transcription by recruiting the SAP18-mSin3 complex to promoters containing the Gli-binding element.",
              "metadata": {
                "id": "524b3521d3fbfd4c34062297",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:GLI1) actsIn tscript(p(HGNC:GLI1))",
              "citation": {
                "type": "PubMed",
                "id": "15545630",
                "name": "Genes Dev 2004 Nov 15 18(22) 2724-9"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "MIM is part of a Gli/Suppressor of Fused complex and potentiates Gli-dependent transcription",
              "metadata": {
                "id": "524b3521d3fbfd4c34062169",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:GLI1) actsIn tscript(p(HGNC:GLI1))",
              "citation": {
                "type": "PubMed",
                "id": "19574535",
                "name": "Am J Respir Cell Mol Biol 2010 May 42(5) 615-25"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": "Epithelial Cells"
              },
              "summary_text": "In the lung, epithelial-produced Shh signals via mesenchymal Gli1-3 transcription factors",
              "metadata": {
                "id": "524b3521d3fbfd4c34062162",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:GLI1) actsIn tscript(p(HGNC:GLI1))",
              "citation": {
                "type": "PubMed",
                "id": "19860666",
                "name": "Curr Mol Med 2009 Sep 9(7) 873-86"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "RTK signaling potentiates GLI activity through PI3K-AKT-mediated GSK3 inactivation or RAS-STIL1-mediated SUFU inactivation, while GPCR signaling to Gs represses GLI activity through adenylate cyclase-mediated PKA activation",
              "metadata": {
                "id": "524b3521d3fbfd4c3406200e",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:GLI1) actsIn tscript(p(HGNC:GLI1))",
              "citation": {
                "type": "PubMed",
                "id": "16339192",
                "name": "Development 2006 Jan 133(1) 3-14"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Smo is targeted to cilia and activates Gli proteins in a cilia-dependent manner.",
              "metadata": {
                "id": "524b3521d3fbfd4c34061fdf",
                "created_by": "selventa"
              }
            }
          ]
        }
      },
      {
        "source": "tscript(p(HGNC:E2F4))",
        "target": "p(HGNC:CCND1)",
        "relation": "directlyIncreases",
        "directed": true,
        "label": "tscript(p(HGNC:E2F4)) directlyIncreases p(HGNC:CCND1)",
        "metadata": {
          "edgeId": "524b3517d3fbfd4c3405197b",
          "createdBy": "selventa",
          "casual": true,
          "evidences": [
            {
              "bel_statement": "tscript(p(HGNC:E2F4)) directlyIncreases p(HGNC:CCND1)",
              "citation": {
                "type": "PubMed",
                "id": "0",
                "name": ""
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "metadata": {
                "id": "524b3521d3fbfd4c34062052",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "tscript(p(HGNC:E2F4)) directlyIncreases p(HGNC:CCND1)",
              "citation": {
                "type": "PubMed",
                "id": "9584162",
                "name": ""
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "human",
                "tissue": "",
                "cell": "trophoblast cell line jeg-3,  fibroblast cell line nih 3t3"
              },
              "summary_text": "E2F-4 activates cyclin D1 promoter activity",
              "metadata": {
                "id": "5302173289e3620bbcd7b2bb",
                "created_by": "gkoroleva01"
              }
            }
          ]
        }
      },
      {
        "source": "a(CHEBI:\"EC 3.5.1.98 (histone deacetylase) inhibitor\")",
        "target": "cat(p(SFAM:\"HDAC Family\"))",
        "relation": "directlyDecreases",
        "directed": true,
        "label": "a(CHEBI:\"EC 3.5.1.98 (histone deacetylase) inhibitor\") directlyDecreases cat(p(SFAM:\"HDAC Family\"))",
        "metadata": {
          "edgeId": "524b3517d3fbfd4c34051978",
          "createdBy": "selventa",
          "casual": true,
          "evidences": [
            {
              "bel_statement": "a(CHEBI:\"EC 3.5.1.98 (histone deacetylase) inhibitor\") directlyDecreases cat(p(SFAM:\"HDAC Family\"))",
              "citation": {
                "type": "PubMed",
                "id": "19487460",
                "name": ""
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "human",
                "tissue": "",
                "cell": "fibroblast cells"
              },
              "summary_text": "The treatment of F-IPF with histone deacetylase (HDAC) inhibitors together with cytokines increased histone H3 and H4 acetylation.",
              "metadata": {
                "id": "54fe154589e3621524ac676d",
                "created_by": "susana.martinez.arbas"
              }
            },
            {
              "bel_statement": "a(CHEBI:\"EC 3.5.1.98 (histone deacetylase) inhibitor\") directlyDecreases cat(p(SFAM:\"HDAC Family\"))",
              "citation": {
                "type": "PubMed",
                "id": "0",
                "name": ""
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "metadata": {
                "id": "524b3521d3fbfd4c340621b2",
                "created_by": "selventa"
              }
            }
          ]
        }
      },
      {
        "source": "tscript(p(HGNC:CTNNB1))",
        "target": "p(HGNC:CCND1)",
        "relation": "directlyIncreases",
        "directed": true,
        "label": "tscript(p(HGNC:CTNNB1)) directlyIncreases p(HGNC:CCND1)",
        "metadata": {
          "edgeId": "524b3517d3fbfd4c34051979",
          "createdBy": "selventa",
          "casual": true,
          "evidences": [
            {
              "bel_statement": "tscript(p(HGNC:CTNNB1)) directlyIncreases p(HGNC:CCND1)",
              "citation": {
                "type": "PubMed",
                "id": "0",
                "name": ""
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "metadata": {
                "id": "524b3521d3fbfd4c3406205a",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "tscript(p(HGNC:CTNNB1)) directlyIncreases p(HGNC:CCND1)",
              "citation": {
                "type": "PubMed",
                "id": "17122440",
                "name": ""
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "human",
                "tissue": "vascular smooth muscle cell",
                "cell": ""
              },
              "summary_text": "In this study we have demonstrated that growth factors induce -catenin/TCF signaling in VSMCs and attenuation of -catenin/TCF signaling inhibits VSMC proliferation. Furthermore, inhibition of -catenin/TCF signaling reduces cyclin D1 expression and elevates p21 expression. We therefore conclude that VSMC proliferation is regulated by -catenin signaling, in part via the modulation of cyclin D1 and p21 -catenin/TCF signaling regulates cyclin D1 reporter activity and mRNA levels",
              "metadata": {
                "id": "52f7c09389e362056c25b4c7",
                "created_by": "ilyayudkevichstudent"
              }
            },
            {
              "bel_statement": "tscript(p(HGNC:CTNNB1)) directlyIncreases p(HGNC:CCND1)",
              "citation": {
                "type": "PubMed",
                "id": "22874762",
                "name": ""
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "human",
                "tissue": "vascular smooth muscle cells",
                "cell": ""
              },
              "summary_text": "In these cells, activation of Wnt/-catenin signaling was evidenced by the translocation of -catenin into the nucleus and the increase in the expression of direct target genes as cyclin D1, axin 2, and VCAN/versican.",
              "metadata": {
                "id": "52f7c11f89e362056c25c8ee",
                "created_by": "ilyayudkevichstudent"
              }
            },
            {
              "bel_statement": "tscript(p(HGNC:CTNNB1)) directlyIncreases p(HGNC:CCND1)",
              "citation": {
                "type": "PubMed",
                "id": "17693601",
                "name": ""
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "rat",
                "tissue": "tissue epithelial",
                "cell": ""
              },
              "summary_text": "We show in cultured explants that isolated activation of beta-catenin signaling in epithelial progenitors induces, in a TCF/Lef-dependent manner, a subset of the transcripts associated with epithelialization, including Pax8, cyclin D1 (Ccnd1) and Emx2.",
              "metadata": {
                "id": "52df0e4fbf21ca0a743fa7ae",
                "created_by": "gkoroleva01"
              }
            }
          ]
        }
      },
      {
        "source": "cat(p(HGNC:CHFR))",
        "target": "p(HGNC:CCNB1)",
        "relation": "decreases",
        "directed": true,
        "label": "cat(p(HGNC:CHFR)) decreases p(HGNC:CCNB1)",
        "metadata": {
          "edgeId": "524b3517d3fbfd4c3405197d",
          "createdBy": "selventa",
          "casual": true,
          "evidences": [
            {
              "bel_statement": "cat(p(HGNC:CHFR)) decreases p(HGNC:CCNB1)",
              "citation": {
                "type": "PubMed",
                "id": "15674323",
                "name": "Oncogene 2005 Apr 14 24(16) 2589-98"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "We conclude that the mechanism by which CHFR delays chromosome condensation involves inhibition of accumulation of Cyclin B1 in the nucleus.",
              "metadata": {
                "id": "524b3521d3fbfd4c3406210d",
                "created_by": "selventa"
              }
            }
          ]
        }
      },
      {
        "source": "cat(p(HGNC:CHFR))",
        "target": "p(HGNC:PLK1)",
        "relation": "decreases",
        "directed": true,
        "label": "cat(p(HGNC:CHFR)) decreases p(HGNC:PLK1)",
        "metadata": {
          "edgeId": "524b3517d3fbfd4c3405197e",
          "createdBy": "selventa",
          "casual": true,
          "evidences": [
            {
              "bel_statement": "cat(p(HGNC:CHFR)) decreases p(HGNC:PLK1)",
              "citation": {
                "type": "PubMed",
                "id": "19326084",
                "name": "Mol Cells. 2009 Mar 31;27(3):359-63. doi: 10.1007/s10059-009-0046-7. Epub 2009 Mar 19."
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "\"Chfr, a checkpoint with FHA and RING finger domains, plays an important role in cell cycle progression and tumor suppression. Chfr possesses the E3 ubiquitin ligase activity and stimulates the formation of polyubiquitin chains by Ub-conjugating enzymes, and induces the proteasome-dependent degradation of a number of cellular proteins, including Plk1 and Aurora A.\"",
              "metadata": {
                "id": "5476456f89e36208687302b4",
                "created_by": "alejandroferreiromorales.cr"
              }
            },
            {
              "bel_statement": "cat(p(HGNC:CHFR)) decreases p(HGNC:PLK1)",
              "citation": {
                "type": "PubMed",
                "id": "21245198",
                "name": "J Cell Sci. 2011 Feb 15;124(Pt 4):532-9. doi: 10.1242/jcs.079731. Epub 2011 Jan 18."
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "mouse",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "\"Mouse fibroblasts lacking Stil by genomic or RNA interference approaches, as well as E9.5 Stil(-/-) embryos, express high levels of the Chfr protein and reduced levels of the Chfr substrate Plk1\"",
              "metadata": {
                "id": "5476467589e36208687331a7",
                "created_by": "alejandroferreiromorales.cr"
              }
            },
            {
              "bel_statement": "cat(p(HGNC:CHFR)) decreases p(HGNC:PLK1)",
              "citation": {
                "type": "PubMed",
                "id": "14638868",
                "name": "Mol Cancer Res 2003 Nov 1(13) 959-69"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "The checkpoint protein CHFR implicated in degradation of Plk1 is involved in the regulation of Plk1 by PKB.",
              "metadata": {
                "id": "524b3521d3fbfd4c340622ab",
                "created_by": "selventa"
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:E2F4)",
        "target": "tscript(p(HGNC:E2F4))",
        "relation": "actsIn",
        "directed": true,
        "label": "p(HGNC:E2F4) actsIn tscript(p(HGNC:E2F4))",
        "metadata": {
          "edgeId": "524b3517d3fbfd4c3405197c",
          "createdBy": "selventa",
          "casual": false,
          "evidences": [
            {
              "bel_statement": "p(HGNC:E2F4) actsIn tscript(p(HGNC:E2F4))",
              "citation": {
                "type": "PubMed",
                "id": "9144170",
                "name": "Proc Natl Acad Sci U S A 1997 May 13 94(10) 4948-53"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "We show here that TGF-beta treatment of HaCaT cells induced the formation of E2F4-RB and E2F4-p107 complexes, which are capable of binding to E2F sites.",
              "metadata": {
                "id": "524b3521d3fbfd4c34061f36",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:E2F4) actsIn tscript(p(HGNC:E2F4))",
              "citation": {
                "type": "PubMed",
                "id": "11799067",
                "name": "Genes Dev 2002 Jan 15 16(2) 245-56"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": "Fibroblasts"
              },
              "summary_text": "researchers explored the possibility that E2F regulators play a broader role by identifying additional genes bound by E2F in living human cells the promoters of 127 genes were bound by the E2F4 transcription factor in primary fibroblasts a subset of these target was also bound by E2F1 need to somehow include that E2F4 and E2F5 usually are acting as repressors, in G0 and G1 and that their ability to be in the nucleus may depend on posttranslational modification, association with RB family members, or heterodimerization with DP2 E2F4 bound to living quiescent cells coincides with recruitment of p130, diminished acetylation of histones at the promoter and gene repression E2F4 and E2F5 could activate transcription under some circumstances, because E2F4 has been detected on certain mouse promoters in late G1/S phase",
              "metadata": {
                "id": "524b3521d3fbfd4c34062222",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:E2F4) actsIn tscript(p(HGNC:E2F4))",
              "citation": {
                "type": "PubMed",
                "id": "16179649",
                "name": "Nucleic Acids Res 2005 33(17) 5458-70"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "E2F1 and to a lesser extent E2F4 and E2F7 occupied the E2F8 promoter. In contrast to E2F1, E2F4 and E2F7 are considered to be repressors of transcription, their presence at the E2F8 promoter indicates that the promoter is regulated by both activating and repressing members of the E2F family.",
              "metadata": {
                "id": "524b3521d3fbfd4c340621d5",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:E2F4) actsIn tscript(p(HGNC:E2F4))",
              "citation": {
                "type": "PubMed",
                "id": "15033491",
                "name": "Biochem Biophys Res Commun 2004 Apr 9 316(3) 930-6"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "aurora B promoter activity was upregulated during M phase, and its cell cycle-dependent element (CDE) and cell cycle-gene homology region (CHR) upstream of the transcription initiation sites regulated the cell cycle-dependent promoter activity. binding of E2F-1, E2F-4, and DP-2, but not of DP-1, to the CDE was detected.",
              "metadata": {
                "id": "524b3521d3fbfd4c340621b6",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:E2F4) actsIn tscript(p(HGNC:E2F4))",
              "citation": {
                "type": "PubMed",
                "id": "16861343",
                "name": "Blood 2006 Aug 1 108(3) 886-95"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Mouse",
                "tissue": "",
                "cell": "erythroid progenitor"
              },
              "summary_text": "Consistent with these observations, cDNA microarray analysis reveals cell cycle control genes as one of the major class of genes down-regulated in E2f4(-/-) FLs, and we provide evidence that E2f4 may directly regulate the transcriptional expression of a number of these genes. We conclude that the macrocytic anemia of E2f4(-/-) mice results primarily from impaired cellular proliferation and that the major role of E2f4 in fetal erythropoiesis is to promote cell cycle progression and cellular proliferation.",
              "metadata": {
                "id": "524b3521d3fbfd4c34062108",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:E2F4) actsIn tscript(p(HGNC:E2F4))",
              "citation": {
                "type": "PubMed",
                "id": "15195143",
                "name": "Oncogene 2004 Aug 19 23(37) 6250-60"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "E2F4 accumulated on the MCM10 and TopBP1 promoters. Our data suggest a model in which UV irradiation-induced DNA damage depends, at least in part, on the accumulation of the E2F4 transcription factor on the MCM10 and TopBP1 promoters, which results in suppression of DNA replication.",
              "metadata": {
                "id": "524b3521d3fbfd4c340620d8",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:E2F4) actsIn tscript(p(HGNC:E2F4))",
              "citation": {
                "type": "PubMed",
                "id": "12150994",
                "name": "Cell 2002 Jul 12 110(1) 19-32"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": "Epithelial Cells"
              },
              "summary_text": "A complex containing Smad3, the transcription factors E2F4/5 and DP1, and the corepressor p107 preexists in the cytoplasm. In response to TGFbeta, this complex moves into the nucleus and associates with Smad4, recognizing a composite Smad-E2F site on c-myc for repression",
              "metadata": {
                "id": "524b3521d3fbfd4c34062046",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:E2F4) actsIn tscript(p(HGNC:E2F4))",
              "citation": {
                "type": "PubMed",
                "id": "16530485",
                "name": "Trends Mol Med 2006 Apr 12(4) 177-85"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "All E2F proteins except E2F7 and E2F8 function in heterodimeric complexes with proteins of the E2F dimerization protein (DP) family (DP1, DP2, DP3 and DP4). E2F3 is important for the control of cellular proliferation, whereas E2F4 and E2F5 are essential for control of the G1 phase and cell-cycle exit, and for normal mouse development.",
              "metadata": {
                "id": "524b3521d3fbfd4c3406202b",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:E2F4) actsIn tscript(p(HGNC:E2F4))",
              "citation": {
                "type": "PubMed",
                "id": "21247883",
                "name": "Nucleic Acids Res 2011 May 39(9) 3558-73"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "The binding of the E2F4-RBL2 complex to E2F4 responsive promoters triggers the recruitment of HDAC complexes or other co-repressors, resulting in the repression of target gene expression",
              "metadata": {
                "id": "524b3521d3fbfd4c34061fe1",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:E2F4) actsIn tscript(p(HGNC:E2F4))",
              "citation": {
                "type": "PubMed",
                "id": "15225871",
                "name": "Gene 2004 Jul 7 336(1) 1-13"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Mouse",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "The interaction of RB and E2F transcription factors represents a functional interaction that has been the predominant focus in the field. RB and the related family members p107 and p130 can each bind E2F to repress genes that are otherwise important for progression from G1 to S phase. The binding of RB, p107, or p130 has two simultaneous consequences: (1) binding prevents E2F from interacting with transcriptional co-activators (e.g., p300); and (2) binding recruits chromatin-modifying enzymes [e.g., histone deacetylases (HDACs)] to silence transcription. E2F itself is a family of transcription factors that include six E2F and three DP proteins, which together form the heterodimeric complex that comprises E2F transcriptional activity (reviewed in Trimarchi and Lees, 2002 and Yee and Wang, 2003). While there is considerable complexity, gene repression in G1 phase utilizes RB and E2Fs 1, 2, 3, and 4, while gene repression in G0 utilizes primarily p130 and E2Fs 4 and 5. binding prevents E2F from interacting with transcriptional co-activators (e.g., p300); and",
              "metadata": {
                "id": "524b3521d3fbfd4c34061fd8",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:E2F4) actsIn tscript(p(HGNC:E2F4))",
              "citation": {
                "type": "PubMed",
                "id": "16144839",
                "name": "J Biol Chem 2005 Nov 11 280(45) 37319-30"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Mouse",
                "tissue": "",
                "cell": "osteoblast"
              },
              "summary_text": "Statistical analysis revealed a cluster of genes that were strongly down-regulated by 1,25(OH)(2)D(3) and which not only function in cell cycle regulation and DNA replication but also mediate checkpoint control, DNA repair, chromosome modifications, and mitosis. Because many of these genes were shown earlier to be regulated by the transcriptional repressor E2F4, the intergenic regions of these 1,25(OH)(2)D(3)-down-regulated genes were searched for the presence of E2F binding sites. This led to the characterization of two novel E2F target genes, chromosome condensation-related SMC-associated protein 1 (Cnap1) and maternal embryonic leucine zipper kinase (Melk).",
              "metadata": {
                "id": "524b3521d3fbfd4c34061f62",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:E2F4) actsIn tscript(p(HGNC:E2F4))",
              "citation": {
                "type": "PubMed",
                "id": "10983977",
                "name": "Mol Cell 2000 Aug 6(2) 293-306"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Mouse",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "We have generated mice deficient in E2F4 activity, we observed a deficiency of various mature hematopoietic cell types together with an increased number of immature cells in several lineages.",
              "metadata": {
                "id": "524b3521d3fbfd4c34061f2f",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:E2F4) actsIn tscript(p(HGNC:E2F4))",
              "citation": {
                "type": "PubMed",
                "id": "18830406",
                "name": "PLoS One 2008 3(10) e3316"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "In human pulmonary epithelial cells, exposure to CSE or histone deacetylase (HDAC) inhibitor rapidly induced autophagy. CSE decreased HDAC activity, resulting in increased binding of early growth response-1 (Egr-1) and E2F factors to the autophagy gene LC3B promoter, and increased LC3B expression. Knockdown of E2F-4 or Egr-1 inhibited CSE-induced LC3B expression. Knockdown of Egr-1 also inhibited the expression of Atg4B, a critical factor for LC3B conversion. Inhibition of autophagy by LC3B-knockdown protected epithelial cells from CSE-induced apoptosis. Egr-1(-/-) mice, which displayed basal airspace enlargement, resisted cigarette-smoke induced autophagy, apoptosis, and emphysema.",
              "metadata": {
                "id": "524b3521d3fbfd4c340622a1",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:E2F4) actsIn tscript(p(HGNC:E2F4))",
              "citation": {
                "type": "PubMed",
                "id": "15855772",
                "name": "Dev Neurosci 2004 26(5-6) 435-45"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Mouse",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "In both the E2F3a and E2F4 transgenic lenses, cyclin A2 and cyclin B1 expression were upregulated. E2F3a and E2F4, but not E2F5, function to induce cell cycle entry, although E2F4 has more modest activity.",
              "metadata": {
                "id": "524b3521d3fbfd4c34062248",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:E2F4) actsIn tscript(p(HGNC:E2F4))",
              "citation": {
                "type": "PubMed",
                "id": "9724731",
                "name": "Proc Natl Acad Sci U S A 1998 Sep 1 95(18) 10493-8"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "p107- or p130-induced repression of E2F4 (p107 = RBL1, p130 = RBL2)",
              "metadata": {
                "id": "524b3521d3fbfd4c34062220",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:E2F4) actsIn tscript(p(HGNC:E2F4))",
              "citation": {
                "type": "PubMed",
                "id": "10436023",
                "name": "Mol Biol Cell 1999 Aug 10(8) 2703-34"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "<E7> E2F-DP dimers, complexed with pRb, p107, or p130, can bind and inhibit E2 promoter elements (Dyson, 1998; Mayol and Grana, 1998). In quiescent cells, the predominant complexes contain E2F4 and p130. E2F1_DP:RB1-|taof(E2F1_DP) E2F2_DP:RB1-|taof(E2F2_DP) E2F3_DP:RB1-|taof(E2F3_DP) E2F4_DP:RB1-|taof(E2F4_DP) E2F1_DP:RBL1-|taof(E2F1_DP) E2F2_DP:RBL1-|taof(E2F2_DP) E2F3_DP:RBL1-|taof(E2F3_DP) E2F4_DP:RBL1-|taof(E2F4_DP) E2F1_DP:NOLC1-|taof(E2F1_DP) E2F2_DP:NOLC1-|taof(E2F2_DP) E2F3_DP:NOLC1-|taof(E2F3_DP) E2F4_DP:NOLC1-|taof(E2F4_DP)",
              "metadata": {
                "id": "524b3521d3fbfd4c3406221a",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:E2F4) actsIn tscript(p(HGNC:E2F4))",
              "citation": {
                "type": "PubMed",
                "id": "11689553",
                "name": "J Biol Chem 2002 Jan 4 277(1) 854-61"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "TGF-beta signaling did not compete with E2F-4 for binding to TIE/E2F, but reduced p300 co-immunoprecipitating with E2F-4. Therefore, TGF-beta signaling may suppress c-myc promoter activity by dissociating p300 from E2F-4.",
              "metadata": {
                "id": "524b3521d3fbfd4c3406220f",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:E2F4) actsIn tscript(p(HGNC:E2F4))",
              "citation": {
                "type": "PubMed",
                "id": "14688249",
                "name": "J Biol Chem 2004 Mar 12 279(11) 10796-807"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Mouse",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Here, we demonstrate that the S phase-specific transcription of the mouse R2 gene is dependent on an upstream promoter activating region (located at nucleotides (nt) -672 to -527 from the transcription start site) and one proximal promoter repressive element (located at nt -112 to -107) that binds E2F4.",
              "metadata": {
                "id": "524b3521d3fbfd4c34062208",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:E2F4) actsIn tscript(p(HGNC:E2F4))",
              "citation": {
                "type": "PubMed",
                "id": "8643455",
                "name": "Proc Natl Acad Sci U S A 1996 May 14 93(10) 4633-7"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "p107 interacts with and modulates the activity of the transcription factor, E2F-4.",
              "metadata": {
                "id": "524b3521d3fbfd4c3406227d",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:E2F4) actsIn tscript(p(HGNC:E2F4))",
              "citation": {
                "type": "PubMed",
                "id": "17328667",
                "name": "DNA Cell Biol 2007 Feb 26(2) 91-9"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Among the members of the E2F family, E2F1 to E2F5, but not E2F6, activated the ASF1B reporter construct.",
              "metadata": {
                "id": "524b3521d3fbfd4c34062163",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:E2F4) actsIn tscript(p(HGNC:E2F4))",
              "citation": {
                "type": "PubMed",
                "id": "15936277",
                "name": "Curr Biol 2005 Jun 7 15(11) 1051-7"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Mouse",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "TUBA3-like target-gene repression essentially depends on E2F6, whereas the loss of E2F6 can be compensated for by E2F4 in the repression of the Cdc6 gene",
              "metadata": {
                "id": "524b3521d3fbfd4c3406215c",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:E2F4) actsIn tscript(p(HGNC:E2F4))",
              "citation": {
                "type": "PubMed",
                "id": "16878159",
                "name": "Oncogene 2006 Dec 14 25(59) 7703-13"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Mouse",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Subsets of E2Fs were specifically bound to the Dmp1 promoter upon mitogenic signaling and E2Fs 1-4 inhibited the Dmp1 promoter in a reporter assay.",
              "metadata": {
                "id": "524b3521d3fbfd4c340620b1",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:E2F4) actsIn tscript(p(HGNC:E2F4))",
              "citation": {
                "type": "PubMed",
                "id": "11799066",
                "name": "Genes Dev 2002 Jan 15 16(2) 235-44"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "table 1 - E2F targets identified by ChIP-CpG microarray analysis",
              "metadata": {
                "id": "524b3521d3fbfd4c340620a6",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:E2F4) actsIn tscript(p(HGNC:E2F4))",
              "citation": {
                "type": "PubMed",
                "id": "17507799",
                "name": "Cell Cycle 2007 May 6(10) 1147-52"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "It was recently demonstrated that by interacting with p130, E2F4 is present in the nuclei and plays a key role in the maintenance of this stable G2 arrest. Increased E2F4 levels and its translocation to the nucleus following genotoxic stress result in downregulation of many mitotic genes and as a result promote a G0-like state.",
              "metadata": {
                "id": "524b3521d3fbfd4c3406209e",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:E2F4) actsIn tscript(p(HGNC:E2F4))",
              "citation": {
                "type": "PubMed",
                "id": "11030352",
                "name": "Mol Cell 2000 Sep 6(3) 729-35"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Thus, E2F4 and E2F5 are dispensable for cell cycle progression but necessary for pocket protein-mediated G1 arrest of cycling cells",
              "metadata": {
                "id": "524b3521d3fbfd4c34061f4b",
                "created_by": "selventa"
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:CHFR)",
        "target": "p(HGNC:CCNB1)",
        "relation": "decreases",
        "directed": true,
        "label": "p(HGNC:CHFR) decreases p(HGNC:CCNB1)",
        "metadata": {
          "edgeId": "54764d4b89e362086873c11a",
          "createdBy": "alejandroferreiromorales.cr",
          "casual": false,
          "evidences": [
            {
              "bel_statement": "p(HGNC:CHFR) decreases p(HGNC:CCNB1)",
              "citation": {
                "type": "PubMed",
                "id": "15674323",
                "name": "Oncogene. 2005 Apr 14;24(16):2589-98."
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "\"Ectopic expression of Cyclin B1 with a mutant nuclear export sequence induced chromosome condensation, and thus overcame the CHFR checkpoint. We conclude that the mechanism by which CHFR delays chromosome condensation involves inhibition of accumulation of Cyclin B1 in the nucleus.\"",
              "metadata": {
                "id": "54764d4b89e362086873c0c6",
                "created_by": "alejandroferreiromorales.cr"
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:CHFR)",
        "target": "p(HGNC:PLK1)",
        "relation": "directlyDecreases",
        "directed": true,
        "label": "p(HGNC:CHFR) directlyDecreases p(HGNC:PLK1)",
        "metadata": {
          "edgeId": "5476501b89e3620868759245",
          "createdBy": "alejandroferreiromorales.cr",
          "casual": false,
          "evidences": [
            {
              "bel_statement": "p(HGNC:CHFR) directlyDecreases p(HGNC:PLK1)",
              "citation": {
                "type": "PubMed",
                "id": "11807090",
                "name": "J Cell Biol. 2002 Jan 21;156(2):249-59. Epub 2002 Jan 21."
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "\" The Chfr-mediated cell cycle delay requires ubiquitin-dependent protein degradation, because inactivating mutations in Chfr, interference with poly-ubiquitination, and inhibition of proteasomes all abolish this delay in mitotic entry. The direct target of the Chfr pathway is Polo-like kinase 1 (Plk1). Ubiquitination of Plk1 by Chfr delays the activation of the Cdc25C phosphatase and the inactivation of the Wee1 kinase, leading to a delay in Cdc2 activation.\"",
              "metadata": {
                "id": "5476501b89e36208687591ef",
                "created_by": "alejandroferreiromorales.cr"
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:CHFR)",
        "target": "kin(p(HGNC:CDK1))",
        "relation": "decreases",
        "directed": true,
        "label": "p(HGNC:CHFR) decreases kin(p(HGNC:CDK1))",
        "metadata": {
          "edgeId": "547651ae89e3620868759715",
          "createdBy": "alejandroferreiromorales.cr",
          "casual": false,
          "evidences": [
            {
              "bel_statement": "p(HGNC:CHFR) decreases kin(p(HGNC:CDK1))",
              "citation": {
                "type": "PubMed",
                "id": "15187257",
                "name": "Methods Mol Biol. 2004;280:229-43."
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "\"We showed that Chfr is a ubiquitin ligase that targets polo-like kinase (Plk1) for degradation, leading to delayed activation of the Cdc25C phosphatase and prolonged inhibitory phosphorylation of Cdc2 at the G2/M transition.\"",
              "metadata": {
                "id": "5491ad4b89e3620efc2a1e7c",
                "created_by": "alejandroferreiromorales.cr"
              }
            },
            {
              "bel_statement": "p(HGNC:CHFR) decreases kin(p(HGNC:CDK1))",
              "citation": {
                "type": "PubMed",
                "id": "11807090",
                "name": "J Cell Biol. 2002 Jan 21;156(2):249-59. Epub 2002 Jan 21."
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "\"Ubiquitination of Plk1 by Chfr delays the activation of the Cdc25C phosphatase and the inactivation of the Wee1 kinase, leading to a delay in Cdc2 activation\"",
              "metadata": {
                "id": "547651ae89e36208687596bd",
                "created_by": "alejandroferreiromorales.cr"
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:CHFR)",
        "target": "cat(p(HGNC:CHFR))",
        "relation": "actsIn",
        "directed": true,
        "label": "p(HGNC:CHFR) actsIn cat(p(HGNC:CHFR))",
        "metadata": {
          "edgeId": "524b3517d3fbfd4c34051970",
          "createdBy": "selventa",
          "casual": false,
          "evidences": [
            {
              "bel_statement": "p(HGNC:CHFR) actsIn cat(p(HGNC:CHFR))",
              "citation": {
                "type": "PubMed",
                "id": "14638868",
                "name": "Mol Cancer Res 2003 Nov 1(13) 959-69"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "The checkpoint protein CHFR implicated in degradation of Plk1 is involved in the regulation of Plk1 by PKB.",
              "metadata": {
                "id": "524b3521d3fbfd4c34062111",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CHFR) actsIn cat(p(HGNC:CHFR))",
              "citation": {
                "type": "PubMed",
                "id": "15674323",
                "name": "Oncogene 2005 Apr 14 24(16) 2589-98"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "We conclude that the mechanism by which CHFR delays chromosome condensation involves inhibition of accumulation of Cyclin B1 in the nucleus.",
              "metadata": {
                "id": "524b3521d3fbfd4c34061f01",
                "created_by": "selventa"
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:RASSF1)",
        "target": "p(HGNC:CCND1)",
        "relation": "decreases",
        "directed": true,
        "label": "p(HGNC:RASSF1) decreases p(HGNC:CCND1)",
        "metadata": {
          "edgeId": "524b3517d3fbfd4c3405198a",
          "createdBy": "selventa",
          "casual": true,
          "evidences": [
            {
              "bel_statement": "p(HGNC:RASSF1) decreases p(HGNC:CCND1)",
              "citation": {
                "type": "PubMed",
                "id": "15867363",
                "name": "Cancer Res 2005 May 1 65(9) 3682-90"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "As shown in Fig. 1B, the exogenous expression of RASSF1A inhibited the phosphorylation of c-Jun and reduced the expression of Cyclin D1.",
              "metadata": {
                "id": "524b3521d3fbfd4c3406224e",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:RASSF1) decreases p(HGNC:CCND1)",
              "citation": {
                "type": "PubMed",
                "id": "19160099",
                "name": "Cancer Invest. 2009 May;27(4):459-65. doi: 10.1080/07357900802620828."
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "\"RASSF1A induces cell cycle arrest through inhibition of cyclin D1 accumulation.\"",
              "metadata": {
                "id": "547613f789e36208686d2a8b",
                "created_by": "alejandroferreiromorales.cr"
              }
            },
            {
              "bel_statement": "p(HGNC:RASSF1) decreases p(HGNC:CCND1)",
              "citation": {
                "type": "PubMed",
                "id": "12024041",
                "name": "Mol Cell Biol 2002 Jun 22(12) 4309-18"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "Epithelium",
                "cell": ""
              },
              "summary_text": "RNA interference-mediated downregulation of endogenous RASSF1A expression in human epithelial cells results in abnormal accumulation of cyclin D1 protein",
              "metadata": {
                "id": "524b3521d3fbfd4c34062288",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:RASSF1) decreases p(HGNC:CCND1)",
              "citation": {
                "type": "PubMed",
                "id": "15867363",
                "name": "Cancer Res 2005 May 1 65(9) 3682-90"
              },
              "experiment_context": {
                "disease": "Lung Neoplasms",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "The exogenous expression of RASSF1A suppressed JNK phosphorylation, and cells stably transfected with RASSF1A showed reduced JNK and c-Jun phosphorylation and Cyclin D1 down-regulation. An in vitro kinase assay showed that the exogenous expression of RASSF1A inhibited JNK activity and that JNK activity suppression due to ectopically expressed RASSF1A was revived by RASSF1A siRNA treatment.",
              "metadata": {
                "id": "524b3521d3fbfd4c34062166",
                "created_by": "selventa"
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:DKK1)",
        "target": "p(HGNC:WNT5A)",
        "relation": "decreases",
        "directed": true,
        "label": "p(HGNC:DKK1) decreases p(HGNC:WNT5A)",
        "metadata": {
          "edgeId": "524b3517d3fbfd4c34051972",
          "createdBy": "selventa",
          "casual": true,
          "evidences": [
            {
              "bel_statement": "p(HGNC:DKK1) decreases p(HGNC:WNT5A)",
              "citation": {
                "type": "PubMed",
                "id": "0",
                "name": ""
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "metadata": {
                "id": "524b3521d3fbfd4c34061fbd",
                "created_by": "selventa"
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:DKK1)",
        "target": "p(SFAM:\"WNT Family\")",
        "relation": "decreases",
        "directed": true,
        "label": "p(HGNC:DKK1) decreases p(SFAM:\"WNT Family\")",
        "metadata": {
          "edgeId": "524b3517d3fbfd4c34051971",
          "createdBy": "selventa",
          "casual": true,
          "evidences": [
            {
              "bel_statement": "p(HGNC:DKK1) decreases p(SFAM:\"WNT Family\")",
              "citation": {
                "type": "PubMed",
                "id": "25369286",
                "name": "plos one. 2014 nov 4;9(11):e111703. doi: 10.1371/journal.pone.0111703. ecollection 2014."
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Dickkopf-1 (DKK1) is a potent inhibitor of Wnt signalling, which exerts anabolic effects on bone and also takes part in the regulation of vascular cells. Our aims were to evaluate serum DKK1 in type 2 diabetes (T2DM) patients and to analyze its relationships with cardiovascular disease (CVD). We also evaluated the relationship between DKK1 and bone metabolism.",
              "metadata": {
                "id": "54e12cc689e362035c315133",
                "created_by": "davidgaralf"
              }
            },
            {
              "bel_statement": "p(HGNC:DKK1) decreases p(SFAM:\"WNT Family\")",
              "citation": {
                "type": "PubMed",
                "id": "25318560",
                "name": "Nat Commun. 2014 Oct 16;5:4992. doi: 10.1038/ncomms5992."
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "mouse",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Here we demonstrate that deficient Wnt signalling elicits synaptic degeneration in the adult striatum. Inducible expression of the secreted Wnt antagonist Dickkopf1 (Dkk1) in adult mice (iDkk1) decreases the number of cortico-striatal glutamatergic synapses and of D1 and D2 dopamine receptor clusters.",
              "metadata": {
                "id": "5489f41189e36205849ee8b5",
                "created_by": "alejandroferreiromorales.cr"
              }
            },
            {
              "bel_statement": "p(HGNC:DKK1) decreases p(SFAM:\"WNT Family\")",
              "citation": {
                "type": "PubMed",
                "id": "25479004",
                "name": "Gene Expr Patterns. 2014 Dec 2. pii: S1567-133X(14)00124-0. doi: 10.1016/j.gep.2014.11.002. [Epub ahead of print]"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Differential expression of canonical (-catenin, Wnt-4, Lrp4, Lrp6) and noncanonical Wnt signaling (Wnt-5b, Wnt-11) and their inhibitors (Dkk1, Axin1, sFRP3, sFRP5, Wif-1) surrounding the cartilage canals and osteochondral junction provides evidence of the complex interactions occurring during endochondral ossification.",
              "metadata": {
                "id": "5489f1dd89e36205849ed3d4",
                "created_by": "alejandroferreiromorales.cr"
              }
            },
            {
              "bel_statement": "p(HGNC:DKK1) decreases p(SFAM:\"WNT Family\")",
              "citation": {
                "type": "PubMed",
                "id": "25436422",
                "name": "FEBS Lett. 2014 Nov 28. pii: S0014-5793(14)00828-X. doi: 10.1016/j.febslet.2014.11.023. [Epub ahead of print]"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Dickkopf1 (DKK1), a canonical Wnt/-catenin pathway antagonist, is closely associated with cardiovascular disease and adipogenesis.",
              "metadata": {
                "id": "5489f36189e36205849edcd1",
                "created_by": "alejandroferreiromorales.cr"
              }
            },
            {
              "bel_statement": "p(HGNC:DKK1) decreases p(SFAM:\"WNT Family\")",
              "citation": {
                "type": "PubMed",
                "id": "25472052",
                "name": "Reprod Fertil Dev. 2014 Dec;27(1):94. doi: 10.1071/RDv27n1Ab3."
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Successful embryonic development depends upon molecules secreted by the reproductive tract. Among such molecules is the protein dickkopf 1 (DKK1), an antagonist of canonical WNT signalling that can also activate the noncanonical, planar cell polarity (PCP) pathway.",
              "metadata": {
                "id": "5489f29989e36205849ed838",
                "created_by": "alejandroferreiromorales.cr"
              }
            },
            {
              "bel_statement": "p(HGNC:DKK1) decreases p(SFAM:\"WNT Family\")",
              "citation": {
                "type": "PubMed",
                "id": "25369286",
                "name": "PLoS One. 2014 Nov 4;9(11):e111703. doi: 10.1371/journal.pone.0111703. eCollection 2014."
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "\"Dickkopf-1 (DKK1) is a potent inhibitor of Wnt signalling, which exerts anabolic effects on bone and also takes part in the regulation of vascular cells. \"",
              "metadata": {
                "id": "5476186189e3620868704bcf",
                "created_by": "alejandroferreiromorales.cr"
              }
            },
            {
              "bel_statement": "p(HGNC:DKK1) decreases p(SFAM:\"WNT Family\")",
              "citation": {
                "type": "PubMed",
                "id": "19351856",
                "name": "Cancer Res 2009 Apr 15 69(8) 3570-8"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "knockdown of Dkk-1 activated Wnt signaling and significantly up-regulated Wnt5a in lung cancer cells",
              "metadata": {
                "id": "524b3521d3fbfd4c34061eed",
                "created_by": "selventa"
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:DNMT1)",
        "target": "cat(p(HGNC:DNMT1))",
        "relation": "actsIn",
        "directed": true,
        "label": "p(HGNC:DNMT1) actsIn cat(p(HGNC:DNMT1))",
        "metadata": {
          "edgeId": null,
          "createdBy": null,
          "casual": null,
          "evidences": [

          ]
        }
      },
      {
        "source": "p(HGNC:DNMT1)",
        "target": "p(HGNC:VEGFA)",
        "relation": "increases",
        "directed": true,
        "label": "p(HGNC:DNMT1) increases p(HGNC:VEGFA)",
        "metadata": {
          "edgeId": "524b3517d3fbfd4c34051981",
          "createdBy": "selventa",
          "casual": true,
          "evidences": [
            {
              "bel_statement": "p(HGNC:DNMT1) increases p(HGNC:VEGFA)",
              "citation": {
                "type": "PubMed",
                "id": "17934516",
                "name": "Oncogene. 2008 Apr 3;27(15):2187-97. Epub 2007 Oct 15."
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "\"Co-immunoprecipitation experiments showed that ICBP90 and DNMT1 are present in the same molecular complex, which was further confirmed by co-localization experiments as assessed by immunocytochemistry. Downregulation of ICBP90 and DNMT1 decreased VEGF gene expression, a major pro-angiogenic factor, whereas those of p16(INK4A) gene and RB1 gene were significantly enhanced. Together, these results indicate that DNMT1 and ICBP90 are involved in VEGF gene expression\"",
              "metadata": {
                "id": "5474c50889e36203f08f5403",
                "created_by": "alejandroferreiromorales.cr"
              }
            },
            {
              "bel_statement": "p(HGNC:DNMT1) increases p(HGNC:VEGFA)",
              "citation": {
                "type": "PubMed",
                "id": "",
                "name": "DNMT1 Stability Is Regulated by Proteins Coordinating Deubiquitination and Acetylation-Driven Ubiquitination\nZhanwen Du, Jing Song, Yong Wang, Yiqing Zhao, Kishore Guda, Shuming Yang, Hung-Ying Kao, Yan Xu, Joseph Willis, Sanford D. Markowitz, David Sedwick, Robert M. Ewing, Zhenghe Wang\nSci Signal. Author manuscript; available in PMC 2011 June 16.\nPublished in final edited form as: Sci Signal. 2010 November 2; 3(146): ra80. Published online 2010 November 2. doi: 10.1126/scisignal.2001462\nPMCID: PMC3116231"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "The interaction of the SRA domain of ICBP90 with a novel domain of DNMT1 is involved in the regulation of VEGF gene expression.",
              "metadata": {
                "id": "5448d02b89e3620aecf44622",
                "created_by": "borislav.simovic"
              }
            },
            {
              "bel_statement": "p(HGNC:DNMT1) increases p(HGNC:VEGFA)",
              "citation": {
                "type": "PubMed",
                "id": "0",
                "name": ""
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "metadata": {
                "id": "524b3521d3fbfd4c340620a4",
                "created_by": "selventa"
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:DNMT1)",
        "target": "p(HGNC:RB1)",
        "relation": "decreases",
        "directed": true,
        "label": "p(HGNC:DNMT1) decreases p(HGNC:RB1)",
        "metadata": {
          "edgeId": "524b3517d3fbfd4c34051983",
          "createdBy": "selventa",
          "casual": true,
          "evidences": [
            {
              "bel_statement": "p(HGNC:DNMT1) decreases p(HGNC:RB1)",
              "citation": {
                "type": "PubMed",
                "id": "19539327",
                "name": "J Urol. 2009 Aug;182(2):756-61. doi: 10.1016/j.juro.2009.03.082. Epub 2009 Jun 18."
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "\"Our data showed that DNMT1 loss dramatically decreased cell proliferation but significantly increased cell migratory and invasive potential. Additionally, in the limited set of genes whose expression and DNA methylation status were determined DNMT1 loss was associated with increased CDKN3 and claudin-3 expression, and also culminated in specific demethylation of Rb1 and RAR-beta promoters.\"",
              "metadata": {
                "id": "5474c68b89e36203f08f66e2",
                "created_by": "alejandroferreiromorales.cr"
              }
            },
            {
              "bel_statement": "p(HGNC:DNMT1) decreases p(HGNC:RB1)",
              "citation": {
                "type": "PubMed",
                "id": "0",
                "name": ""
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "metadata": {
                "id": "524b3521d3fbfd4c34061fe9",
                "created_by": "selventa"
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:DNMT1)",
        "target": "p(HGNC:CDKN2A)",
        "relation": "decreases",
        "directed": true,
        "label": "p(HGNC:DNMT1) decreases p(HGNC:CDKN2A)",
        "metadata": {
          "edgeId": "524b3517d3fbfd4c34051982",
          "createdBy": "selventa",
          "casual": true,
          "evidences": [
            {
              "bel_statement": "p(HGNC:DNMT1) decreases p(HGNC:CDKN2A)",
              "citation": {
                "type": "PubMed",
                "id": "19667129",
                "name": ""
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "human",
                "tissue": "tissue  human lung diploid fibroblasts",
                "cell": "cell  tig-3"
              },
              "summary_text": "These results provide compelling evidence that DNA damage provokes p16Ink4a gene expression, at least partly, through blocking the levels of DNMT1 gene expression by elevated levels of ROS.",
              "metadata": {
                "id": "52df0fb7bf21ca0a743fa893",
                "created_by": "gkoroleva01"
              }
            },
            {
              "bel_statement": "p(HGNC:DNMT1) decreases p(HGNC:CDKN2A)",
              "citation": {
                "type": "PubMed",
                "id": "20157424",
                "name": ""
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "mouse",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "DNA damage response regulates p16INK4a gene expression through DNMT1",
              "metadata": {
                "id": "52d5f862bf21ca08f0812d66",
                "created_by": "gkoroleva01"
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:EGR1)",
        "target": "p(HGNC:E2F4)",
        "relation": "association",
        "directed": true,
        "label": "p(HGNC:EGR1) association p(HGNC:E2F4)",
        "metadata": {
          "edgeId": "5525711889e36205c497337b",
          "createdBy": "susana.martinez.arbas",
          "casual": false,
          "evidences": [
            {
              "bel_statement": "p(HGNC:EGR1) association p(HGNC:E2F4)",
              "citation": {
                "type": "PubMed",
                "id": "18830406",
                "name": ""
              },
              "experiment_context": {
                "disease": "COPD",
                "species_common_name": "human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "E2F-4 formed a complex with Egr-1 following cellular stimulation with CSE or the HDAC inhibitor TSA (Fig. 6C).",
              "metadata": {
                "id": "5525711889e36205c49732ce",
                "created_by": "susana.martinez.arbas"
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:EGR1)",
        "target": "tscript(p(HGNC:EGR1))",
        "relation": "actsIn",
        "directed": true,
        "label": "p(HGNC:EGR1) actsIn tscript(p(HGNC:EGR1))",
        "metadata": {
          "edgeId": "524b3517d3fbfd4c3405196d",
          "createdBy": "selventa",
          "casual": false,
          "evidences": [
            {
              "bel_statement": "p(HGNC:EGR1) actsIn tscript(p(HGNC:EGR1))",
              "citation": {
                "type": "PubMed",
                "id": "12571843",
                "name": "Arthritis Rheum 2003 Feb 48(2) 348-59"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Modified assertion",
              "metadata": {
                "id": "524b3521d3fbfd4c34061f23",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:EGR1) actsIn tscript(p(HGNC:EGR1))",
              "citation": {
                "type": "PubMed",
                "id": "10984481",
                "name": "J Biol Chem 2000 Dec 8 275(49) 38524-31"
              },
              "experiment_context": {
                "disease": "Neoplasms",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Lysates from LAPC4 cells infected with Ad-EGR1 observed EGR1 expression which leads to the fold induction of  the Connexin 26 gene by 9.0+/-0.1",
              "metadata": {
                "id": "524b3521d3fbfd4c3406203c",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:EGR1) actsIn tscript(p(HGNC:EGR1))",
              "citation": {
                "type": "PubMed",
                "id": "11756172",
                "name": "Blood 2002 Jan 1 99(1) 199-206"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": "umbilical vein endothelial cell"
              },
              "summary_text": "Together, the results demonstrate that OxPAPC induces TF expression in HUVECs through activation of PKC/ERK/EGR-1 and Ca(++)/calcineurin/NFAT pathways rather than by NF-kappa B-mediated transcription",
              "metadata": {
                "id": "524b3521d3fbfd4c340620e7",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:EGR1) actsIn tscript(p(HGNC:EGR1))",
              "citation": {
                "type": "PubMed",
                "id": "12556466",
                "name": "J Biol Chem 2003 Apr 4 278(14) 11802-10"
              },
              "experiment_context": {
                "disease": "Neoplasms",
                "species_common_name": "Mouse",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "mouse genes up-regulated by Egr1",
              "metadata": {
                "id": "524b3521d3fbfd4c34061f88",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:EGR1) actsIn tscript(p(HGNC:EGR1))",
              "citation": {
                "type": "PubMed",
                "id": "16912034",
                "name": "J Biol Chem 2006 Oct 13 281(41) 30479-84"
              },
              "experiment_context": {
                "disease": "neuroblastoma",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Differential transcriptional regulation of EGR-1 and Smad3/4 by GSK-3 isoforms was also confirmed using isoform-specific siRNA and dominant negative mutants in human neuroblastoma SH-SY5Y cells (Fig. 4C) and further suggests that the opposite effects of these two isoforms in regulating transcription factors are not unique to cortical neurons.",
              "metadata": {
                "id": "524b3521d3fbfd4c3406208d",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:EGR1) actsIn tscript(p(HGNC:EGR1))",
              "citation": {
                "type": "PubMed",
                "id": "16912034",
                "name": "J Biol Chem 2006 Oct 13 281(41) 30479-84"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Rat",
                "tissue": "",
                "cell": "neuron"
              },
              "summary_text": "Moreover, protein-DNA array studies identified two novel GSK-3-regulated transcription factors, early growth response 1 and Smad3/4, which were oppositely affected by GSK-3alpha or GSK-3beta silencing or inhibition Binding activity of EGR-1-responsive element with EGR-1 was down-regulated by transfection with siRNA for GSK-3{alpha} but up-regulated by siRNA for GSK-3beta compared with the non-targeting siRNA control. Luciferase reporter assays confirmed that the transcriptional activity of EGR-1 was decreased by GSK-3{alpha} siRNA and its dominant negative mutant but increased by GSK-3beta siRNA and its dominant negative mutants (Fig. 4A).",
              "metadata": {
                "id": "524b3521d3fbfd4c34062047",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:EGR1) actsIn tscript(p(HGNC:EGR1))",
              "citation": {
                "type": "PubMed",
                "id": "20190820",
                "name": "Oncogene 2010 May 6 29(18) 2628-37"
              },
              "experiment_context": {
                "disease": "Prostatic Neoplasms",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Egr-1 increased the transcription of HB-EGF (epidermal growth factor), amphiregulin and epiregulin, resulting in autocrine activation of the EGF receptor (EGFR) and downstream MEK/ERK cascade. ",
              "metadata": {
                "id": "524b3521d3fbfd4c34062179",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:EGR1) actsIn tscript(p(HGNC:EGR1))",
              "citation": {
                "type": "PubMed",
                "id": "12571843",
                "name": "Arthritis Rheum 2003 Feb 48(2) 348-59"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": "Fibroblasts"
              },
              "summary_text": "TIMP-1 and Egr-1 were coexpressed in synovial fibroblasts of inflamed joints, and Egr-1 activated the expression of TIMP-1.",
              "metadata": {
                "id": "524b3521d3fbfd4c34061f0d",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:EGR1) actsIn tscript(p(HGNC:EGR1))",
              "citation": {
                "type": "PubMed",
                "id": "14557062",
                "name": "Gene 2003 Oct 2 315 33-41"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "Endothelium, Vascular",
                "cell": ""
              },
              "summary_text": "Among them, thymus-expressed chemokine (TECK) and IP-30 were dramatically induced by Egr-1, but TNFalpha-related apoptosis inducing ligand (TRAIL) was significantly repressed by Egr-1, suggesting that Egr-1 is a key mediator of inflammation and apoptosis in vascular cells.",
              "metadata": {
                "id": "524b3521d3fbfd4c34062221",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:EGR1) actsIn tscript(p(HGNC:EGR1))",
              "citation": {
                "type": "PubMed",
                "id": "10734128",
                "name": "J Biol Chem 2000 Mar 31 275(13) 9749-57"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Mouse",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Nab2 potentiated Lhb transactivation by all EGR family members except EGR4",
              "metadata": {
                "id": "524b3521d3fbfd4c340621d9",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:EGR1) actsIn tscript(p(HGNC:EGR1))",
              "citation": {
                "type": "PubMed",
                "id": "9988683",
                "name": "J Biol Chem 1999 Feb 19 274(8) 4513-20"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Rat",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Egr-1 efficiently transactivated a PRL-1 promoter reporter construct containing an intact not mutant Egr-1 site, and the Egr-1 site largely accounted for PRL-1 gene up-regulation in response to mitogen stimulation.",
              "metadata": {
                "id": "524b3521d3fbfd4c340621d8",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:EGR1) actsIn tscript(p(HGNC:EGR1))",
              "citation": {
                "type": "PubMed",
                "id": "9453297",
                "name": "Hypertension 1998 Jan 31(1 Pt 2) 162-9"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Downstream to such signaling cascades, multiple transcription factors such as AP-1, NF-kappaB, Sp-1, and Egr-1 are activated",
              "metadata": {
                "id": "524b3521d3fbfd4c340621d7",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:EGR1) actsIn tscript(p(HGNC:EGR1))",
              "citation": {
                "type": "PubMed",
                "id": "18830406",
                "name": "PLoS One 2008 3(10) e3316"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "In human pulmonary epithelial cells, exposure to CSE or histone deacetylase (HDAC) inhibitor rapidly induced autophagy. CSE decreased HDAC activity, resulting in increased binding of early growth response-1 (Egr-1) and E2F factors to the autophagy gene LC3B promoter, and increased LC3B expression. Knockdown of E2F-4 or Egr-1 inhibited CSE-induced LC3B expression. Knockdown of Egr-1 also inhibited the expression of Atg4B, a critical factor for LC3B conversion. Inhibition of autophagy by LC3B-knockdown protected epithelial cells from CSE-induced apoptosis. Egr-1(-/-) mice, which displayed basal airspace enlargement, resisted cigarette-smoke induced autophagy, apoptosis, and emphysema.",
              "metadata": {
                "id": "524b3521d3fbfd4c340621cb",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:EGR1) actsIn tscript(p(HGNC:EGR1))",
              "citation": {
                "type": "PubMed",
                "id": "15071354",
                "name": "J Cardiovasc Pharmacol 2004 May 43(5) 669-76"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": "Endothelial Cells"
              },
              "summary_text": "Induction of TF gene expression by shear stress and also by CD40L is mediated via AP-1, NF-B, and Egr-1 enhancers.19   19. Mazzolai L, Silacci P, Bouzourene K, et al. Tissue factor activity is upregulated in human endothelial cells exposed to oscillatory shear stress. Thromb Haemost. 2002;87:10621068.",
              "metadata": {
                "id": "524b3521d3fbfd4c340621ca",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:EGR1) actsIn tscript(p(HGNC:EGR1))",
              "citation": {
                "type": "PubMed",
                "id": "16951379",
                "name": "J Immunol 2006 Sep 15 177(6) 4141-8"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Mouse",
                "tissue": "vascular smooth muscle",
                "cell": "Myocytes, Smooth Muscle"
              },
              "summary_text": "Egr-1 has been characterized as a transcriptional regulator of both PDGF-A and PDGF-C gene expression (18, 19).",
              "metadata": {
                "id": "524b3521d3fbfd4c340621b8",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:EGR1) actsIn tscript(p(HGNC:EGR1))",
              "citation": {
                "type": "PubMed",
                "id": "19144181",
                "name": "Arthritis Res Ther 2009 11(1) R8"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Rat",
                "tissue": "",
                "cell": "chondrocyte"
              },
              "summary_text": "Egr-1 DNA binding activity is increased by TNF?-induced MEK1/2 signalling in chondrocytes.......Competitive inhibition of Egr transcription factor-DNA binding attenuates TNF? decreases in cartilage matrix transcripts.",
              "metadata": {
                "id": "524b3521d3fbfd4c340621ab",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:EGR1) actsIn tscript(p(HGNC:EGR1))",
              "citation": {
                "type": "PubMed",
                "id": "19737531",
                "name": "Biochem Biophys Res Commun 2009 Dec 11 390(2) 196-200"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Mouse",
                "tissue": "",
                "cell": "Macrophages"
              },
              "summary_text": "These results suggest that CpG ODN activates the TLR9-MyD88-ERK1/2 pathway causing expression of Egr-1 and its target genes such as TF and Nab2, thus inducing foam cell formation.",
              "metadata": {
                "id": "524b3521d3fbfd4c34062183",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:EGR1) actsIn tscript(p(HGNC:EGR1))",
              "citation": {
                "type": "PubMed",
                "id": "10508235",
                "name": "Physiol Rev 1999 Oct 79(4) 1283-316"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "A variety of stimuli, including TPA, PDGF, and mechanical injury, induce Egr-1 expression in smooth muscle cells; the induced Egr-1 displaces members of the Sp family and activates the PDGF-A promoter further (431). Egr-1 is also involved in activation of a shear-stress-response element in the A-chain promoter in endothelial cells (239).",
              "metadata": {
                "id": "524b3521d3fbfd4c3406213d",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:EGR1) actsIn tscript(p(HGNC:EGR1))",
              "citation": {
                "type": "PubMed",
                "id": "17917537",
                "name": "Curr Opin Rheumatol 2007 Nov 19(6) 568-73"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": "Fibroblasts"
              },
              "summary_text": "A GC-rich Egr-1 binding element was mapped within the proximal promoter of the human COL1A2 gene, and binding of Egr-1 to this element was required for full TGF-b stimulation of COL1A2 transcription.",
              "metadata": {
                "id": "524b3521d3fbfd4c34062126",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:EGR1) actsIn tscript(p(HGNC:EGR1))",
              "citation": {
                "type": "PubMed",
                "id": "10669633",
                "name": "Arterioscler Thromb Vasc Biol 2000 Feb 20(2) 377-84"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Transient transfection analyses coupled with the gel mobility shift assays  indicate that Egr-1 plays a major role in inducing flt-1 gene expression.",
              "metadata": {
                "id": "524b3521d3fbfd4c340620f4",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:EGR1) actsIn tscript(p(HGNC:EGR1))",
              "citation": {
                "type": "PubMed",
                "id": "15475598",
                "name": "J Appl Physiol 2005 Feb 98(2) 732-8"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": "Fibroblasts"
              },
              "summary_text": "In addition, hypoxia-induced upregulations of cyclin D and epidermal growth factor receptor were attenuated by Egr-1 antisense oligonucleotides.",
              "metadata": {
                "id": "524b3521d3fbfd4c340620ea",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:EGR1) actsIn tscript(p(HGNC:EGR1))",
              "citation": {
                "type": "PubMed",
                "id": "15492129",
                "name": "Hypertension 2004 Dec 44(6) 944-51"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Rat",
                "tissue": "vascular smooth muscle",
                "cell": "Myocytes, Smooth Muscle"
              },
              "summary_text": "PDGF-BB stimulated Egr-1 activity in a time-dependent manner. Increase in PDGF-BBstimulated Egr-1 binding activation occurred at 15 minutes and peaked by 2 hours, and decreased thereafter to become undetectable after 8 hours. PDGF-AA also stimulated Egr-1 (DNA) binding activity in the same time-dependent manner",
              "metadata": {
                "id": "524b3521d3fbfd4c340620e8",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:EGR1) actsIn tscript(p(HGNC:EGR1))",
              "citation": {
                "type": "PubMed",
                "id": "18698092",
                "name": "J Lipid Res 2008 Dec 49(12) 2590-604"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": "megakaryocyte"
              },
              "summary_text": "human thromboxane A(2) (TXA(2)) receptor (TP) are encoded by a single gene but are transcriptionally regulated by distinct promoters, termed promoter 1 (Prm1) and Prm3, respectively...Site-directed mutagenesis of four overlapping Sp1/Egr1 elements and an NF-E2/AP1 element within the proximal region substantially reduced Prm1 activity...Collectively, these data establish that Sp1, Egr1, and NF-E2 regulate core Prm1 activity in the megakaryocytic-platelet progenitor cells, whereas GATA-1 and Ets-1 act as critical upstream activators, hence providing the first genetic basis for the expression of the human TXA(2) receptor (TP) within the vasculature.",
              "metadata": {
                "id": "524b3521d3fbfd4c340620e0",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:EGR1) actsIn tscript(p(HGNC:EGR1))",
              "citation": {
                "type": "PubMed",
                "id": "15958557",
                "name": "Cancer Res 2005 Jun 15 65(12) 5133-43"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Mouse",
                "tissue": "",
                "cell": "Fibroblasts"
              },
              "summary_text": "Egr1-null mouse embryo fibroblasts bypass replicative senescence and exhibit a loss of DNA damage response and an apparent immortal growth, suggesting loss of p53 functions. ..........   Electrophoretic mobility shift assay as well as chromatin immunoprecipitation confirmed that p53 is a direct target of Egr1.",
              "metadata": {
                "id": "524b3521d3fbfd4c340620d6",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:EGR1) actsIn tscript(p(HGNC:EGR1))",
              "citation": {
                "type": "PubMed",
                "id": "12947119",
                "name": "J Biol Chem 2003 Nov 7 278(45) 44246-54"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "treating HepG2 cells with OM specifically leads to prominent increases of the levels of c/EBPbeta and Egr1 bound to the LDLR promoter in vivo the N-terminal transactivation domain of Egr1 specifically interacts with c/EBPbeta The OM treatment further enhances this interaction, resulting in a large increase in the Egr1 transactivating activity Egr1 regulates LDLR transcription via a novel mechanism of protein-protein interaction with c/EBPbeta.",
              "metadata": {
                "id": "524b3521d3fbfd4c340620c3",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:EGR1) actsIn tscript(p(HGNC:EGR1))",
              "citation": {
                "type": "PubMed",
                "id": "12556466",
                "name": "J Biol Chem 2003 Apr 4 278(14) 11802-10"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Mouse",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "provide newinsights of Egr1 involvement in proliferation and survival of TRAMP C2 prostatecancer cells by the identification of several new target genes controllinggrowth, cell cycle progression, and apoptosis such as cyclin D2, P19ink4d, andFas.",
              "metadata": {
                "id": "524b3521d3fbfd4c340620b6",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:EGR1) actsIn tscript(p(HGNC:EGR1))",
              "citation": {
                "type": "PubMed",
                "id": "18390831",
                "name": "Am J Physiol Lung Cell Mol Physiol 2008 Jun 294(6) L1094-101"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Rat",
                "tissue": "",
                "cell": "Alveolar type I cell"
              },
              "summary_text": "Cotransfection experiments revealed that the mouse RAGE promoter was activated by early growth response gene 1 (Egr-1) and inhibited by thyroid transcription factor-1 (TTF-1) via interaction with specific regulatory elements. A rat ATI cell line (R3/1) with endogenous RAGE expression also differentially regulated RAGE when transfected with TTF-1 or Egr-1.",
              "metadata": {
                "id": "524b3521d3fbfd4c340620af",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:EGR1) actsIn tscript(p(HGNC:EGR1))",
              "citation": {
                "type": "PubMed",
                "id": "17967787",
                "name": "Circ Res 2008 Jan 4 102(1) 42-50"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": "Myocytes, Smooth Muscle"
              },
              "summary_text": "siRNA-mediated knockdown of Egr-1 inhibited or significantly reduced hemin-induced increase in the procoagulant TF and active PAI-1. .....Consistent with EMSA and RT-PCR, ChIP assays demonstrated that hemin promoted Egr-1 interaction not only with TF and NAB-2 promoters, but also with the proximal PAI-1 promoter, within 30 to 60 minutes (Figure 8B).",
              "metadata": {
                "id": "524b3521d3fbfd4c340620ab",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:EGR1) actsIn tscript(p(HGNC:EGR1))",
              "citation": {
                "type": "PubMed",
                "id": "12556466",
                "name": "J Biol Chem 2003 Apr 4 278(14) 11802-10"
              },
              "experiment_context": {
                "disease": "Prostatic Neoplasms",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Therefore high constitutive Egr1 expression delays apoptosis of prostate cancer cells mediated by Fas L, in part by down-regulating CD95 expression.",
              "metadata": {
                "id": "524b3521d3fbfd4c34062080",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:EGR1) actsIn tscript(p(HGNC:EGR1))",
              "citation": {
                "type": "PubMed",
                "id": "17917537",
                "name": "Curr Opin Rheumatol 2007 Nov 19(6) 568-73"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Mouse",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Furthermore, transgenic mice that overexpress active TGF-b or interleukin- 13 on an Egr-1-deficient genetic background fail to develop lung fibrosis [34].",
              "metadata": {
                "id": "524b3521d3fbfd4c3406207b",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:EGR1) actsIn tscript(p(HGNC:EGR1))",
              "citation": {
                "type": "PubMed",
                "id": "12427732",
                "name": "J Biol Chem 2003 Jan 24 278(4) 2571-80"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "These data suggest negative regulatory elements in the first intron of the ph/snGPx gene, and DNase protection assays revealed the existence of several protein-binding sites. The corresponding trans-regulatory proteins (SP1, ERG1, GATA1, SREBP1, USF1, and CREBP1) were identified, and in vivo binding of EGR1 and SREBP1 was shown by chromatin immunoprecipitation.%",
              "metadata": {
                "id": "524b3521d3fbfd4c3406206e",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:EGR1) actsIn tscript(p(HGNC:EGR1))",
              "citation": {
                "type": "PubMed",
                "id": "16452686",
                "name": "J Neurosci 2006 Feb 1 26(5) 1624-34"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": "neuron"
              },
              "summary_text": "Regulation of the mRNAs encoding the psmb9 (Lmp2) and psme2 (PA28beta) proteasome subunits, along with the proteasome-regulatory kinase serum/glucocorticoid-regulated kinase (SGK) and the proteasome-associated antigen peptide transporter subunit 1 (Tap1), was confirmed after transfection of a neuronal cell line with Zif268. Conversely, these mRNAs were upregulated in cerebral cortex tissue from Zif268 knock-out mice relative to controls, confirming that Zif268 suppresses their expression in the CNS.",
              "metadata": {
                "id": "524b3521d3fbfd4c3406206d",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:EGR1) actsIn tscript(p(HGNC:EGR1))",
              "citation": {
                "type": "PubMed",
                "id": "12457461",
                "name": "Biochem J 2003 Mar 15 370(Pt 3) 1019-25"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "NAB2, a repressor of Egr-1 activation, also blocked the induction of PPAR gamma by TGF beta in VSMC",
              "metadata": {
                "id": "524b3521d3fbfd4c3406206c",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:EGR1) actsIn tscript(p(HGNC:EGR1))",
              "citation": {
                "type": "PubMed",
                "id": "14573617",
                "name": "J Biol Chem 2004 Jan 2 279(1) 70-6"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "KLF5 mediates a novel distinct delayed persistent induction of PDGF-A chain in response to the model agonist, phorbol ester, through a cis-element previously shown to mediate phorbol ester induction on to PDGF-A chain through the early growth response factor (Egr-1)",
              "metadata": {
                "id": "524b3521d3fbfd4c34062062",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:EGR1) actsIn tscript(p(HGNC:EGR1))",
              "citation": {
                "type": "PubMed",
                "id": "14530283",
                "name": "J Biol Chem 2003 Dec 26 278(52) 52298-306"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Mouse",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Insulin induced Csf1 (Macrophage colony stimulating factor) was reduced to 40% in cells pretreated with Egr-1 morpholino oligonucleotides. Similar results were obtained also in TNFalpha mediated insulin resistant 3T3-L1 cells. ",
              "metadata": {
                "id": "524b3521d3fbfd4c3406202a",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:EGR1) actsIn tscript(p(HGNC:EGR1))",
              "citation": {
                "type": "PubMed",
                "id": "19106114",
                "name": "Mol Hum Reprod 2008 Dec 22"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "We therefore characterized LHB transcriptional regulation by GNRH1 using promoter-reporter analyses in LbetaT2 cells.EGR1 bound to two binding sites on the LHB promoter and this binding was increased by GNRH1. Mutation of either site or knockdown of endogenous EGR1 decreased basal and/or GNRH1-regulated promoter activity.",
              "metadata": {
                "id": "524b3521d3fbfd4c3406201e",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:EGR1) actsIn tscript(p(HGNC:EGR1))",
              "citation": {
                "type": "PubMed",
                "id": "15265859",
                "name": "J Biol Chem 2004 Oct 8 279(41) 43107-16"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Mouse",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "TABLE II Genes expressed more highly in Egr-1 null regenerating liver Summary of microarray expression analysis comparing wild type and Egr-1 null regenerating liver 48 h after partial hepatectomy. Genes whose expression is at least 3-fold greater in Egr-1 null regenerating liver are listed, along with the fold difference in expression and Unigene number.",
              "metadata": {
                "id": "524b3521d3fbfd4c3406200d",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:EGR1) actsIn tscript(p(HGNC:EGR1))",
              "citation": {
                "type": "PubMed",
                "id": "10508235",
                "name": "Physiol Rev 1999 Oct 79(4) 1283-316"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "Muscle, Smooth",
                "cell": ""
              },
              "summary_text": "A variety of stimuli, including TPA, PDGF, and mechanical injury, induce Egr-1 expression in smooth muscle cells; the induced Egr-1 displaces members of the Sp family and activates the PDGF-A promoter further (431). Egr-1 is also involved in activation of a shear-stress-response element in the A-chain promoter in endothelial cells (239).",
              "metadata": {
                "id": "524b3521d3fbfd4c3406200c",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:EGR1) actsIn tscript(p(HGNC:EGR1))",
              "citation": {
                "type": "PubMed",
                "id": "11809863",
                "name": "Mol Pharmacol 2002 Feb 61(2) 379-90"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Mutagenesis revealed that an intact Sp1-binding site is essential for observing transcriptional repression by Egr-1 and that Egr-1 suppressed the transcription of the beta(1)-AR gene by competing with Sp1 for binding to their overlapping sites.",
              "metadata": {
                "id": "524b3521d3fbfd4c34062009",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:EGR1) actsIn tscript(p(HGNC:EGR1))",
              "citation": {
                "type": "PubMed",
                "id": "18772333",
                "name": "Am J Pathol 2008 Oct 173(4) 1085-99"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Mouse",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "The transcription factor early growth response-1 (Egr-1) mediates the stimulation of collagen transcription elicited by TGF-beta and is necessary for the development of pulmonary fibrosis in mice.",
              "metadata": {
                "id": "524b3521d3fbfd4c34061fbb",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:EGR1) actsIn tscript(p(HGNC:EGR1))",
              "citation": {
                "type": "PubMed",
                "id": "16037570",
                "name": "Circ Res 2005 Aug 19 97(4) 305-13"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Mouse",
                "tissue": "",
                "cell": "Macrophages"
              },
              "summary_text": "In RAW 267.4 mouse macrophages, LPS induced maximum Egr-1 mRNA expression 1 hour after treatment (data not shown). Maximum Egr-1 protein expression and DNA binding activity occurred 2 hours after treatment (data not shown).",
              "metadata": {
                "id": "524b3521d3fbfd4c34061fab",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:EGR1) actsIn tscript(p(HGNC:EGR1))",
              "citation": {
                "type": "PubMed",
                "id": "11591707",
                "name": "J Biol Chem 2001 Dec 7 276(49) 45604-13"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "In addition, overexpression of the Egr-interacting protein, NAB1, resulted in increased GnRH-stimulated MKP-2 gene transcription. Consistent with the putative role of Egr-1 in MKP-2 promoter regulation, Egr-1 protein expression closely correlated with the expression of MKP-2 protein in alpha T3-1 cells. Together, these data suggest that Egr-1 may be a key factor in mediating GnRH-dependent transcriptional activation of the MKP-2 gene",
              "metadata": {
                "id": "524b3521d3fbfd4c34061f3c",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:EGR1) actsIn tscript(p(HGNC:EGR1))",
              "citation": {
                "type": "PubMed",
                "id": "10364563",
                "name": "Circ Res 1999 Jun 11 84(11) 1258-67"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Interestingly, the site bound by GCF2 overlaps those for specificity protein-1 (Sp1) and early growth response factor-1 (Egr-1), zinc finger transcription factors that direct basal and inducible expression of the PDGF-A gene.",
              "metadata": {
                "id": "524b3521d3fbfd4c34061f3b",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:EGR1) actsIn tscript(p(HGNC:EGR1))",
              "citation": {
                "type": "PubMed",
                "id": "9242190",
                "name": "Circ Res 1997 Aug 81(2) 282-8"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Reverse-transcription polymerase chain reaction revealed that FGF-1 induced Egr-1 mRNA expression within 30 minutes",
              "metadata": {
                "id": "524b3521d3fbfd4c34061ef7",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:EGR1) actsIn tscript(p(HGNC:EGR1))",
              "citation": {
                "type": "PubMed",
                "id": "11830539",
                "name": "Cancer Res 2002 Feb 1 62(3) 827-34"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "We demonstrate that early growth response factor 1 (Egr-1), which is induced by hypoxia, can activate the basal transcriptional activity of the EGFR promoter. Egr-1 not only transactivates the EGFR promoter activity but also enhances endogenous EGFR expression.",
              "metadata": {
                "id": "524b3521d3fbfd4c34061ef0",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:EGR1) actsIn tscript(p(HGNC:EGR1))",
              "citation": {
                "type": "PubMed",
                "id": "14630715",
                "name": "Endocrinology 2004 Mar 145(3) 1290-3"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "The PAX8-independent effect of APE/Ref-1 was specific for the NIS promoter, resulting not present for the promoter of the thyroperoxidase (TPO) gene. It was, at least in part, due to the up-regulation of the transcriptional activity of the ubiquitous factor early growth response-1 (Egr-1)",
              "metadata": {
                "id": "524b3521d3fbfd4c34061ee1",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:EGR1) actsIn tscript(p(HGNC:EGR1))",
              "citation": {
                "type": "PubMed",
                "id": "19307576",
                "name": "Proc Natl Acad Sci U S A 2009 Apr 7 106(14) 5761-6"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "In this study, using a combination of bioinformatics and molecular approaches, we report that microRNA (hsa-miR-106a) regulates IL-10 expression. The hsa-miR-106a binding site in the 3' UTR of IL10 has been identified by site-directed mutagenesis studies. Also, the involvement of transcription factors, Sp1 and Egr1, in the regulation of hsa-miR-106a expression and concomitant decrease in the IL-10 expression, has also been demonstrated. In summary, our results showed that IL-10 expression may be regulated by miR-106a, which is in turn transcriptionally regulated by Egr1 and Sp1.  ",
              "metadata": {
                "id": "524b3521d3fbfd4c340622a9",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:EGR1) actsIn tscript(p(HGNC:EGR1))",
              "citation": {
                "type": "PubMed",
                "id": "15225550",
                "name": "Mol Cell 2004 Jul 2 15(1) 83-94"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "In contrast, induction of Egr1 by UV-C irradiation leads to repression of p300/CBP transcription: Egr1 is preferentially phosphorylated, leading to regulation of target genes that cause cell death.",
              "metadata": {
                "id": "524b3521d3fbfd4c340622a3",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:EGR1) actsIn tscript(p(HGNC:EGR1))",
              "citation": {
                "type": "PubMed",
                "id": "12556466",
                "name": "J Biol Chem 2003 Apr 4 278(14) 11802-10"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Therefore high constitutive  Egr1 expression delays apoptosis of prostate cancer cells mediated by Fas L, in  part by down-regulating CD95 expression.",
              "metadata": {
                "id": "524b3521d3fbfd4c34062274",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:EGR1) actsIn tscript(p(HGNC:EGR1))",
              "citation": {
                "type": "PubMed",
                "id": "10606246",
                "name": "Cancer Res 1999 Dec 1 59(23) 5989-94"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Cotransfection of HepG2 cells with an Egr-1 expression vector and an IGF-II P3 promoter-luciferase reporter plasmid showed that the transcription of IGF-II was activated by Egr-1 in a dose-dependent manner.",
              "metadata": {
                "id": "524b3521d3fbfd4c3406222a",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:EGR1) actsIn tscript(p(HGNC:EGR1))",
              "citation": {
                "type": "PubMed",
                "id": "17099140",
                "name": "Am J Respir Cell Mol Biol 2007 Apr 36(4) 480-90"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "human NL9 cells were exposed to CSE to determine whether cigarette smoke can induce EGR-1 expression. A QRT-PCR analysis showed that in response to 20% CSE, EGR-1 mRNA expression quickly reached its maximal level at 30 min, and then decreased after 4 h (Figure 2A). The increase of EGR-1 mRNA expression was reflected in increased EGR-1 protein production and EGR-1 transcriptional activity, respectively.",
              "metadata": {
                "id": "524b3521d3fbfd4c34062229",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:EGR1) actsIn tscript(p(HGNC:EGR1))",
              "citation": {
                "type": "PubMed",
                "id": "15469929",
                "name": "Proc Natl Acad Sci U S A 2004 Oct 12 101(41) 14895-900"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": "Fibroblasts"
              },
              "summary_text": "This induction of Egr-1 protein expression by CSE was accompanied by an increase in the binding activity of Egr-1 to its consensus oligonucleotide sequences in a time-dependent manner",
              "metadata": {
                "id": "524b3521d3fbfd4c340621f7",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:EGR1) actsIn tscript(p(HGNC:EGR1))",
              "citation": {
                "type": "PubMed",
                "id": "11316810",
                "name": "J Biol Chem 2001 Jul 6 276(27) 25512-9"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Modified assertion",
              "metadata": {
                "id": "524b3521d3fbfd4c34062296",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:EGR1) actsIn tscript(p(HGNC:EGR1))",
              "citation": {
                "type": "PubMed",
                "id": "17922653",
                "name": "Biochemistry (Mosc) 2007 Sep 72(9) 954-61"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": "t-cell"
              },
              "summary_text": "Egr1 and NFAT2 are shown to cooperatively control gene expression of the regulatory factor Id3 and recombinase Rag2, whose functions are critical for T-lymphocyte differentiation. ",
              "metadata": {
                "id": "524b3521d3fbfd4c3406226b",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:EGR1) actsIn tscript(p(HGNC:EGR1))",
              "citation": {
                "type": "PubMed",
                "id": "10339488",
                "name": "Blood 1999 Jun 1 93(11) 3811-23"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Fig. 9.  Overexpression of full-length EGR-1, but not a transcriptionally inactive mutant, results in activation of the TF promoter in HUVEC.",
              "metadata": {
                "id": "524b3521d3fbfd4c34062249",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:EGR1) actsIn tscript(p(HGNC:EGR1))",
              "citation": {
                "type": "PubMed",
                "id": "10702309",
                "name": "J Biol Chem 2000 Mar 10 275(10) 7365-72"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Modified assertion",
              "metadata": {
                "id": "524b3521d3fbfd4c34062244",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:EGR1) actsIn tscript(p(HGNC:EGR1))",
              "citation": {
                "type": "PubMed",
                "id": "8662759",
                "name": "J Biol Chem 1996 Jun 7 271(23) 13530-6"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Mouse",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "CKII phosphorylation of Egr-1 resulted in a decrease",
              "metadata": {
                "id": "524b3521d3fbfd4c340621ae",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:EGR1) actsIn tscript(p(HGNC:EGR1))",
              "citation": {
                "type": "PubMed",
                "id": "9858508",
                "name": "J Exp Med 1998 Dec 21 188(12) 2215-24"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Modified assertion",
              "metadata": {
                "id": "524b3521d3fbfd4c340621aa",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:EGR1) actsIn tscript(p(HGNC:EGR1))",
              "citation": {
                "type": "PubMed",
                "id": "10551840",
                "name": "J Biol Chem 1999 Nov 12 274(46) 32795-802"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Rat",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Modified assertion",
              "metadata": {
                "id": "524b3521d3fbfd4c34062196",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:EGR1) actsIn tscript(p(HGNC:EGR1))",
              "citation": {
                "type": "PubMed",
                "id": "12618431",
                "name": "J Biol Chem 2003 May 23 278(21) 18859-67"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "ERK and p38 inhibit the expression of 4E-BP1 repressor of translation through induction of Egr-1",
              "metadata": {
                "id": "524b3521d3fbfd4c34062186",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:EGR1) actsIn tscript(p(HGNC:EGR1))",
              "citation": {
                "type": "PubMed",
                "id": "14679188",
                "name": "J Biol Chem 2004 Mar 5 279(10) 8792-801"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Expression of dominant negative Egr-1 and SP3 blocked up-regulation of the ACE promoter by HGF but only reduced up-regulation by PMA.",
              "metadata": {
                "id": "524b3521d3fbfd4c34062178",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:EGR1) actsIn tscript(p(HGNC:EGR1))",
              "citation": {
                "type": "PubMed",
                "id": "19307156",
                "name": "Clin Immunol 2009 Jun 131(3) 385-94"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": "Th1 cell"
              },
              "summary_text": "Here, we characterize the essential human T-bet promoter elements and show that binding of EGR1 to this promoter induces T-bet transcription. Notably, overexpression of EGR1 transactivates and, synergistically in concert with TCR signaling, induces T-bet expression in activated T cells.",
              "metadata": {
                "id": "524b3521d3fbfd4c34062173",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:EGR1) actsIn tscript(p(HGNC:EGR1))",
              "citation": {
                "type": "PubMed",
                "id": "17917537",
                "name": "Curr Opin Rheumatol 2007 Nov 19(6) 568-73"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "synovium",
                "cell": "Fibroblasts"
              },
              "summary_text": "PPAR-g interferes with the activation function of Egr-1 [45], a transcription factor that is essential for stimulation of collagen synthesis (see above).",
              "metadata": {
                "id": "524b3521d3fbfd4c34062171",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:EGR1) actsIn tscript(p(HGNC:EGR1))",
              "citation": {
                "type": "PubMed",
                "id": "16093249",
                "name": "J Biol Chem 2005 Oct 21 280(42) 35136-47"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Furthermore, the heparanase promoter region containing the EGR1 sites was also inducible in tumor cells and induction corresponded to HPSE expression levels. These studies show that EGR1 regulates heparanase transcription in tumor cells and importantly, can have a repressive or activating role depending on the tumor type.",
              "metadata": {
                "id": "524b3521d3fbfd4c34062168",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:EGR1) actsIn tscript(p(HGNC:EGR1))",
              "citation": {
                "type": "PubMed",
                "id": "12517959",
                "name": "J Immunol 2003 Jan 15 170(2) 931-40"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Nox4 expression was significantly increased in cells  overexpressing EGR-1.",
              "metadata": {
                "id": "524b3521d3fbfd4c34062165",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:EGR1) actsIn tscript(p(HGNC:EGR1))",
              "citation": {
                "type": "PubMed",
                "id": "11956220",
                "name": "J Biol Chem 2002 Jun 21 277(25) 22222-30"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "The sequence between -246 and -225 bp consists of overlapping binding sites (Sp1/Egr-1/Sp1) that are recognized by Sp1, Sp3, and PMA-inducible Egr-1 is essential for PMA activation. Sp3 inhibits Sp1 and Egr-1 activation of MAO B gene expression",
              "metadata": {
                "id": "524b3521d3fbfd4c34062161",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:EGR1) actsIn tscript(p(HGNC:EGR1))",
              "citation": {
                "type": "PubMed",
                "id": "17202132",
                "name": "J Biol Chem 2007 Mar 2 282(9) 6619-28"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "The transcription factor Egr-1 activates cyclin-dependent protein kinase 5 (Cdk5) during nerve growth factor (NGF)-induced differentiation of PC12 cells into neurons ",
              "metadata": {
                "id": "524b3521d3fbfd4c3406214d",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:EGR1) actsIn tscript(p(HGNC:EGR1))",
              "citation": {
                "type": "PubMed",
                "id": "14522979",
                "name": "J Biol Chem 2003 Dec 12 278(50) 50377-85"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Modified assertion",
              "metadata": {
                "id": "524b3521d3fbfd4c34062142",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:EGR1) actsIn tscript(p(HGNC:EGR1))",
              "citation": {
                "type": "PubMed",
                "id": "8063705",
                "name": "J Biol Chem 1994 Aug 19 269(33) 20885-98"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Rat",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Egr-1 also stimulates endogenous PNMT mRNA expression in the RS1 cells.",
              "metadata": {
                "id": "524b3521d3fbfd4c3406213f",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:EGR1) actsIn tscript(p(HGNC:EGR1))",
              "citation": {
                "type": "PubMed",
                "id": "9867871",
                "name": "J Biol Chem 1999 Jan 1 274(1) 503-9"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Modified assertion",
              "metadata": {
                "id": "524b3521d3fbfd4c34062130",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:EGR1) actsIn tscript(p(HGNC:EGR1))",
              "citation": {
                "type": "PubMed",
                "id": "10984481",
                "name": "J Biol Chem 2000 Dec 8 275(49) 38524-31"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "p57KIP2 (6.3)",
              "metadata": {
                "id": "524b3521d3fbfd4c34062127",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:EGR1) actsIn tscript(p(HGNC:EGR1))",
              "citation": {
                "type": "PubMed",
                "id": "9789819",
                "name": "J Physiol Paris 92(3-4) 257-64"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Together our data show that mAChR can activate transcription from the AChE promoter via increased synthesis of Egr-1.",
              "metadata": {
                "id": "524b3521d3fbfd4c34062125",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:EGR1) actsIn tscript(p(HGNC:EGR1))",
              "citation": {
                "type": "PubMed",
                "id": "10936194",
                "name": "J Neurochem 2000 Sep 75(3) 1123-31"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "It has been observed, in fact, that EGR-1 protein in vitro binds to two sites  in the regulatory region of synapsin I gene and stimulates synapsin I gene  transcription in trans -activation assays (Thiel et al., 1994 ).",
              "metadata": {
                "id": "524b3521d3fbfd4c340620c5",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:EGR1) actsIn tscript(p(HGNC:EGR1))",
              "citation": {
                "type": "PubMed",
                "id": "9737720",
                "name": "FASEB J 1998 Sep 12(12) 1173-82"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Glucose causes a coordinated transcriptional activation of the IEGs c-fos, c-jun, JunB, zif-268, and nur-77 in the pancreatic beta-cell line INS-1",
              "metadata": {
                "id": "524b3521d3fbfd4c340620be",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:EGR1) actsIn tscript(p(HGNC:EGR1))",
              "citation": {
                "type": "PubMed",
                "id": "16858414",
                "name": "EMBO J 2006 Aug 9 25(15) 3534-45"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "HGF-induced upregulation of Snail transcription involves activation of the mitogen-activated protein kinase (MAPK) pathway and requires the activity of early growth response factor-1 (Egr-1).",
              "metadata": {
                "id": "524b3521d3fbfd4c3406209b",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:EGR1) actsIn tscript(p(HGNC:EGR1))",
              "citation": {
                "type": "PubMed",
                "id": "15289351",
                "name": "Cancer Res 2004 Aug 1 64(15) 5425-33"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "We show also that 1,25D(3) treatment of HL60 cells markedly increases the binding of Egr1 to an element in the p35 gene promoter, whereas transfection of an excess of this Egr1-binding oligonucleotide ( promoter decoy ) reduces p35 gene transcription and cell differentiation.",
              "metadata": {
                "id": "524b3521d3fbfd4c3406209a",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:EGR1) actsIn tscript(p(HGNC:EGR1))",
              "citation": {
                "type": "PubMed",
                "id": "15346645",
                "name": "Free Radic Res 2004 Jun 38(6) 541-51"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": "Myocytes, Smooth Muscle"
              },
              "summary_text": "Native and oxidized low density lipoprotein induction of tissue factor gene expression in smooth muscle cells is mediated by both Egr-1 and Sp1",
              "metadata": {
                "id": "524b3521d3fbfd4c3406208c",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:EGR1) actsIn tscript(p(HGNC:EGR1))",
              "citation": {
                "type": "PubMed",
                "id": "15247255",
                "name": "J Biol Chem 2004 Sep 24 279(39) 40289-95"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "vascular smooth muscle",
                "cell": ""
              },
              "summary_text": "Binding and transient transfection analysis in primary vascular smooth muscle cells revealed that PDGF-C, like PDGF-A, is under the transcriptional control of the zinc finger nuclear protein Egr-1 (early growth response-1).",
              "metadata": {
                "id": "524b3521d3fbfd4c34062044",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:EGR1) actsIn tscript(p(HGNC:EGR1))",
              "citation": {
                "type": "PubMed",
                "id": "11567222",
                "name": "Hum Pathol 2001 Sep 32(9) 935-9"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "high levels of Egr1 coupled with low levels of NAB2 can result in high, unrestrained Egr1 transcriptional activity in human prostate cancers",
              "metadata": {
                "id": "524b3521d3fbfd4c34062035",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:EGR1) actsIn tscript(p(HGNC:EGR1))",
              "citation": {
                "type": "PubMed",
                "id": "9359835",
                "name": "Biochem J 1997 Nov 15 328 ( Pt 1) 69-74"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Transfection experiments also demonstrate that EGR-1 is able to enhance PC2 promoter activity.",
              "metadata": {
                "id": "524b3521d3fbfd4c34061f86",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:EGR1) actsIn tscript(p(HGNC:EGR1))",
              "citation": {
                "type": "PubMed",
                "id": "14557062",
                "name": "Gene 2003 Oct 2 315 33-41"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Table 2: Genes downregulated by Egr-1 in HUVEC",
              "metadata": {
                "id": "524b3521d3fbfd4c34061f48",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:EGR1) actsIn tscript(p(HGNC:EGR1))",
              "citation": {
                "type": "PubMed",
                "id": "8035792",
                "name": "Mol Cell Biol 1994 Aug 14(8) 5099-107"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "EGR1 and EGR2 increased IL-3 promoter activity when the transfected cells were stimulated with phorbol-12-myristate-13-acetate and A23187.",
              "metadata": {
                "id": "524b3521d3fbfd4c34061f25",
                "created_by": "selventa"
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:CTNNB1)",
        "target": "tscript(p(HGNC:CTNNB1))",
        "relation": "actsIn",
        "directed": true,
        "label": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
        "metadata": {
          "edgeId": "524b3517d3fbfd4c3405197a",
          "createdBy": "selventa",
          "casual": false,
          "evidences": [
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "11564756",
                "name": "J Cell Biol 2001 Sep 17 154(6) 1185-96"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": "Fibroblasts"
              },
              "summary_text": "By expressing E-cadherin subdomains, we show that the growth-suppressive effect of E-cadherin required the presence of its cytoplasmic beta-catenin interaction domain and/or correlated strictly with the ability to negatively interfere with beta-catenin transcriptional activity.",
              "metadata": {
                "id": "524b3521d3fbfd4c34062227",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "16484682",
                "name": "Am J Respir Cell Mol Biol 2006 Jul 35(1) 3-9"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "from full text - Figure 1 ",
              "metadata": {
                "id": "524b3521d3fbfd4c34061fbe",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "12500268",
                "name": "Microsc Res Tech 2003 Jan 1 60(1) 115-27"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Rat",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "catenins alpha, beta and gamma are intracellular attachment proteins that mediate the linkage of the cadherin-catenin complex with the actin cytoskeleton",
              "metadata": {
                "id": "524b3521d3fbfd4c34062099",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "18826597",
                "name": "Mol Cancer 2008 7 73"
              },
              "experiment_context": {
                "disease": "Carcinoma of large intestine",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Taken together, our results suggest that Rac1 and the Rac1-specific activator Tiam1 are components of transcriptionally active beta-catenin/TCF complexes at Wnt-responsive promoters, and the presence of Rac1 and Tiam1 within these complexes serves to enhance target gene transcription. ",
              "metadata": {
                "id": "524b3521d3fbfd4c34062060",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "14737101",
                "name": "Oncogene 2004 Jan 22 23(3) 654-64"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Downregulated genes from Table 1.",
              "metadata": {
                "id": "524b3521d3fbfd4c34062012",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "12554773",
                "name": "Mol Endocrinol 2003 Apr 17(4) 507-19"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Modified assertion",
              "metadata": {
                "id": "524b3521d3fbfd4c3406207c",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "12810642",
                "name": "Cancer Res 2003 Jun 15 63(12) 3145-53"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "Epithelium",
                "cell": ""
              },
              "summary_text": "Transfection of normal colon epithelial cells with activated beta-catenin up-regulated levels of VEGF-A mRNA and protein by 250-300%.",
              "metadata": {
                "id": "524b3521d3fbfd4c34061f72",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "11274170",
                "name": "J Biol Chem 2001 Jun 8 276(23) 20108-15"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Mouse",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Modified assertion",
              "metadata": {
                "id": "524b3521d3fbfd4c34061f67",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "11572874",
                "name": "J Biol Chem 2001 Nov 30 276(48) 45113-9"
              },
              "experiment_context": {
                "disease": "Neoplasms",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Investigation of the mechanism for the overexpression of Id2 in colon carcinoma cells demonstrated that the Id2 promoter is activated, and the Id2 protein is up-regulated by beta-catenin. We have also used an electrophoretic mobility shift assay and supershift to identify a motif in the Id2 promoter that binds to TCF4 protein.",
              "metadata": {
                "id": "524b3521d3fbfd4c340621e9",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "17666529",
                "name": "Proc Natl Acad Sci U S A 2007 Aug 7 104(32) 13040-5"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Mouse",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "overexpression of HIPK2 suppresses LEF1/beta-catenin-mediated transcriptional activation of cyclin D1 expression. Our results indicated that HIPK2 suppressed ?-catenin-mediated activation of cyclin D1 (Fig. 3F). The suppressive effect of HIPK2 did not require phosphorylation on the critical Ser/Thr residues of ?-catenin because HIPK2 suppressed the transcriptional activity of a constitutively active form of ?-catenin (CA-?-catenin) in which amino acids 2948 were deleted (Fig. 3F). Interestingly, the kinase-inactive form of HIPK2 (HIPK2K221A) showed a similar efficacy in suppressing cyclin D1 expression, suggesting that the kinase activity of HIPK2 was dispensable. ",
              "metadata": {
                "id": "524b3521d3fbfd4c340621e6",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "20519507",
                "name": "J Biol Chem 2010 Jun 2"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": "Epithelial Cells"
              },
              "summary_text": "TGF-beta1 stimulated beta-catenin activation in tubular epithelial cells and ectopic expression of beta-catenin induced PAI-1 expression, whereas inhibition of beta-catenin abolished its induction.",
              "metadata": {
                "id": "524b3521d3fbfd4c340621df",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "15003504",
                "name": "Biochem Biophys Res Commun 2004 Mar 26 316(1) 12-7"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "The intracellular domain of CD43 interacts with beta-catenin and causes an upregulation of the beta-catenin target genes c-MYC and CyclinD1.",
              "metadata": {
                "id": "524b3521d3fbfd4c340621de",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "17244647",
                "name": "J Cell Sci 2007 Feb 15 120(Pt 4) 586-95"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": "neuron"
              },
              "summary_text": "As expected, Wnt-5a blocked the Wnt-3a-induced activation of beta-catenin. ",
              "metadata": {
                "id": "524b3521d3fbfd4c340621db",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "19933277",
                "name": "J Biol Chem 2010 Jan 29 285(5) 3157-67"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Rat",
                "tissue": "",
                "cell": "Alveolar type I cell"
              },
              "summary_text": "These results suggest that AT2 cells may function as facultative progenitors, where activation of Wnt/beta-catenin signaling during lung injury promotes alveolar epithelial survival, migration, and differentiation toward an AT1-like phenotype.",
              "metadata": {
                "id": "524b3521d3fbfd4c340621da",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "19005493",
                "name": "Nat Rev Cancer 2008 Dec 8(12) 929-41"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Mouse",
                "tissue": "",
                "cell": "Fibroblasts"
              },
              "summary_text": "Proteolysis of E-cadherin and the subsequent activation of ?-catenin are features of epithelialmesenchymal transition, which occurs when cell adhesions are lost and the process of cell migration begins. Hence, the shedding of E-cadherin by ADAM10 modulates the subcellular localization of ?-catenin and downstream signalling to cyclin D1, enhancing cell proliferation42.",
              "metadata": {
                "id": "524b3521d3fbfd4c340621d0",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "19933277",
                "name": "J Biol Chem 2010 Jan 29 285(5) 3157-67"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Mouse",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "FIGURE 4. Bleomycin-induced lung injury activates Wnt/Beta-catenin signaling in mouse lung.",
              "metadata": {
                "id": "524b3521d3fbfd4c340621ce",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "11278246",
                "name": "J Biol Chem 2001 May 18 276(20) 17479-83"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "This binding induces a conformational change in the complex, resulting in the inhibition of GSK3beta phosphorylation of beta -catenin",
              "metadata": {
                "id": "524b3521d3fbfd4c340621cd",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "9990071",
                "name": "Proc Natl Acad Sci U S A 1999 Feb 16 96(4) 1603-8"
              },
              "experiment_context": {
                "disease": "Neoplasms",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "High expression of beta-catenin in transfectants, as well as in additionally analyzed colorectal cell lines, was associated with decreased expression of ZO-1, which is involved in epithelial polarization. Thus, accumulation of beta-catenin indirectly affects the expression of uPAR in vitro and in vivo. Simultaneously, the expression of the zonula occludens-1 (ZO-1) gene, coding for a member of the MAGUK protein family that is related to -catenin, was suppressed. We conclude that activation of the -catenin-Tcf/Lef complex might facilitate loss of epithelial polarization and enhance proteolytic activity in human colorectal carcinomas.",
              "metadata": {
                "id": "524b3521d3fbfd4c340621c6",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "15149841",
                "name": "Exp Cell Res 2004 Jun 10 296(2) 99-108"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Since genes encoding ecto-5'-nucleotidase (eN) and adenosine deaminase (ADA) contain TCF/LEF consensus binding sites, we asked whether Wnt/beta-catenin signaling, a pathway that is deregulated in several human tumors, targets the expression of these genes and thus influence extracellular adenosine generation. Our results show that beta-catenin strongly increased the activity of the 969-bp promoter of eN and this increase depended on the presence of TCF-1 transcription factor.",
              "metadata": {
                "id": "524b3521d3fbfd4c340621af",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "10953028",
                "name": "J Clin Invest 2000 Aug 106(4) 533-9"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "We show here that the gastrin gene is a downstream target of the beta-catenin/TCF-4 signaling pathway and that cotransfection of a constitutively active beta-catenin expression construct causes a threefold increase in gastrin promoter activity.",
              "metadata": {
                "id": "524b3521d3fbfd4c340621a8",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "12447692",
                "name": "Oncogene 2002 Nov 28 21(54) 8293-301"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Mouse",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "We identified three genes involved in glutamine metabolism, encoding glutamine synthetase (GS), ornithine aminotransferase (OAT) and the glutamate transporter GLT-1. By Northern blot and immunohistochemical analysis we demonstrated that these three genes were specifically induced by activation of the beta-catenin pathway in the liver",
              "metadata": {
                "id": "524b3521d3fbfd4c3406219d",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "16724116",
                "name": "EMBO J 2006 Jun 7 25(11) 2326-37"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "This appears to be due to the ability of HIC1 to associate with TCF-4 and to recruit TCF-4 and beta-catenin to the HIC1 bodies.",
              "metadata": {
                "id": "524b3521d3fbfd4c3406219b",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "9990071",
                "name": "Proc Natl Acad Sci U S A 1999 Feb 16 96(4) 1603-8"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "There are four genes affected by beta-catenin overexpression; three overexpressed genes code for two components of the AP-1 transcription complex, c-jun and fra-1, and for the urokinase-type plasminogen activator receptor (uPAR), whose transcription is activated by AP-1 The direct interaction of the beta-catenin-T cell-factor/lymphoid-enhancer-factor complex with the promoter region of c-jun and fra-1 was shown in a gel shift assay",
              "metadata": {
                "id": "524b3521d3fbfd4c34062197",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "19047049",
                "name": "J Biol Chem 2009 Jan 30 284(5) 2657-71"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Further analyses indicate that activation of SIRT1 (deacetylase) by resveratrol (a natural antioxidant) induces SIRT1-p300 association and acetyltransferase inactivation, leading to deacetylation of HA/CD44-induced beta-catenin and NFkappaB-p65, inhibition of beta-catenin-T-cell factor/lymphocyte enhancer factor and NFkappaB-specific transcriptional activation, and the impairment of MDR1 and Bcl-x(L) gene expression.",
              "metadata": {
                "id": "524b3521d3fbfd4c3406218e",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "19020503",
                "name": "Nature 2009 Jan 8 457(7226) 200-4"
              },
              "experiment_context": {
                "disease": "hepatocellular carcinoma",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Furthermore, analysis of hepatocellular carcinomas revealed that rare gp130 alterations are always accompanied by beta-catenin-activating mutations",
              "metadata": {
                "id": "524b3521d3fbfd4c3406217b",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "14964308",
                "name": "Nat Rev Cancer 2004 Feb 4(2) 118-32"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Subsequently, it (beta-catenin) translocates to the nucleus, where it binds to members of the TCF/LEF1 family of transcription factors and modulates the expression of their target genes, including c-MYC, cyclin D1, fibronectin,MMP7, ID2, CD44, NrCAM, axin-2 (conductin), TCF1 and others, which are mostly genes implicated in cell proliferation and tumour progression.",
              "metadata": {
                "id": "524b3521d3fbfd4c34062153",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "14500370",
                "name": "Cancer Res 2003 Sep 1 63(17) 5370-5"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "The -catenin target, c-Myc (27) , which is oncogenic in the mammary gland (28) , was next evaluated using a c-Myc promoter reporter gene (Fig. 1B)Citation . c-Myc promoter activity was markedly increased in PDK1- and PKC{alpha}-expressing cells, but not in Akt1-expressing cells; promoter dependence on -catenin activation was again absent in HAB85 cells lacking the oncogenic -catenin allele (Fig. 1B)Citation .",
              "metadata": {
                "id": "524b3521d3fbfd4c3406214c",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "10027409",
                "name": "Am J Pathol 1999 Feb 154(2) 515-23"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Mouse",
                "tissue": "intestinal epithelium",
                "cell": ""
              },
              "summary_text": "we analyzed CD44 expression in the intestinal mucosa of mice and humans with genetic defects in either APC or Tcf-4, leading to constitutive activation or blockade of the beta-catenin/Tcf-4 pathway...  the intestinal epithelium of Tcf-4-/- mice did not show any CD44 staining (Figure 5D) (via immunohistochemistry from full text)",
              "metadata": {
                "id": "524b3521d3fbfd4c34062149",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "16858403",
                "name": "EMBO J 2006 Jul 26 25(14) 3275-85"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "In contrast, expression of an emerin mutant, lacking its APC-like domain (GFP-emerinDelta), dominantly stimulates beta-catenin activity and increases nuclear accumulation of beta-catenin.",
              "metadata": {
                "id": "524b3521d3fbfd4c34062136",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "10362259",
                "name": "Oncogene 1999 May 6 18(18) 2883-91"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "The matrilysin promoter is upregulated as much as 12-fold by beta-catenin in colon tumor cell lines in a manner inversely proportional to the endogenous levels of beta-catenin/Tcf complex and is dependent upon a single optimal Tcf-4 recognition site.In HT29 and HCT116 cells, which have a moderate to low level of endogenous beta-catenin/Tcf complex, cotransfection of WTMAT-Luc with an expression vector encoding an inherently stable truncated form of human beta-catenin (DeltaN89beta-catenin, Munemitsu et al., 1996) resulted in a sixfold and 12.5-fold induction of matrilysin promoter activity, respectively ",
              "metadata": {
                "id": "524b3521d3fbfd4c3406211a",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "11035789",
                "name": "Proc Natl Acad Sci U S A 2000 Oct 24 97(22) 12103-8"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "To investigate whether IGF-1 also enhanced transactivation potential, a reporter gene assay was performed in HEK293 cells. We used a reporter construct incorporating multimeric Lef/Tcf promoter sequences upstream of a luciferase reporter (TOPFLASH) and a control construct containing mutated promoter sequences (FOPFLASH, ref. 21). We cotransfected TOPFLASH or FOPFLASH, ?-catenin, and human wild-type Tcf-4 wild-type expression constructs into 293 cells. Optimized luciferase assays showed a basal level of TOP/FOP activity of between 4:1 and 20:1. Forty-eight hours after transfection, serum-starved 293 cells were treated with IGF-1 or insulin for 3 or 6 h. These factors alone failed to alter basal reporter activity (Fig. 6  b). A 16-h pretreatment of the transfectants with LiCl had a dramatic effect on reporter activity, with significant enhancement at 50 mM LiCl (P < 0.01 by Tukey's test for comparison with activity in the absence of LiCl). We saw a further increase in reporter activity when we added 50 ng/ml (6.5 nM) IGF-1 to transfectants pretreated with LiCl at 10 mM (P < 0.01 after 6 h of IGF-1 treatment) and at 50 mM (P < 0.01 after 3 h of IGF-1 treatment and P < 0.001 after 6 h).",
              "metadata": {
                "id": "524b3521d3fbfd4c34062115",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "16575872",
                "name": "Genes Chromosomes Cancer 2006 Jun 45(6) 565-74"
              },
              "experiment_context": {
                "disease": "Neoplasms",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "In addition, several upstream inhibitors of WNT/beta-catenin signaling like WIF1 and PRDC were also strongly up-regulated in the CTNNB1-mutated Wilms tumors",
              "metadata": {
                "id": "524b3521d3fbfd4c34062114",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "16543216",
                "name": "Genes Dev 2006 Mar 15 20(6) 637-42"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "A report in the previous issue of Genes & Development Sierra et al. (2006) points to a separate mechanism for APC regulation of beta-cateninrepressing it on the chromatin.",
              "metadata": {
                "id": "524b3521d3fbfd4c3406210f",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "18291362",
                "name": "Eur J Pharmacol 2008 Mar 31 583(1) 26-31"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Further studies revealed that transcriptional activities of beta-catenin were significantly inhibited by sulindac and that the inhibition was sulindac dosage-dependent. The transcriptional targets of beta-catenin, c-myc, cyclin D1 and cdk 4 were also dramatically downregulated. ",
              "metadata": {
                "id": "524b3521d3fbfd4c34062107",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "14688481",
                "name": "Cancer Biol Ther 2(6) 702-6"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "The MUC1 cytoplasmic domain (CD) binds directly to the Wnt effector, beta-catenin, and colocalizes with beta-catenin in the nucleus;",
              "metadata": {
                "id": "524b3521d3fbfd4c34062105",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "22232214",
                "name": "J Clin Invest 2012 Feb 1 122(2) 624-38"
              },
              "experiment_context": {
                "disease": "leukemia",
                "species_common_name": "Mouse",
                "tissue": "",
                "cell": "Stem Cells"
              },
              "summary_text": "active beta-catenin was preferentially localized in the nucleus in LSCs with intact CD27 signaling, whereas only a minority of normal HSCs or Cd27-/- LSCs expressed beta-catenin in the nucleus (Figure 5C).",
              "metadata": {
                "id": "524b3521d3fbfd4c340620ff",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "15558022",
                "name": "Oncogene 2005 Jan 20 24(4) 597-604"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Constitutive activation of beta-catenin pathway is responsible for the initiation of the vast majority of colon cancers. Here we show that the EDN1 gene is directly regulated by beta-catenin in colon cancer cells. A specific DNA element within the EDN1 promoter is required for activation, and is associated with beta-catenin's cognate DNA binding partner, TCF4, in vivo. Inhibition of beta-catenin signaling results in lowered expression of EDN1, while enhancement of beta-catenin signaling leads to further activation of the gene. ",
              "metadata": {
                "id": "524b3521d3fbfd4c340620f9",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "15004225",
                "name": "Mol Biol Cell 2004 May 15(5) 2156-63"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Dose- and time-dependent studies with DCA demonstrated that treatment of colon cancer cells (SW480 and LoVo) with low concentrations of DCA (5 or 50 M) significantly increase tyrosine phosphorylation of {beta}-catenin at 30 min (Figure 1).",
              "metadata": {
                "id": "524b3521d3fbfd4c340620f5",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "16823493",
                "name": "J Clin Invest 2006 Jul 116(7) 2012-21"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "We show suppression of DP expression leads to nuclear localization of the desmosomal protein plakoglobin and a 2-fold reduction in canonical Wnt/beta-catenin signaling through Tcf/Lef1 transcription factors.",
              "metadata": {
                "id": "524b3521d3fbfd4c340620f3",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "18258680",
                "name": "Endocrinology 2008 May 149(5) 2341-51"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "We found previously that the bipartite transcription factor beta-catenin/T cell factor (cat/TCF), the major effector of the canonical Wnt signaling pathway, activates intestinal glu expression and GLP-1 production. ",
              "metadata": {
                "id": "524b3521d3fbfd4c340620f2",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "16169070",
                "name": "Cell 2005 Sep 23 122(6) 957-68"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "background: (from text) Axin-1 is a negative regulator of the Wnt pathway that controls the levels of the transcriptional activator ?-catenin (Behrens et al., 1996). In the absence of Wnt signals, ?-catenin is degraded by an Axin-1-containing multiprotein complex , while activation of the pathway with, e.g., dishevelled (Dvl) inhibits ?-catenin degradation and induces Lef/Tcf-dependent transcription (Huelsken and Birchmeier, 2001).   evidence: (from text) In the assay, moderate overexpression of Dvl in HEK293 cells caused a 4-fold increase in reporter gene activity. However, this increase was reduced to 1.5-fold in a dose-dependent manner, when full-length ANP32A or CRMP1 were coexpressed (Figure 6C). The activity of protein fragments in the Wnt signaling assay correlated with their ability to bind Axin-1. ",
              "metadata": {
                "id": "524b3521d3fbfd4c340620df",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "15907834",
                "name": "Dev Biol 2005 Jul 1 283(1) 226-39"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Mouse",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Analysis of mouse BMP4 and N-myc promoter reveals the presence of multiple LEF/TCF DNA binding sites, several of which are conserved between mouse and human (Figs. 7A and B) (DePinho et al., 1986; Ebara et al., 1997). Co-transfection of luciferase reporter plasmids containing these sequences along with expression plasmids encoding either an activated b-catenin containing mutations in the GSK-3b phosphorylation sites (b-catenin/4145) or with a TCF3-VP16 fusion protein demonstrated that both promoter sequences could be activated by transcriptional mediators of Wnt signaling (Figs. 7A and B).",
              "metadata": {
                "id": "524b3521d3fbfd4c340620c7",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "11691783",
                "name": "Cancer Res 2001 Nov 1 61(21) 7722-6"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "The promoter activity of ENC1 was elevated approximately 3-fold by transfection of an activated form of beta-catenin together with wild-type T-cell factor (Tcf)4 in HeLa cells.",
              "metadata": {
                "id": "524b3521d3fbfd4c340620b8",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "11931652",
                "name": "Biochem J 2002 Apr 15 363(Pt 2) 253-62"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "The MMP-26 promoter was able to drive luciferase expression in human A549 lung carcinoma, HT1080 fibrosarcoma and HEK293 embryonic kidney cells.... Sequential deletion and mutation analysis, and electrophoretic mobility-shift assay have identified the T-cell factor-4 (Tcf-4) motif and the activator protein-1 site as the major regulatory elements of the MMP-26 promoter. Since previous studies have established that the Tcf-4 transcription factor is subjected exclusively to regulation through the beta-catenin/E(epithelial)-cadherin pathway, this implies the specific expression of MMP-26 in cancer cells of epithelial origin.",
              "metadata": {
                "id": "524b3521d3fbfd4c340620b7",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "18399550",
                "name": "Anat Rec (Hoboken) 2008 May 291(5) 593-600"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "The expression of ING4 was markedly reduced in human lung adenocarcinoma tissues. Overexpression of ING4 can induce growth inhibition in A549 cells both in vitro and in vivo, and also induce up-regulation of p27, down-regulation of cyclinD1, SKP2, and Cox2, and inactivation of the Wnt-1/beta-catenin pathway. ",
              "metadata": {
                "id": "524b3521d3fbfd4c340620ac",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "17108104",
                "name": "Cancer Res 2006 Nov 15 66(22) 10677-82"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "hARD1 knockdown repressed the promoter activity of the cyclin D1 gene, which inhibited the transcription of cyclin D1. Moreover, hARD1 knockdown reduced the binding of beta-catenin/TCF4 transcription factor to cyclin D1 promoter and repressed its transcriptional activity. Inversely, hARD1 expression increased the transcriptional activity of beta-catenin",
              "metadata": {
                "id": "524b3521d3fbfd4c340620a1",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "12615699",
                "name": "Cancer Res 2003 Mar 1 63(5) 895-901"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "aberrant transactivation of a certain set of target genes by the beta-catenin and T-cell factor/lymphoid enhancer factor complex has been considered crucial for the initiation of intestinal tumorigenesis Abcb1a gene contains multiple beta-catenin-T-cell factor4-binding elements in its promoter and is one of the immediate targets of the complex",
              "metadata": {
                "id": "524b3521d3fbfd4c34062096",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "17113388",
                "name": "Curr Biol 2006 Nov 21 16(22) 2239-44"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "MALDI-TOF mass spectrometry (MS) identified two CK2 phosphorylation sites (S42, S61) within the amino terminus of hLEF-1, and mutation of these sites reduced binding to beta-catenin in vitro and transactivation in vivo.",
              "metadata": {
                "id": "524b3521d3fbfd4c34062086",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "15142975",
                "name": "Development 2004 Jun 131(12) 2791-801"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Mouse",
                "tissue": "",
                "cell": "neuron"
              },
              "summary_text": "To determine whether this TCF binding element is functional, we compared the activities of the Ngn1 gene promoter (nt -2670 to +74) containing either an intact or mutated version of this DNA sequence (Fig. 6A). Cultured NPCs were transfected with a luciferase reporter construct under the control of the wild-type or mutant Ngn1 gene promoter. We found that the transcriptional activity of the mutant promoter was markedly reduced compared with that of the wild-type (Fig. 6B).To determine whether this TCF binding element is functional, we compared the activities of the Ngn1 gene promoter (nt -2670 to +74) containing either an intact or mutated version of this DNA sequence (Fig. 6A). Cultured NPCs were transfected with a luciferase reporter construct under the control of the wild-type or mutant Ngn1 gene promoter. We found that the transcriptional activity of the mutant promoter was markedly reduced compared with that of the wild-type (Fig. 6B).    ",
              "metadata": {
                "id": "524b3521d3fbfd4c34062084",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "15979100",
                "name": "Life Sci 2005 Jul 29 77(11) 1249-62"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "We showed that the expression of c-myc binding protein (MYCBP) in colon carcinoma cells was consistently upregulated by overexpressed LEF-1, which is confirmed by microarray data, RT-PCR and luciferase assay. We suggest that the MYCBP gene can be a direct target of beta-catenin/LEF-1 pathway through its LEF-1 binding site(s) in the MYCBP promoter, and that MYCBP up-regulation in colon carcinoma cell may play a co-activator role of c-MYC.",
              "metadata": {
                "id": "524b3521d3fbfd4c34062081",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "15053919",
                "name": "Biochim Biophys Acta 2004 Apr 1 1691(1) 1-15"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "More specifically, pathological overexpression of ILK results in down-regulation of E-cadherin expression, and nuclear accumulation of beta-catenin, leading to the subsequent activation of the beta-catenin/Tcf transcription complex, the downstream components of the Wnt signalling pathway. ",
              "metadata": {
                "id": "524b3521d3fbfd4c3406207f",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "15668231",
                "name": "J Biol Chem 2005 Jan 24"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Inhibition of GSK-3ss activity by LiCl augmented accumulation of ss-catenin and caused induction of versican-Luc activity as well as versican mRNA levels.",
              "metadata": {
                "id": "524b3521d3fbfd4c34062076",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "18536717",
                "name": "Nat Genet 2008 Jul 40(7) 862-70"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Mouse",
                "tissue": "embryonic tissue",
                "cell": ""
              },
              "summary_text": "Next, we crossed the transgenic Wntb-catenin reporter line BAT-lacZ (BAT-gal) into the Gata6 flox/flox:Sftpc-cre mutants and stained embryos for b-galactosidase expression at E13.5 and E16.5. We have previously reported that b-galactosidase expression from this Wnt reporter declines rapidly in airway epithelium after E11.5 (ref. 12). Notably, there was a pronounced increase in b-galactosidase expression in the airway epithelium of Gata6 flox/flox:Sftpc-cre mutants, indicating that Wntb-catenin signaling was upregulated in airway epithelium upon loss of Gata6 expression (Fig. 5ch).",
              "metadata": {
                "id": "524b3521d3fbfd4c34062070",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "18819930",
                "name": "Mol Cancer Res 2008 Sep 6(9) 1421-30"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "We discovered that Sox7 protein physically interacts with beta-catenin and suppresses beta-catenin-mediated transcription by depleting active beta-catenin. ",
              "metadata": {
                "id": "524b3521d3fbfd4c3406206b",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "21707762",
                "name": "Exp Dermatol 2011 Jun 26"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": "Fibroblasts"
              },
              "summary_text": "Our data demonstrated that beta-catenin can protect NHSFs from H(2) O(2) -induced premature senescence by alleviating oxidative stress",
              "metadata": {
                "id": "524b3521d3fbfd4c34062069",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "11856748",
                "name": "J Biol Chem 2002 May 17 277(20) 17933-43"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "We provide evidence that the androgen receptor (AR) can promote nuclear translocation of beta-catenin in LNCaP and PC3 prostate cancer cells.",
              "metadata": {
                "id": "524b3521d3fbfd4c34062067",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "17937616",
                "name": "Biol Chem 2007 Oct 388(10) 1027-33"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "The GPx2 promoter contains five putative beta-catenin/TCF binding sites. Accordingly, the promoter was active in two cell lines with a constitutively active Wnt pathway, HepG2 and SW480, but not in BHK-21 cells in which the pathway is silent. Overexpression of beta-catenin/TCF activated the GPx2 promoter in all three cell lines.",
              "metadata": {
                "id": "524b3521d3fbfd4c34062058",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "19661059",
                "name": "J Biol Chem 2009 Oct 9 284(41) 28021-32"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Rat",
                "tissue": "",
                "cell": "fetal lung type II cell"
              },
              "summary_text": "Pleiotrophin increased the tyrosine phosphorylation of beta-catenin, promoted beta-catenin translocation into the nucleus, and activated T cell factor/lymphoid enhancer factor transcription factors",
              "metadata": {
                "id": "524b3521d3fbfd4c34062057",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "12651860",
                "name": "J Biol Chem 2003 May 30 278(22) 20259-67"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Mouse",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "the first located at -48 bp and the second located at -701 bp, are susceptible to beta-catenin/TCF4 transactivation. Co-transfection with a beta-catenin expression vector enhanced the promoter activity whereas E-cadherin had the opposite effect. Binding of beta-catenin/TCF4 complexes from SW480 nuclear extracts to these sequences was confirmed by electrophoretic shift and supershift mobility assays. Altogether these results are consistent with the idea that the beta-catenin/TCF4 transactivation pathway contributes to SMC3 overexpression in intestinal tumorigenesis.",
              "metadata": {
                "id": "524b3521d3fbfd4c34062029",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "17317723",
                "name": "FASEB J 2007 Jun 21(8) 1831-43"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Mouse",
                "tissue": "Endothelium",
                "cell": ""
              },
              "summary_text": "We used immortalized MCEC with a stable, normal endothelial phenotype.  Treatment with Tobacco smoke 12.8 puffs/l caused time-dependent translocation of beta-catenin to the nucleus within 30 min of treatment and increased total beta-catenin levels.",
              "metadata": {
                "id": "524b3521d3fbfd4c3406201a",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "15239100",
                "name": "Hepatology 2004 Jul 40(1) 167-76"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Mouse",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "leukocyte cell-derived chemotaxin 2 (LECT2) gene as a direct target of beta-catenin LECT2 expression is specifically induced in different mouse models that express activated beta-catenin in the liver",
              "metadata": {
                "id": "524b3521d3fbfd4c34062018",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "17317723",
                "name": "FASEB J 2007 Jun 21(8) 1831-43"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Mouse",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "When ApoE/ mice were exposed or shamexposed to cigarette smoke for 1 h daily for 15 days, body weight was unaffected. Statistically significant increases in Akt (168% increase, P\t0.01), GSK-3 phosphorylation (237% increase, P\t0.01) (Fig. 9A, C), and -catenin (288% increase, P\t0.05) were associated with enhanced -catenin accumulation in the nuclear fraction (Fig. 9B, C) and increased expression of COX-2 protein (63% increase, P\t0.05) in CT of smoke exposed ApoE/mice compared with control mice.",
              "metadata": {
                "id": "524b3521d3fbfd4c3406200a",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "17606995",
                "name": "J Cell Sci 2007 Jul 15 120(Pt 14) 2402-12"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Mouse",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Dvl binds to the intracellular domain of the frizzled transmembrane receptors, and also to axin to block its activity, which results in the activation of beta-catenin and, consequently, in a transcriptional switch. ",
              "metadata": {
                "id": "524b3521d3fbfd4c34062007",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "19029933",
                "name": "Oncogene 2008 Nov 24 27(55) 6908-19"
              },
              "experiment_context": {
                "disease": "Neoplasm",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "other studies have indicated that Lkb1 downregulates the b-catenin pathway through either activation of GSK3a negative regulator of b-cateninor through diverting MARK2/ Par1a from its capacity to activate the pathway (Spicer et al., 2003; Lin-Marq et al., 2005).",
              "metadata": {
                "id": "524b3521d3fbfd4c34062002",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "19018094",
                "name": "Blood 2009 Feb 12 113(7) 1513-21"
              },
              "experiment_context": {
                "disease": "Multiple Myeloma",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "In addition, enzastaurininduced b-catenin coimmunoprecipitated with its cofactor T-cell factor 4 (Figure S1B), subsequently activating the T-cell factor 4 promoter in MM.1S, HEK293, and HeLa cell lines, as shown by the TOP-FLASH reporter assay (Figure S1C). Taken together, these results demonstrate that enzastaurin triggers accumulation of transcriptionally active b- catenin because of inhibition of its degradation, rather than induced overexpression.",
              "metadata": {
                "id": "524b3521d3fbfd4c34062000",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "22461429",
                "name": "Am J Respir Cell Mol Biol 2012 Mar 29"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": "Epithelial Cells"
              },
              "summary_text": "These data show that activation of the Wnt signaling pathway is capable of inducing an EMT program in lung epithelial cells, through beta-catenin, and that this process is controlled by JNK1",
              "metadata": {
                "id": "524b3521d3fbfd4c34061ff7",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "14551209",
                "name": "J Biol Chem 2003 Dec 5 278(49) 48805-14"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "he Wnt/beta-catenin signaling pathway can activate Msx2 via the binding of Lef1 endogenous Smad4, but not Smad1, was part of the Lef1 transcriptional complex in response to beta-catenin activation, dismissing any implication of BMP signaling in this response.",
              "metadata": {
                "id": "524b3521d3fbfd4c34061fed",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "12881717",
                "name": "Oncogene 2003 Jul 17 22(29) 4594-610"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Mouse",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Deletion of exon 3 from the endogenous beta-catenin gene in differentiating mammary alveolar epithelium of the mouse results in the generation of an activated protein that lacks amino acids 5-80. This is accompanied by a loss of mammary epithelial differentiation and a transdifferentiation process...known and unknown genes activated in the transdifferentiation process were identified. A new 20 kDa protein (PANE1) induced upon transdifferentiation",
              "metadata": {
                "id": "524b3521d3fbfd4c34061fd7",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "12185585",
                "name": "Oncogene 2002 Aug 29 21(38) 5861-7"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Our results indicate that MT1-MMP is a direct down-stream target in the Wnt signaling pathway, and that one of the ways accumulated beta-catenin contributes to colorectal carcinogenesis is by transactivating this gene.",
              "metadata": {
                "id": "524b3521d3fbfd4c34061fd2",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "12086873",
                "name": "Cancer Cell 2002 Mar 1(2) 145-55"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "In many cancers, inactivation of the adenomatous polyposis coli (APC) or Axin tumor suppressor proteins or activating mutations in beta-catenin lead to elevated beta-catenin levels, enhanced binding of beta-catenin to T cell factor (TCF) proteins, and increased expression of TCF-regulated genes",
              "metadata": {
                "id": "524b3521d3fbfd4c34061fc9",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "15367660",
                "name": "Mol Cell Biol 2004 Oct 24(19) 8386-94"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Mouse",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Expression of beta-catenin target genes, including those for T (brachyury), Axin2, and cyclin D1, was not increased in Duplin(-/-) embryos, suggesting that the developmental defect is not simply attributable to upregulation of Wnt signaling caused by the lack of this inhibitor.",
              "metadata": {
                "id": "524b3521d3fbfd4c34061fc3",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "12086873",
                "name": "Cancer Cell 2002 Mar 1(2) 145-55"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Rat",
                "tissue": "",
                "cell": "kidney epithelial cell"
              },
              "summary_text": "gene for the basic helix-loop-helix transcription factor ITF-2 (immunoglobulin transcription factor-2) was activated in rat E1A-immortalized RK3E cells following neoplastic transformation by beta-catenin",
              "metadata": {
                "id": "524b3521d3fbfd4c34061fc1",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "15240568",
                "name": "J Cell Biol 2004 Jul 5 166(1) 37-47"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Mouse",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "We provide in vitro and in vivo evidence that a bipartite beta-catenin/TCF4 transcription factor, the effector of the Wnt signaling pathway, is required for SOX9 expression in epithelial cells.",
              "metadata": {
                "id": "524b3521d3fbfd4c34061fb4",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "17006939",
                "name": "Hepatology 2006 Oct 44(4) 992-1002"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Mouse",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Here we report that delivery of the human HGF gene delivery in mice led to hepatomegaly via beta-catenin activation in the liver in 1- and 4-week studies. The mechanisms of beta-catenin activation in the 1-week study included loss of c-Met-beta-catenin association as well as canonical beta-catenin activation, leading to its nuclear translocation.",
              "metadata": {
                "id": "524b3521d3fbfd4c34061fb2",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "15716380",
                "name": "J Cell Biol 2005 Feb 14 168(4) 633-42"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "We identified the neuronal cell adhesion molecule L1, as a target gene of beta-catenin-TCF signaling in colorectal cancer cells. The L1 gene promoter is activated by -catenin-TCF signaling in colon cancer cells (from full text).",
              "metadata": {
                "id": "524b3521d3fbfd4c34061f9d",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "11085512",
                "name": "Cancer Res 2000 Nov 1 60(21) 5959-62"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "With WNT signaling activation, beta-catenin is stabilized and translocated to the nucleus to associate with TCFs. The TCF-beta-catenin complex regulates the transcription of target genes such as c-myc and cyclin D1",
              "metadata": {
                "id": "524b3521d3fbfd4c34061f9c",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "18701488",
                "name": "Cancer Res 2008 Aug 15 68(16) 6643-51"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "We confirmed activation of the WNT pathway through the demonstration of enzastaurin-mediated loss of ?-catenin S37/41 phosphorylation with resultant ?-catenin accumulation in the cytoplasm and subsequent translocation to the nucleus (Fig. S1 A-C). This resulted in a dose-dependent increase in the transcriptional activity of ?-catenin (Fig. S1, D and E).",
              "metadata": {
                "id": "524b3521d3fbfd4c34061f89",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "16849547",
                "name": "Cancer Res 2006 Jul 15 66(14) 7024-31"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": "hepatocyte"
              },
              "summary_text": "We then did ChIP assay in HepG2 cells to confirm in vivo binding of -catenin/Tcf-4 to the NOS2 promoter. The DNA--catenin/Tcf-4 complexes were immunoprecipitated with antibodies shown in Fig. 2C followed by reversal of cross-linking and PCR amplification using primers flanking the TBE1 (?3.8 kb) and TBE2 (?6.1 kb) and nuclear factor-{kappa}B (NF-{kappa}B)/signal transducers and activators of transcription 1 (STAT1; ?5.8 to ?5.2 kb) sites in the NOS2 promoter (Fig. 2C). Agarose gel analysis of PCR products showed that the TBE1 or TBE2 containing DNA was immunoprecipitated by anti--catenin (Fig. 2C, lane B) or anti-Tcf-4 (Fig. 2C, lane T) antibodies, and only a weak background was observed by IgG (Fig. 2C, lane I). These evidences indicate that -catenin/Tcf-4 specifically binds to the NOS2 promoter TBE1 and TBE2 regions in vivo. Overexpression of beta-catenin and Tcf-4 significantly increased both basal and cytokine-induced NOS2 promoter activity (P < 0.01), and the induction was dependent on intact TBE sites. Transfection with control Tcf-4 (Fig. 4A, lane 1) or -catenin (Fig. 4A, lane 2) empty vectors did not induce NOS2 mRNA or protein, whereas induction of both endogenous mRNA and protein was observed with overexpression of Tcf-4 (Fig. 4A, lane 3) or -catenin (Fig. 4A, lane 4). ",
              "metadata": {
                "id": "524b3521d3fbfd4c34061f84",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "17317723",
                "name": "FASEB J 2007 Jun 21(8) 1831-43"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "We used immortalized MCEC with a stable, normal endothelial phenotype.  Treatment with Tobacco smoke 12.8 puffs/l caused time-dependent translocation of beta-catenin to the nucleus within 30 min of treatment and increased total beta-catenin levels.",
              "metadata": {
                "id": "524b3521d3fbfd4c34061f81",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "11328805",
                "name": "J Biol Chem 2001 Jul 27 276(30) 28443-50"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "To examine whether HRG-induced membrane dynamics and beta -catenin nuclear translocation lead to increased beta -catenin/TCFLEF signaling, we examined the effect of HRG on the transcriptional activation from a synthetic LEF/beta -catenin responsive promoter construct containing three LEFTCF binding sites. As shown in Fig. 3A, suppression of PI 3-kinase by LY294002 or a dominant-negative mutant of the p85 subunit of PI 3-kinase (5), as well as its downstream effector AKT, was accompanied by blockade of beta -catenin nuclear signaling-associated transactivation from the LEFTCF promoter in HRG-treated cells. ",
              "metadata": {
                "id": "524b3521d3fbfd4c34061f7d",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "18245266",
                "name": "Am J Physiol Lung Cell Mol Physiol 2008 Apr 294(4) L778-86"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "Epithelium",
                "cell": ""
              },
              "summary_text": "The minimal ?-catenin-responsive promoter TOPFLASH was activated approximately twofold by HGF within 6 h; this activation was sustained for at least 17 h, in agreement with our findings that the COX-2 promoter also had sustained activation by HGF (compare Fig. 4B and 3B).",
              "metadata": {
                "id": "524b3521d3fbfd4c34061f7b",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "16799642",
                "name": "Oncogene 2006 Dec 14 25(59) 7747-57"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "We now report that molecular and pharmacological inhibition of ILK activity in mammalian cells directly modulates Wnt signaling by suppressing the stabilization and nuclear translocation of beta-catenin, as well as beta-catenin/Lef-mediated transcription. I",
              "metadata": {
                "id": "524b3521d3fbfd4c34061f77",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "14707084",
                "name": "J Immunol 2004 Jan 15 172(2) 1099-108"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Mouse",
                "tissue": "",
                "cell": "leukocyte"
              },
              "summary_text": "The up-regulated genes included proliferation-inducing transcription factors such as c-fos, fosB, and other nuclear proteins (AHNAK, glucocorticoid-induced lymphoid Zinc finger (GILZ), and cysteine- rich protein (CRP)1 and CRP2), cell cycle regulators (checkpoint suppressor 1, cyclin-dependent kinase 15 kinase, cdc-like kinase 2, and end-binding protein 3, which binds mitotic spindles), and signaling molecules such as the CL100 dual-specificity phosphatase.",
              "metadata": {
                "id": "524b3521d3fbfd4c34061f70",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "11507052",
                "name": "Cancer Res 2001 Aug 15 61(16) 6050-4"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "To determine whether activation of the Wnt pathway directly up-regulates the VEGF promoter, an oncogenic -cateninS37A was transfected with the 2.8-kb VEGF-pGL2 reporter into HeLa cells. A critical serine phosphorylation site at amino acid 37 that ordinarily targets -catenin for degradation has been mutated (10) . Fig. 1D.  Citation  illustrates a linear dose response to the effects of -cateninS37A. The peak response was observed when 1.25 g of expression vector was cotransfected with 0.75 g of reporter vector, resulting in a >30-fold stimulation of VEGF promoter activity. In independent studies, HeLa cells were treated with 25 mM LiCl, an inhibitor of GSK-3 kinase activity. GSK-3 is a negative regulator of Wnt signaling, and inhibiting GSK-3 with LiCl resulted in a 2.2-fold increase in VEGF promoter activity. Collectively, these findings indicate that activation of Wnt signaling up-regulates VEGF expression in colonic neoplasia. (from full text) ",
              "metadata": {
                "id": "524b3521d3fbfd4c34061f65",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "19073771",
                "name": "Diabetes 2009 Mar 58(3) 609-19"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": "preadipocyte"
              },
              "summary_text": "RESULTS: Dact1 is a preadipocyte gene that decreases during adipogenesis. However, Dact1 knockdown impairs adipogenesis through activation of the Wnt/beta-catenin signaling pathway, and this is reversed by treatment with the secreted Wnt antagonist, secreted Frizzled-related protein 1 (Sfrp1).",
              "metadata": {
                "id": "524b3521d3fbfd4c34061f5a",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "12200448",
                "name": "J Biol Chem 2002 Nov 1 277(44) 42386-93"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "In this screen, we identified the CXC chemokine interleukin 8 (IL-8) as a direct target of beta-catenin-Tcf4. IL-8 is constitutively expressed in various cancers, and it has been implicated in tumor progression through its mitogenic, motogenic, and angiogenic activities. The IL-8 promoter contains a unique consensus Tcf/Lef site that is critical for IL-8 activation by beta-catenin.",
              "metadata": {
                "id": "524b3521d3fbfd4c34061f57",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "14559787",
                "name": "Cancer Res 2003 Oct 1 63(19) 6116-20"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "moreover a reporter-gene assay using luciferase activity as a marker and an electromobility shift assay indicated that FGF18 is a downstream transcription target in the beta-catenin/Tcf4 pathway",
              "metadata": {
                "id": "524b3521d3fbfd4c34061f52",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "19933277",
                "name": "J Biol Chem 2010 Jan 29 285(5) 3157-67"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Rat",
                "tissue": "",
                "cell": "Alveolar type II cell"
              },
              "summary_text": "We also show that Adeno-ICAT-GFP expression strongly suppresses the level of AT1 markers, T1alpha and RAGE, compared with Adeno-GFP- or S37A-beta-catenin-infected cells (Fig. 7)...FIGURE 7. Inhibition of beta-catenin/TCF-dependent transcription by ICAT antagonizes expression of markers of AT1 cell differentiation.",
              "metadata": {
                "id": "524b3521d3fbfd4c34061f49",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "19244345",
                "name": "Mol Biol Cell 2009 Apr 20(8) 2297-310"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "This process requires the presence of E-cadherin for efficient caveolin-1mediated sequestration of -catenin to the plasma membrane, because metastatic HT29(US) cells lacking E-cadherin do not down-regulate survivin and this ability is restored upon reexpression of E-cadherin (Torres et al., 2007).",
              "metadata": {
                "id": "524b3521d3fbfd4c34061f2c",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "16488995",
                "name": "Cancer Res 2006 Feb 15 66(4) 1964-73"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Mouse",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Figure 1. Altered gene expression in the ovaries of Catnbflox(ex3)/+;Amhr2cre/+ mice. Ovarian gene expression analyses comparing Catnbflox(ex3)/+;Amhr2cre/+ ovaries with Catnbflox(ex3)/+ control animals were done using Affymetrix microarrays, and selected genes overexpressed in Catnbflox(ex3)/+;Amhr2cre/+ ovaries (except Rpl19, which was used for standardization) were categorized. Ovarian the Catnb(flox(ex3)/+);Amhr2(cre/+) mouse model, which expresses a dominant-stable mutant of beta-catenin in granulosa cells all upregulated",
              "metadata": {
                "id": "524b3521d3fbfd4c34061f14",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "18048388",
                "name": "Carcinogenesis 2008 Jan 29(1) 84-92"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "We found that Dickkopf (Dkk)-3, a member of Dkk family of Wnt antagonists, is frequently inactivated in lung cancer and plays a role in suppressing lung cancer cell growth through inhibition of beta-catenin/T-cell factor (TCF)-4 signaling. Dkk3 is the only Dkk family member abundantly expressed in normal lung, but silenced by promoter hypermethylation in a large fraction of lung cancer cell lines and lung tumors. Downregulation of Dkk3 was correlated with tumor progression and expression of nuclear beta-catenin in lung tumors. Ectopic expression of Dkk3 in lung cancer cells with Dkk3 hypermethylation induced apoptosis and inhibited TCF-4 activity as well as nuclear accumulation of beta-catenin and expression of TCF-4 targets c-Myc and cyclin D1. Furthermore, small interference RNA knock down of Dkk3 in cells lacking Dkk3 hypermethylation was sufficient to promote cell proliferation, beta-catenin nuclear translocation and expression of c-Myc. These observations suggested that epigenetic inactivation of Dkk3 activates the Wnt/beta-catenin pathway, thereby promoting the growth of lung cancer cells.",
              "metadata": {
                "id": "524b3521d3fbfd4c34061f0e",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "16099633",
                "name": "Curr Opin Cell Biol 2005 Oct 17(5) 459-65"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "There is a pool of cell-surface-associated ?-catenin that is specifically targeted to the nucleus as a result of phosphorylation of tyrosine 142. Activation of c-Met by HGF/SF results in release of ?-catenin from the plasma membrane and translocation to the nucleus in association with BCL9-2, a protein homologous to Drosophila Legless, which is responsible for escorting ?-catenin into the nucleus [18] enhancing its transcriptional activity.",
              "metadata": {
                "id": "524b3521d3fbfd4c34061f0b",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "18180285",
                "name": "Mol Cell Biol 2008 Mar 28(5) 1489-502"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Mouse",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "lysates from 4-month-old wild-type and Iqgap2-/- mice, as well as those from 2-year-old Iqgap2-/- mice affected with HCC, were probed with an antibody specifically recognizing the active form of ?-catenin, dephoshorylated on Ser37 or Thr41 (Upstate Biotechnology/Millipore). As shown in Fig. 5C, the dephosphorylated (active) ?-catenin was specifically detected in HCC livers and not in samples from younger wild-type or Iqgap2-/- mice (without HCC).",
              "metadata": {
                "id": "524b3521d3fbfd4c34061f09",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "17452641",
                "name": "Proc Natl Acad Sci U S A 2007 May 1 104(18) 7516-21"
              },
              "experiment_context": {
                "disease": "Multiple Myeloma",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": " MM cell lines responded to the Wnt ligand Wnt3A, the GSK3beta-inhibitor lithium chloride, and an active mutant form of beta-catenin with both significantly increased proliferation and higher levels of nonphosphorylated nuclear beta-catenin.",
              "metadata": {
                "id": "524b3521d3fbfd4c34061ef2",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "15304487",
                "name": "J Biol Chem 2004 Sep 24 279(39) 40255-8"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "estrogen receptor (ER) alpha- and beta-catenin precipitated within the same immunocomplexes, reciprocally enhanced the transactivation of cognate reporter genes, and were reciprocally recruited to cognate response elements in the promoters of endogenous target genes.",
              "metadata": {
                "id": "524b3521d3fbfd4c34061ee8",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "14990565",
                "name": "J Biol Chem 2004 May 14 279(20) 20794-806"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Rat",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Here we report that beta-catenin, Lef-1, Ets transcription factors, and the AP-1 protein c-Jun each weakly enhanced luciferase expression from a OPN promoter-luciferase reporter construct",
              "metadata": {
                "id": "524b3521d3fbfd4c34061ee5",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "16705313",
                "name": "Br J Cancer 2006 Jun 5 94(11) 1672-7"
              },
              "experiment_context": {
                "disease": "colorectal adenoma",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Here we show a correlated high expression of beta-catenin and securin (hPTTG1) in colorectal adenomas and carcinomas and further demonstrate that securin is a target of beta-catenin transcriptional activation.",
              "metadata": {
                "id": "524b3521d3fbfd4c340622b2",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "15378020",
                "name": "Oncogene 2004 Nov 4 23(52) 8520-6"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Through computational screening and subsequent experimental analysis, we identified a novel TCF target gene, DKK1, which has been shown to be a potent inhibitor of Wnt signaling. ",
              "metadata": {
                "id": "524b3521d3fbfd4c340622af",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "15067007",
                "name": "J Biol Chem 2004 Jun 4 279(23) 24659-65"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Transfection studies carried out in the presence of Dkk-1 revealed that Wnt11 could effectively repress canonical signaling downstream of both Dvl1 and -catenin (Fig. 2B). activated forms of LRP (LRPC2), Dishevelled 1 (Myri-Dsh), and -catenin were transfected into P19 embryonal carcinoma (EC) cells in the presence or absence of Wnt11 or Wnt1. ",
              "metadata": {
                "id": "524b3521d3fbfd4c340622ac",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "17692806",
                "name": "Cancer Cell 2007 Aug 12(2) 145-59"
              },
              "experiment_context": {
                "disease": "Lung Neoplasms",
                "species_common_name": "Mouse",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Disruption of E-cadherin caused massive formation of intratumoral vessels that was reversible in the early phase of induction. Vascularized tumors grew more rapidly, developed invasive fronts, and gave rise to micrometastasis. beta-catenin was identified as a critical effector of E-cadherin disruption leading to upregulation of VEGF-A and VEGF-C. In vivo, lung tumor cells with disrupted E-cadherin expressed beta-catenin target genes normally found in other endodermal lineages suggesting that reprogramming may be involved in metastatic progression.",
              "metadata": {
                "id": "524b3521d3fbfd4c3406229e",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "12498294",
                "name": "Dig Dis Sci 2002 Dec 47(12) 2738-42"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Nuclear beta-catenin enhances the activating expression of MMP-7 genes by binding with the T-cell factor/lymphoid enhancer factor family of transcription factors",
              "metadata": {
                "id": "524b3521d3fbfd4c3406227b",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "10489374",
                "name": "Science 1999 Sep 17 285(5435) 1923-6"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Here it is shown that one of the target genes of Tcf4 in epithelial cells is Tcf1 (NOTE: TCF7 is the current gene symbol for Tcf1) ....(from full text) ... Tcf1 expression is regulated by APC and beta -catenin-Tcf4.  ...We sequenced 1/2 kb directly upstream of promoter I and found the region to be a CpG island containing two potential Tcf0binding motifs (Fig. 2B). The combination of beta -catenin and Tcf4 transactivated the enhancer three- to fourfold in a transient reporter assay (Fig. 2C). Furthermore, expression of a dominant-negative Tcf4 (Delta NTcf4, which lacks the beta -catenin interaction domain) inhibited enhancer activity in LS174T colorectal cancer cells (Fig. 2D).",
              "metadata": {
                "id": "524b3521d3fbfd4c34062278",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "11719433",
                "name": "Cancer Res 2001 Nov 15 61(22) 8089-93"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Here we show that beta-catenin activates the human laminin-5 gamma2 gene through two T-cell factor-binding elements in a synergistic manner together with hepatocyte growth factor and conclude that laminin-5 gamma2 is another important target gene of nuclear beta-catenin during tumor progression.",
              "metadata": {
                "id": "524b3521d3fbfd4c34062277",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "21980461",
                "name": "PLoS One 2011 6(9) e25450"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": "Fibroblasts"
              },
              "summary_text": "Furthermore, TGF-beta induced the expression of collagen1alpha1, alpha-sm-actin and fibronectin, which was attenuated by beta-catenin specific siRNA and by pharmacological inhibition of beta-catenin",
              "metadata": {
                "id": "524b3521d3fbfd4c34062275",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "20519507",
                "name": "J Biol Chem 2010 Jun 2"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": "kidney epithelial cell"
              },
              "summary_text": "Delivery of Wnt1 gene activated beta-catenin and promoted PAI-1 expression after obstructive injury, whereas blockade of Wnt/beta-catenin signaling by Dickkopf-1 gene inhibited PAI-1 induction. ",
              "metadata": {
                "id": "524b3521d3fbfd4c34062272",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "19661059",
                "name": "J Biol Chem 2009 Oct 9 284(41) 28021-32"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Rat",
                "tissue": "",
                "cell": "Alveolar type II cell"
              },
              "summary_text": "Wnt3a increased the binding of b-catenin to the promoter of cyclin D1 (CNND1), a known target of TCF/LEF/b-catenin (Fig. 9B)....b-Catenin bound to both TCF/LEF binding sites on the Dlk1 promoter, and this binding was enhanced by Wnt3a (Fig. 9B).",
              "metadata": {
                "id": "524b3521d3fbfd4c34062271",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "12898599",
                "name": "J Pathol 2003 Aug 200(5) 627-32"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "One other possible cause of beta-catenin accumulation is overexpression of insulin-like growth factors (IGFs), as both IGF-I and IGF-II have been shown to stabilize beta-catenin.",
              "metadata": {
                "id": "524b3521d3fbfd4c3406226e",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "18432252",
                "name": "Nat Rev Cancer 2008 May 8(5) 387-98"
              },
              "experiment_context": {
                "disease": "Neoplasm",
                "species_common_name": "Mouse",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "The identification of the protooncogene MYC as a direct transcriptional target of Wnt?-catenin signalling in 1998 shed light on the transforming activity of the Wnt pathway in cancer106",
              "metadata": {
                "id": "524b3521d3fbfd4c3406225f",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "11850407",
                "name": "Genes Dev 2002 Feb 15 16(4) 439-51"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "It also associates specifically with phosphorylated IkappaBalpha and beta-catenin destruction motifs, probably functioning in multiple transcriptional programs by activating the NF-kappaB pathway and inhibiting the beta-catenin pathway.",
              "metadata": {
                "id": "524b3521d3fbfd4c3406225d",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "17692806",
                "name": "Cancer Cell 2007 Aug 12(2) 145-59"
              },
              "experiment_context": {
                "disease": "Lung Neoplasms",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Supplimental figure S7: VEGFC mRNA expression increased by constitutive active form of beta-catenin. However, beta-catenin siRNA did not attenuate this increase. ",
              "metadata": {
                "id": "524b3521d3fbfd4c34062254",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "17587809",
                "name": "Cells Tissues Organs 2007 185(1-3) 61-5"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": " During EMT,  - catenin dissociates from the E-cadherin/catenin cell membrane complexes, accumulates in the cytoplasm and translocates into the nucleus where it acts as a transcriptional coactivator through its binding with the members of the T cell factor/lymphoid enhancer factor (TCF/LEF) transcription factor family",
              "metadata": {
                "id": "524b3521d3fbfd4c34062251",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "18075512",
                "name": "Nat Rev Cancer 2008 Jan 8(1) 61-70"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "from full text - By contrast, oncogenic factors have been shown to promote BIRC5 transcription. This is the case for TCF4 ?-catenin (50), a developmentally regulated transcriptional activator complex participating in colon cancer, signal transduction and activator of transcription 3 (STAT3) (51), which is an oncogenic transcription factor involved in cytokine signalling, and a group of E2F transcription factors (52)",
              "metadata": {
                "id": "524b3521d3fbfd4c3406223e",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "10921920",
                "name": "J Biol Chem 2000 Oct 20 275(42) 32871-8"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "beta-Catenin is efficiently phosphorylated by glycogen synthase kinase-3beta in the Axin complex in the cytoplasm, resulting in the down-regulation.",
              "metadata": {
                "id": "524b3521d3fbfd4c3406222f",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "18598779",
                "name": "Int J Biochem Cell Biol 2008 40(12) 2889-900"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "In HEK293T cells, SRY repressed beta-catenin-mediated TCF-dependent gene activation in the presence of a specific GSK3beta inhibitor or an activated beta-catenin mutant, suggesting that SRY inhibits Wnt signaling at the level of beta-catenin. Three SRY mutant proteins with nuclear localization defects, encoded by XY male-to-female patients, failed to inhibit beta-catenin; surprisingly four SRY sex reversed mutants with defective DNA-binding activity showed near wild-type SRY inhibitory activity. Moreover the potent transactivator SRY-VP16 fusion protein also showed wild-type SRY inhibitory activity. Thus SRY inhibition of beta-catenin involves neither DNA-binding nor transactivation functions of SRY.",
              "metadata": {
                "id": "524b3521d3fbfd4c34062228",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "16452189",
                "name": "Cancer Res 2006 Feb 1 66(3) 1354-62"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Two members of the FGF family, FGF20 (P = 1.2e?07) and FGF9 (P = 6.1e?06), were up-regulated >6-fold in OEAs with Wnt signaling pathway defects (n = 12) (mutated beta-catenin) compared with those with intact Wnt signaling (n = 18). FGF9 as an indirect, rather than direct, transcriptional target of the Wnt signaling pathway (from full text).",
              "metadata": {
                "id": "524b3521d3fbfd4c3406221f",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "11691783",
                "name": "Cancer Res 2001 Nov 1 61(21) 7722-6"
              },
              "experiment_context": {
                "disease": "Neoplasms",
                "species_common_name": "Human",
                "tissue": "Epithelium",
                "cell": ""
              },
              "summary_text": "The promoter activity of ENC1 was elevated approximately 3-fold by transfection of an activated form of beta-catenin together with wild-type T-cell factor (Tcf)4 in HeLa cells.",
              "metadata": {
                "id": "524b3521d3fbfd4c3406221c",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "12482967",
                "name": "Mol Cell Biol 2003 Jan 23(1) 131-9"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "These results suggest that Wnt-5a can inhibit beta-catenin-mediated transcriptional stimulation via TAK1.",
              "metadata": {
                "id": "524b3521d3fbfd4c34062212",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "21980461",
                "name": "PLoS One 2011 6(9) e25450"
              },
              "experiment_context": {
                "disease": "Chronic Obstructive Pulmonary Disease",
                "species_common_name": "Human",
                "tissue": "",
                "cell": "Fibroblasts"
              },
              "summary_text": "Stimulation with TGF-B1 also resulted in a significant induction of active Beta-catenin in fibroblasts from individuals with and without COPD. Interestingly, the induction of active Beta-catenin was significantly higher in fibroblasts from individuals with COPD than those without COPD (figure 7A). ",
              "metadata": {
                "id": "524b3521d3fbfd4c34062211",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "19018094",
                "name": "Blood 2009 Feb 12 113(7) 1513-21"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "we next investigated target genes of b-catenin, in particular, c-Jun, c-Myc, and cyclin D1, and their possible contribution to the anti-MM effect of enzastaurin. Our results show that b-catenin induces c-Jun, whereas c-Myc was markedly down-regulated #(this is protein - western blots in fig 3A)",
              "metadata": {
                "id": "524b3521d3fbfd4c3406220e",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "12183361",
                "name": "Genes Dev 2002 Aug 15 16(16) 2058-72"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Overexpression of either beta -catenin or plakoglobin induced Nr-CAM in a variety of cell types and the LEF/TCF binding sites in the Nr-CAM promoter were required for its activation by catenins. The Nr-CAM gene promoter contains several LEF-1 binding sites that can complex with LEF-1 and beta -catenin (from full text).",
              "metadata": {
                "id": "524b3521d3fbfd4c34062209",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "16952352",
                "name": "Exp Cell Res 2006 Nov 1 312(18) 3620-30"
              },
              "experiment_context": {
                "disease": "Neoplasms",
                "species_common_name": "Rat",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "All single or double-mutant-transfected cells continued to show HGF-induced nuclear translocation of FLAG-beta-catenin except the mutations affecting 654 and 670 simultaneously (Y654/670F), which coincided with the lack of formation of beta-catenin-TCF complex and DNA synthesis, in response to the HGF treatment.",
              "metadata": {
                "id": "524b3521d3fbfd4c34062205",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "15617677",
                "name": "Dev Biol 2005 Jan 15 277(2) 316-31"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Mouse",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Members of the Dickkopf (Dkk) family of secreted proteins are potent inhibitors of Wnt/beta-catenin signaling.",
              "metadata": {
                "id": "524b3521d3fbfd4c34062200",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "19648923",
                "name": "Nat Immunol 2009 Sep 10(9) 992-9"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": "t-cell"
              },
              "summary_text": "Here we show that early GATA-3 expression, required for T(H)2 differentiation, was induced by T cell factor 1 (TCF-1) and its cofactor beta-catenin, mainly from the proximal Gata3 promoter upstream of exon 1b",
              "metadata": {
                "id": "524b3521d3fbfd4c340621f8",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "17306568",
                "name": "Immunity 2007 Feb 26(2) 227-39"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": "t-cell"
              },
              "summary_text": "We find that endothelial-cell-derived wnts, acting through Frizzled receptors, induce matrix metalloproteinase (MMP) 2 and MMP9 expression in effector T cells. Blocking wnt signaling, or MMP activity, reduces T cell migration through the basement membrane in vitro and into inflamed skin in vivo. Wnt signaling stabilizes beta-catenin protein in T cells and directly targets the MMP promoters through tandem TCF sites. ",
              "metadata": {
                "id": "524b3521d3fbfd4c340621f4",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "18077326",
                "name": "Proc Natl Acad Sci U S A 2007 Dec 18 104(51) 20344-9"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Fhit and b-catenin Form Complexes at Promoters of Target Genes and Regulate Growth. In this context, we next examined whether Fhit is recruited to promoters of TCF/b-catenin target genes. Indeed, in ChIP experiments Fhit and b-catenin were detected at the axin2, cyclin D1, MMP14, and survivin promoters in MCF-7 cells. In binding to the beta-catenin C-terminal domain, Fhit represses transcription of target genes such as cyclin D1, axin2, MMP-14, and survivin. ",
              "metadata": {
                "id": "524b3521d3fbfd4c340621f2",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "12019147",
                "name": "Cancer Res 2002 May 15 62(10) 2744-8"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Affymetrix Genechip expression profiling of parental cells and gene-targeted derivatives identified numerous novel genes whose expression was dependent on the presence of oncogenic beta-catenin. The transforming growth factor-beta family member bone morphogenetic protein 4 (BMP4), whose receptor is mutated in a rare inherited gastrointestinal cancer predisposition syndrome, was the most highly differentially expressed gene. ",
              "metadata": {
                "id": "524b3521d3fbfd4c340621f0",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "14737101",
                "name": "Oncogene 2004 Jan 22 23(3) 654-64"
              },
              "experiment_context": {
                "disease": "Neoplasms",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "we demonstrated constitutive TCF activation in primary desmoid cultures and showed that b-catenin binds and activates TCF-3 in these tumors (Tejpar et al., 2001).",
              "metadata": {
                "id": "524b3521d3fbfd4c3406229c",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "11713273",
                "name": "Mol Cell Biol 2001 Dec 21(24) 8365-70"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Mouse",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Whereas TIP49a activated beta-catenin transcriptional activities,  TIP49b repressed them",
              "metadata": {
                "id": "524b3521d3fbfd4c34062293",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "15358837",
                "name": "Mol Endocrinol 2004 Dec 18(12) 3035-49"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Mouse",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "We observed that estrogen treatment prompts nuclear localization of active beta-catenin in the uterine epithelium.",
              "metadata": {
                "id": "524b3521d3fbfd4c34062292",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "22056988",
                "name": "Nature 2011 Dec 1 480(7375) 118-22"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "PKM2-dependent beta-catenin transactivation is instrumental in EGFR-promoted tumour cell proliferation and brain tumour development. ",
              "metadata": {
                "id": "524b3521d3fbfd4c34062290",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "14751232",
                "name": "Biochem Biophys Res Commun 2004 Feb 20 314(4) 1001-7"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Modified assertion",
              "metadata": {
                "id": "524b3521d3fbfd4c3406226a",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "11477086",
                "name": "J Biol Chem 2001 Oct 26 276(43) 40113-9"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Modified assertion",
              "metadata": {
                "id": "524b3521d3fbfd4c34062269",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "15576404",
                "name": "Development 2005 Jan 132(1) 49-60"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Mouse",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "removal of beta-catenin abolishes canonical Wnt signaling",
              "metadata": {
                "id": "524b3521d3fbfd4c3406223c",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "12036951",
                "name": "Cancer Res 2002 Jun 1 62(11) 3322-6"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "We have recently identified ICAT, a beta-catenin-interacting protein that interferes with the interaction between beta-catenin and TCF-4, thereby negatively regulating Wnt signaling.",
              "metadata": {
                "id": "524b3521d3fbfd4c34062226",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "17229088",
                "name": "Eur J Neurosci 2006 Dec 24(12) 3387-92"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "GSK3alpha reduces nuclear levels of beta-catenin, whilst reporter gene assays demonstrated that GSK3alpha inhibits beta-catenin-directed Tcf/Lef-dependent transcription",
              "metadata": {
                "id": "524b3521d3fbfd4c340621b0",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "15492751",
                "name": "Lab Invest 2005 Jan 85(1) 124-36"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "promoter studies were performed and revealed control of MTAP expression by LEF/TCF/beta-catenin.",
              "metadata": {
                "id": "524b3521d3fbfd4c340621a6",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "12408868",
                "name": "Cell 2002 Oct 18 111(2) 241-50"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "disruption of beta-catenin/TCF-4 activity in CRC cells induces a rapid G1 arrest",
              "metadata": {
                "id": "524b3521d3fbfd4c3406219f",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "10910037",
                "name": "Cancer Res 2000 Jul 1 60(13) 3354-8"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Here we report isolation of a novel murine gene, Drctnnb1a (down-regulated by Ctnnb1, a), the expression of which was experimentally down-regulated in response to the activated form of beta-catenin.",
              "metadata": {
                "id": "524b3521d3fbfd4c34062191",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "17621269",
                "name": "Oncogene 2007 Jul 9"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "n the absence of Wnt stimulation, the level of beta-catenin is reduced via glycogen synthase kinase (GSK)-3beta-mediated phosphorylation and subsequent proteasome-dependent degradation.",
              "metadata": {
                "id": "524b3521d3fbfd4c34062164",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "10987283",
                "name": "Cancer Res 2000 Sep 1 60(17) 4761-6"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Corresponding to the accumulation of beta-catenin, expression of the MDR1 gene product was steadily up-regulated in adenomas and adenocarcinomas of 10 patients with familial adenomatous polyposis.",
              "metadata": {
                "id": "524b3521d3fbfd4c34062157",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "10514384",
                "name": "Am J Pathol 1999 Oct 155(4) 1033-8"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Here we report the identification of the matrix metalloproteinase MMP-7 as another target gene of beta-catenin/TCF-4. MMP-7 is overexpressed in 80% of human colorectal cancers and known to be an important factor for early tumor growth, with a potential function also for later progression steps, like invasion and metastasis.",
              "metadata": {
                "id": "524b3521d3fbfd4c34062156",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "21868364",
                "name": "J Cell Sci 2011 Sep 15 124(Pt 18) 3174-86"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Rat",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Forced REST upregulation (Fig. 3A,B) caused a downregulation of TSC2 with a gain of ?-catenin levels (Fig. 3C) and activity (Fig. 3D,E). ",
              "metadata": {
                "id": "524b3521d3fbfd4c34062154",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "16251184",
                "name": "J Biol Chem 2005 Dec 16 280(50) 41342-51"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "activation of beta-catenin-mediated transcription required ERK, PI3K, and Akt signaling.",
              "metadata": {
                "id": "524b3521d3fbfd4c34062150",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "10318916",
                "name": "Proc Natl Acad Sci U S A 1999 May 11 96(10) 5522-7"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Here, we show that the cyclin D1 gene is a direct target for transactivation by the beta-catenin/LEF-1 pathway through a LEF-1 binding site in the cyclin D1 promoter.",
              "metadata": {
                "id": "524b3521d3fbfd4c34062144",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "11254732",
                "name": "J Immunol 2001 Apr 1 166(7) 4713-20"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "This is the first demonstration that LPS exposure activates AKT, inactivates GSK-3, and causes accumulation and transcriptional activity of beta-catenin in the nucleus of any cell, including alveolar macrophages.",
              "metadata": {
                "id": "524b3521d3fbfd4c3406212d",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "19108950",
                "name": "Cancer Lett 2009 May 8 277(1) 29-37"
              },
              "experiment_context": {
                "disease": "Neoplasm",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Restoration of SOX7 induced colorectal cancer cell apoptosis, inhibited cell proliferation and colony formation. In addition, SOX7 efficiently suppressed beta-catenin-mediated transcriptional activity.",
              "metadata": {
                "id": "524b3521d3fbfd4c34062128",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "15760903",
                "name": "J Biol Chem 2005 May 13 280(19) 19185-95"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Mouse",
                "tissue": "",
                "cell": "chondrocyte"
              },
              "summary_text": "Delta-beta-catenin expression markedly increased expression of MMP-2, MMP-3, MMP-7, MMP-9, MT3-MMP, and ADAMTS5. However, when activated beta-catenin mutant (delta-beta-catenin)",
              "metadata": {
                "id": "524b3521d3fbfd4c3406211b",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "12810642",
                "name": "Cancer Res 2003 Jun 15 63(12) 3145-53"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Transfection of normal colon epithelial cells with activated beta-catenin up-regulated levels of VEGF-A mRNA and protein by 250-300%.",
              "metadata": {
                "id": "524b3521d3fbfd4c34062118",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "12569091",
                "name": "J Biol Chem 2003 Apr 11 278(15) 13487-95"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Mouse",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "a beta-catenin signaling inhibitor, ICAT, inhibited expression of beta III-tubulin.",
              "metadata": {
                "id": "524b3521d3fbfd4c34062110",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "15806138",
                "name": "Lab Invest 2005 Jun 85(6) 768-79"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "We show here that beta-catenin can directly induce transcription from the TCF4 promoter, the effect being enhanced by the p300 coactivator.",
              "metadata": {
                "id": "524b3521d3fbfd4c340620de",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "11170292",
                "name": "Genes Chromosomes Cancer 2001 Mar 30(3) 316-21"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "From mutations file",
              "metadata": {
                "id": "524b3521d3fbfd4c340620d7",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "15492215",
                "name": "Proc Natl Acad Sci U S A 2004 Oct 26 101(43) 15370-5"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "14-3-3zeta Interacts with beta-Catenin and Activates beta-Catenin-Dependent Promoters in HEK293T cells and Colon Carcinoma cells. ",
              "metadata": {
                "id": "524b3521d3fbfd4c340620cb",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "15817151",
                "name": "Exp Cell Res 2005 May 1 305(2) 253-65"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "the promoter of the Wnt/beta-catenin/TCF target gene matrilysin",
              "metadata": {
                "id": "524b3521d3fbfd4c340620c2",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "12508284",
                "name": "Bioessays 2003 Jan 25(1) 66-71"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "In contrast, MUC1 has a highly conserved cytoplasmic tail, which binds beta-catenin, a key component of adherens junctions and a regulator of transcription, in a process that is tightly regulated by MUC1 phosphorylation.",
              "metadata": {
                "id": "524b3521d3fbfd4c340620b3",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "11691915",
                "name": "Nucleic Acids Res 2001 Nov 1 29(21) 4274-83"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Our studies also demonstrate the presence of a functional transactivation domain in SOX7 protein C-terminus, as well as the ability of SOX7 protein to significantly reduce Wnt/beta-catenin-stimulated transcription",
              "metadata": {
                "id": "524b3521d3fbfd4c340620b2",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "18703780",
                "name": "Circ Res 2008 Sep 26 103(7) 694-701"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": "Myocytes, Smooth Muscle"
              },
              "summary_text": "Then active beta-catenin associated with Tcf4 and translocated into the nucleus. This enhanced the expression of the cell cycle activator cyclin D1.",
              "metadata": {
                "id": "524b3521d3fbfd4c340620aa",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "16982607",
                "name": "J Biol Chem 2006 Nov 17 281(46) 35021-9"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Phosphorylation of Ser188 by PKA inhibited the ability of FRAT1 to activate beta-catenin-dependent transcription.",
              "metadata": {
                "id": "524b3521d3fbfd4c340620a2",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "10446041",
                "name": "Science 1999 Aug 13 285(5430) 1028-32"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "In addition, there is evidence that ILK promotes translocation of b-catenin to the nucleus, and b-catenin can regulate the cyclin D1 promoter through the TCF/LEF transcription factor",
              "metadata": {
                "id": "524b3521d3fbfd4c3406208e",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "14563838",
                "name": "J Biol Chem 2003 Dec 26 278(52) 52491-6"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Modified assertion",
              "metadata": {
                "id": "524b3521d3fbfd4c3406204f",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "14636578",
                "name": "Mol Cell 2003 Nov 12(5) 1201-11"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "The Wnt/beta-catenin pathway rapidly induces the transcription of the cell-type-restricted transcription factor Pitx2 that is required for effective cell-specific proliferation activating growth-regulating genes",
              "metadata": {
                "id": "524b3521d3fbfd4c34062040",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "12719544",
                "name": "Proc Natl Acad Sci U S A 2003 May 13 100(10) 5834-9"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Mouse",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Modified assertion",
              "metadata": {
                "id": "524b3521d3fbfd4c3406203f",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "16581771",
                "name": "Mol Cell Biol 2006 Apr 26(8) 2955-64"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Chromatin immunoprecipitation analysis indicates that CCN1/Cyr61 is a direct target of canonical Wnt/beta-catenin signaling.",
              "metadata": {
                "id": "524b3521d3fbfd4c34062037",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "14647429",
                "name": "Oncogene 2004 Mar 11 23(10) 1829-37"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Mouse",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "While most beta-catenin protein is localized to the cell membrane and is involved in cell-cell adhesion, accumulation of free cytoplasmic beta-catenin will translocate into the nucleus where it functions in a bipartite transcription factor complex, whose targets include invasion and metastasis promoting endopeptidases, matrix metalloproteinases (MMP).",
              "metadata": {
                "id": "524b3521d3fbfd4c34062036",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "12234972",
                "name": "Cancer Res 2002 Sep 15 62(18) 5126-8"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Moreover, in CRC cells, induction of dominant-negative TCF proteins and the consequent abrogation of beta-catenin/TCF-mediated transcriptional activation lead to a strong down-regulation of Met expression. ",
              "metadata": {
                "id": "524b3521d3fbfd4c34062028",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "12949799",
                "name": "Int J Cancer 2003 Nov 1 107(2) 229-37"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Cad5CD overexpression inhibits beta-catenin/Tcf4 transcriptional activity, as determined by results from microarray experiments.",
              "metadata": {
                "id": "524b3521d3fbfd4c3406201c",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "14660579",
                "name": "J Biol Chem 2004 Feb 20 279(8) 6840-6"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Modified assertion",
              "metadata": {
                "id": "524b3521d3fbfd4c34061ff4",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "16965538",
                "name": "FEBS J 2006 Oct 273(20) 4594-602"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Mouse",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "CKI phosphorylation of mDvl-1 at two highly conserved residues, serines 139 and 142, was observed by MS and confirmed by phosphopeptide mapping of in vivo phosphorylated protein. Phosphorylation of these sites is dependent on casein kinase I epsilon activity in vivo.",
              "metadata": {
                "id": "524b3521d3fbfd4c34061fb9",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "16204248",
                "name": "J Biol Chem 2005 Dec 2 280(48) 39795-801"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Mouse",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "TIS7 has the capacity to down-regulate beta-catenin/Tcf-4 transcriptional activity.",
              "metadata": {
                "id": "524b3521d3fbfd4c34061f92",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "19248765",
                "name": "Biochem Biophys Res Commun 2009 Apr 17 381(4) 625-9"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "T-cell factor (Tcf) transcriptional activation by stabilization of beta-catenin and can upregulate the expression of mRNA encoding cysteine-rich protein 61 (Cyr61), a secreted extracellular matrix protein that stimulates angiogenesis.",
              "metadata": {
                "id": "524b3521d3fbfd4c34061f21",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) actsIn tscript(p(HGNC:CTNNB1))",
              "citation": {
                "type": "PubMed",
                "id": "17287208",
                "name": "J Biol Chem 2007 Apr 13 282(15) 11221-9"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Phosphorylation of beta-catenin by AKT increases its transcriptional activity and promotes tumor cell invasion, indicating that AKT-dependent regulation of beta-catenin plays a critical role in tumor invasion and development.",
              "metadata": {
                "id": "524b3521d3fbfd4c34061f05",
                "created_by": "selventa"
              }
            }
          ]
        }
      },
      {
        "source": "complex(GOCC:\"PRC1 complex\")",
        "target": "p(HGNC:DKK1)",
        "relation": "decreases",
        "directed": true,
        "label": "complex(GOCC:\"PRC1 complex\") decreases p(HGNC:DKK1)",
        "metadata": {
          "edgeId": "524b3517d3fbfd4c34051973",
          "createdBy": "selventa",
          "casual": true,
          "evidences": [
            {
              "bel_statement": "complex(GOCC:\"PRC1 complex\") decreases p(HGNC:DKK1)",
              "citation": {
                "type": "PubMed",
                "id": "0",
                "name": ""
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "metadata": {
                "id": "524b3521d3fbfd4c3406225c",
                "created_by": "selventa"
              }
            }
          ]
        }
      },
      {
        "source": "complex(GOCC:\"PRC1 complex\")",
        "target": "complex(GOCC:\"ESC/E(Z) complex\")",
        "relation": "decreases",
        "directed": true,
        "label": "complex(GOCC:\"PRC1 complex\") decreases complex(GOCC:\"ESC/E(Z) complex\")",
        "metadata": {
          "edgeId": "550084fa89e3621814f3b2d6",
          "createdBy": "susana.martinez.arbas",
          "casual": false,
          "evidences": [
            {
              "bel_statement": "complex(GOCC:\"PRC1 complex\") decreases complex(GOCC:\"ESC/E(Z) complex\")",
              "citation": {
                "type": "PubMed",
                "id": "24652950",
                "name": ""
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "PRC1 silences the expression of PRC2 target genes by blocking the recruitment of transcriptional activation factors and preventing initiation of transcription.",
              "metadata": {
                "id": "550084fa89e3621814f3b254",
                "created_by": "susana.martinez.arbas"
              }
            }
          ]
        }
      },
      {
        "source": "p(SFAM:\"HDAC Family\")",
        "target": "p(HGNC:E2F4)",
        "relation": "decreases",
        "directed": true,
        "label": "p(SFAM:\"HDAC Family\") decreases p(HGNC:E2F4)",
        "metadata": {
          "edgeId": "551fdc4089e36205507f4386",
          "createdBy": "susana.martinez.arbas",
          "casual": false,
          "evidences": [
            {
              "bel_statement": "p(SFAM:\"HDAC Family\") decreases p(HGNC:E2F4)",
              "citation": {
                "type": "PubMed",
                "id": "18830406",
                "name": ""
              },
              "experiment_context": {
                "disease": "COPD",
                "species_common_name": "human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "HDACs form complexes with and thereby regulate the activity of members of the E2F family of transcription factors...E2F-4 formed a complex with Egr-1 following cellular stimulation with CSE or the HDAC inhibitor TSA (Fig. 6C).",
              "metadata": {
                "id": "551fdc4089e36205507f42ea",
                "created_by": "susana.martinez.arbas"
              }
            }
          ]
        }
      },
      {
        "source": "p(SFAM:\"HDAC Family\")",
        "target": "p(HGNC:HDAC1)",
        "relation": "hasMember",
        "directed": true,
        "label": "p(SFAM:\"HDAC Family\") hasMember p(HGNC:HDAC1)",
        "metadata": {
          "edgeId": "551fd8e889e36205507d4775",
          "createdBy": "susana.martinez.arbas",
          "casual": false,
          "evidences": [
            {
              "bel_statement": "p(SFAM:\"HDAC Family\") hasMember p(HGNC:HDAC1)",
              "citation": {
                "type": "PubMed",
                "id": "15050820",
                "name": ""
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Figure 1. Human HDACs.",
              "metadata": {
                "id": "551fd8e889e36205507d46da",
                "created_by": "susana.martinez.arbas"
              }
            }
          ]
        }
      },
      {
        "source": "p(SFAM:\"HDAC Family\")",
        "target": "p(HGNC:HDAC2)",
        "relation": "hasMember",
        "directed": true,
        "label": "p(SFAM:\"HDAC Family\") hasMember p(HGNC:HDAC2)",
        "metadata": {
          "edgeId": "5526dcaf89e36201cc9a4c67",
          "createdBy": "susana.martinez.arbas",
          "casual": false,
          "evidences": [
            {
              "bel_statement": "p(SFAM:\"HDAC Family\") hasMember p(HGNC:HDAC2)",
              "citation": {
                "type": "PubMed",
                "id": "22978694",
                "name": ""
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Fig.3. Classes of histone deacetylases (HDACs/SIRTs).",
              "metadata": {
                "id": "5526dcaf89e36201cc9a4bb2",
                "created_by": "susana.martinez.arbas"
              }
            }
          ]
        }
      },
      {
        "source": "p(SFAM:\"HDAC Family\")",
        "target": "p(HGNC:HDAC3)",
        "relation": "hasMember",
        "directed": true,
        "label": "p(SFAM:\"HDAC Family\") hasMember p(HGNC:HDAC3)",
        "metadata": {
          "edgeId": "55293bd689e3620d90c11895",
          "createdBy": "susana.martinez.arbas",
          "casual": false,
          "evidences": [
            {
              "bel_statement": "p(SFAM:\"HDAC Family\") hasMember p(HGNC:HDAC3)",
              "citation": {
                "type": "PubMed",
                "id": "15169878",
                "name": "Mol Cell Biol. 2004 Jun;24(12):5106-18.\nActivation of the growth-differentiation factor 11 gene by the histone deacetylase (HDAC) inhibitor trichostatin A and repression by HDAC3.\nZhang X1, Wharton W, Yuan Z, Tsai SC, Olashaw N, Seto E."
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Human and mouse HDACs are divided into three classes: class I (HDAC1, -2, -3, and -8), class II (HDAC4, -5, -6, -7, -9, -10), and class III (SIRT1 to -7).",
              "metadata": {
                "id": "55293bd689e3620d90c117bd",
                "created_by": "susana.martinez.arbas"
              }
            }
          ]
        }
      },
      {
        "source": "p(SFAM:\"HDAC Family\")",
        "target": "cat(p(SFAM:\"HDAC Family\"))",
        "relation": "actsIn",
        "directed": true,
        "label": "p(SFAM:\"HDAC Family\") actsIn cat(p(SFAM:\"HDAC Family\"))",
        "metadata": {
          "edgeId": "524b3517d3fbfd4c3405196b",
          "createdBy": "selventa",
          "casual": false,
          "evidences": [
            {
              "bel_statement": "p(SFAM:\"HDAC Family\") actsIn cat(p(SFAM:\"HDAC Family\"))",
              "citation": {
                "type": "PubMed",
                "id": "12486003",
                "name": "EMBO J 2002 Dec 16 21(24) 6820-31"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Mouse",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Trichostatin A (TSA) inhibits all histone deacetylases (HDACs) of both class I and II, whereas trapoxin (TPX) cannot inhibit HDAC6, a cytoplasmic member of class II HDACs. ",
              "metadata": {
                "id": "524b3521d3fbfd4c340621fc",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(SFAM:\"HDAC Family\") actsIn cat(p(SFAM:\"HDAC Family\"))",
              "citation": {
                "type": "PubMed",
                "id": "16357169",
                "name": "Cancer Res 2005 Dec 15 65(24) 11588-96"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Here, we describe such differentiation induced by the histone deacetylase inhibitor tributyrin. ",
              "metadata": {
                "id": "524b3521d3fbfd4c34061ef6",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(SFAM:\"HDAC Family\") actsIn cat(p(SFAM:\"HDAC Family\"))",
              "citation": {
                "type": "PubMed",
                "id": "11902584",
                "name": "Nat Rev Cancer 2002 Jan 2(1) 38-47"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "HDACs are also activated by hypoxia a specific HDAC inhibitor, trichostatin A, reduces hypoxia-induced angiogenesis",
              "metadata": {
                "id": "524b3521d3fbfd4c34062236",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(SFAM:\"HDAC Family\") actsIn cat(p(SFAM:\"HDAC Family\"))",
              "citation": {
                "type": "PubMed",
                "id": "15602009",
                "name": "Pharmacol Rev 2004 Dec 56(4) 515-48"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": "Macrophages, Alveolar"
              },
              "summary_text": "In cigarette smokers and patients with COPD, there is a marked reduction in activity of HDAC and reduced expression of HDAC2 in alveolar macrophages (Ito et al., 2001aGo) and an even greater reduction in HDAC2 expression in peripheral lung tissue (Ito et al., 2001",
              "metadata": {
                "id": "524b3521d3fbfd4c34062093",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(SFAM:\"HDAC Family\") actsIn cat(p(SFAM:\"HDAC Family\"))",
              "citation": {
                "type": "PubMed",
                "id": "12635173",
                "name": "Nat Rev Cancer 2002 Feb 2(2) 101-12"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "overexpression of NCOA1 increases tamoxifen's agonist activity in experimental cell systems105,106 treatment of breast cancer cell lines with the HDAC inhibitor Trichostatin A (TSA) inhibited their proliferation.",
              "metadata": {
                "id": "524b3521d3fbfd4c34062083",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(SFAM:\"HDAC Family\") actsIn cat(p(SFAM:\"HDAC Family\"))",
              "citation": {
                "type": "PubMed",
                "id": "12189205",
                "name": "Proc Natl Acad Sci U S A 2002 Sep 3 99(18) 11700-5"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Suberoylanilide hydroxamic acid (SAHA) is a potent inhibitor of histone deacetylases (HDACs)",
              "metadata": {
                "id": "524b3521d3fbfd4c340621c5",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(SFAM:\"HDAC Family\") actsIn cat(p(SFAM:\"HDAC Family\"))",
              "citation": {
                "type": "PubMed",
                "id": "18830406",
                "name": "PLoS One 2008 3(10) e3316"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "In human pulmonary epithelial cells, exposure to CSE or histone deacetylase (HDAC) inhibitor rapidly induced autophagy. CSE decreased HDAC activity, resulting in increased binding of early growth response-1 (Egr-1) and E2F factors to the autophagy gene LC3B promoter, and increased LC3B expression. Knockdown of E2F-4 or Egr-1 inhibited CSE-induced LC3B expression. Knockdown of Egr-1 also inhibited the expression of Atg4B, a critical factor for LC3B conversion. Inhibition of autophagy by LC3B-knockdown protected epithelial cells from CSE-induced apoptosis. Egr-1(-/-) mice, which displayed basal airspace enlargement, resisted cigarette-smoke induced autophagy, apoptosis, and emphysema.",
              "metadata": {
                "id": "524b3521d3fbfd4c340620c4",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(SFAM:\"HDAC Family\") actsIn cat(p(SFAM:\"HDAC Family\"))",
              "citation": {
                "type": "PubMed",
                "id": "11292684",
                "name": "FASEB J 2001 Apr 15(6) 1110-2"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": "Macrophages"
              },
              "summary_text": "In addition, there was a significant correlation between IL-1?stimulated TNF-? release and HDAC activity (r=-0.79, p=0.0021).",
              "metadata": {
                "id": "524b3521d3fbfd4c340621ff",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(SFAM:\"HDAC Family\") actsIn cat(p(SFAM:\"HDAC Family\"))",
              "citation": {
                "type": "PubMed",
                "id": "10851266",
                "name": "Int J Mol Med 2000 Jul 6(1) 51-4"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Like sodium butyrate, trichostatin A enhanced TNF-alpha-induced C3 secretion, but suppressed TNF-alpha-induced factor B secretion. These effects were also observed at the level of mRNA. Trichostatin A modulated TNF-alpha-induced C3 and factor B secretion in a manner similar to that induced by sodium butyrate, suggesting that both sodium butyrate and trichostatin A exert certain counter-regulatory effects associated with histone hyperacetylation",
              "metadata": {
                "id": "524b3521d3fbfd4c34062176",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(SFAM:\"HDAC Family\") actsIn cat(p(SFAM:\"HDAC Family\"))",
              "citation": {
                "type": "PubMed",
                "id": "15234474",
                "name": "Neurosci Lett 2004 Jul 15 365(1) 64-8"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Mouse",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "The expression of 10 histone deacetylases (HDAC1-10) mRNAs in mouse neuroblastoma Neuro-2a and microglia N9 cell cultures after treatment by inhibitors of HDACs, sodium butyrate and trichostatin A was studied to elucidate whether HDAC inhibitors affect the gene expression of HDACs In both Neuro-2a and N9 cells the highest increase was observed for HDAC5 and -6 mRNA, whereas, HDAC4 had a prominent increase in mRNA levels after drug treatment only in N9 microglia cell line but not in Neuro-2a.",
              "metadata": {
                "id": "524b3521d3fbfd4c340620e3",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(SFAM:\"HDAC Family\") actsIn cat(p(SFAM:\"HDAC Family\"))",
              "citation": {
                "type": "PubMed",
                "id": "16987807",
                "name": "J Biol Chem 2006 Nov 17 281(46) 34725-9"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "In contrast to MYC, the members of the MAD family function as transcriptional repressors at least in part by recruiting mSIN3-histone deacetylase complexes (summarized in Fig. S2D) (8).",
              "metadata": {
                "id": "524b3521d3fbfd4c340620ed",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(SFAM:\"HDAC Family\") actsIn cat(p(SFAM:\"HDAC Family\"))",
              "citation": {
                "type": "PubMed",
                "id": "15130492",
                "name": "Dev Cell 2004 May 6(5) 673-84"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Mouse",
                "tissue": "",
                "cell": "myoblast"
              },
              "summary_text": "TSA does not stimulate cell proliferation (Figure 1C), excluding the possibility that the formation of hypernucleated myotubes with increased size is a consequence of an increased number of undifferenti-ated myoblasts available for the fusion process. These findings suggest that TSA promotes neither hyperplasia nor hypertrophy, but rather that it acts as an inducer of myoblast fusion, as indicated by the increased fusion index (Figure 1D).",
              "metadata": {
                "id": "524b3521d3fbfd4c340620fd",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(SFAM:\"HDAC Family\") actsIn cat(p(SFAM:\"HDAC Family\"))",
              "citation": {
                "type": "PubMed",
                "id": "16473865",
                "name": "Am J Physiol Lung Cell Mol Physiol 2006 Jul 291(1) L46-57"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": "Monocytes"
              },
              "summary_text": "CSE (1%,, 2.5% and 5%) significantly decreased HDAC activity (Fig. 6), which was associated with the decreased levels of HDAC1, HDAC2, and HDAC3 protein levels at 4 and 24 h",
              "metadata": {
                "id": "524b3521d3fbfd4c34062091",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(SFAM:\"HDAC Family\") actsIn cat(p(SFAM:\"HDAC Family\"))",
              "citation": {
                "type": "PubMed",
                "id": "12975471",
                "name": "J Clin Invest 2003 Sep 112(6) 863-71"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Mouse",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Here we show that Hop can inhibit SRF-dependent transcriptional activation by recruiting histone deacetylase (HDAC) activity and can form a complex that includes HDAC2.",
              "metadata": {
                "id": "524b3521d3fbfd4c34062132",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(SFAM:\"HDAC Family\") actsIn cat(p(SFAM:\"HDAC Family\"))",
              "citation": {
                "type": "PubMed",
                "id": "22848425",
                "name": "PLoS One 2012 7(7) e41033"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Mouse",
                "tissue": "",
                "cell": "astrocyte"
              },
              "summary_text": "To validate the microarray results, a subset of 6 genes that show differential expression as a result of treatment with all three drugs were selected for RT-qPCR analysis. The genes chosen for validation include Toll-like receptor 4 (TLR4), Roundabout axon guidance receptor, homolog 3 (Robo3), Homeobox protein a10 (Hoxa10), medium polypeptide of neurofilament (Nfm), glial fibrillary acidic protein (GFAP), and the orphan nuclear receptor Nurr1. Changes in gene expression of DEGs were normalized against the levels of glyceraldehyde 3-phosphate dehydrogenase (GAPDH) expression. Figure 4 shows that for all 6 genes, the significant up- or down-regulation that was determined by microarray analysis was also seen when qPCR was performed.",
              "metadata": {
                "id": "524b3521d3fbfd4c34062100",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(SFAM:\"HDAC Family\") actsIn cat(p(SFAM:\"HDAC Family\"))",
              "citation": {
                "type": "PubMed",
                "id": "12054478",
                "name": "Arch Biochem Biophys 2002 May 15 401(2) 271-6"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "We conclude that histone deacetylation contributes to the repression of cyclin B1 expression in G(0) and G(1), and that this mechanism requires, in part, the E-box.",
              "metadata": {
                "id": "524b3521d3fbfd4c34061fb1",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(SFAM:\"HDAC Family\") actsIn cat(p(SFAM:\"HDAC Family\"))",
              "citation": {
                "type": "PubMed",
                "id": "10942396",
                "name": "Blood 2000 Aug 15 96(4) 1490-5"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Although these inhibitors induce apoptosis in several cell lines, the precise mechanism by which they do so remains obscure. This study shows that HDAC inhibitors, sodium butyrate and trichostatin A (TSA), abrogate interleukin (IL)-2-mediated gene expression in IL-2-dependent cells... Although histone hyperacetylation is believed to lead to transcriptional activation, the results showed an abrogation of IL-2-mediated induction of c-myc, bag-1, and LC-PTP gene expression.",
              "metadata": {
                "id": "524b3521d3fbfd4c34062106",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(SFAM:\"HDAC Family\") actsIn cat(p(SFAM:\"HDAC Family\"))",
              "citation": {
                "type": "PubMed",
                "id": "19842832",
                "name": "Exp Lung Res 2009 Aug 35(6) 439-85"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": "Macrophages"
              },
              "summary_text": "A reduced level of HDAC2 expression and HDAC activity are observed in bronchoalveolar macrophages from healthy smokers, when compared with non-smokers [56]...The mRNA expression of HDAC3 is also significantly reduced in AM of COPD smokers and healthy smokers when compared with that of nonsmokers [58].",
              "metadata": {
                "id": "524b3521d3fbfd4c34062135",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(SFAM:\"HDAC Family\") actsIn cat(p(SFAM:\"HDAC Family\"))",
              "citation": {
                "type": "PubMed",
                "id": "11960000",
                "name": "Proc Natl Acad Sci U S A 2002 Apr 16 99(8) 5442-7"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Mouse",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Here we report that the mouse homolog of Su(fu) [mSu(fu)] specifically interacts with SAP18, a component of the mSin3 and histone deacetylase complex. In addition, we demonstrate that mSu(fu) functionally cooperates with SAP18 to repress transcription by recruiting the SAP18-mSin3 complex to promoters containing the Gli-binding element.",
              "metadata": {
                "id": "524b3521d3fbfd4c3406218f",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(SFAM:\"HDAC Family\") actsIn cat(p(SFAM:\"HDAC Family\"))",
              "citation": {
                "type": "PubMed",
                "id": "15345672",
                "name": "Endocrinology 2004 Dec 145(12) 5485-92"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "This repression was blocked by treatment with the histone deacetylase inhibitor, trichostatin A, suggesting that repression by E2 may involve regulation of histone acetylation",
              "metadata": {
                "id": "524b3521d3fbfd4c34062235",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(SFAM:\"HDAC Family\") actsIn cat(p(SFAM:\"HDAC Family\"))",
              "citation": {
                "type": "PubMed",
                "id": "12054741",
                "name": "Biochem Biophys Res Commun 2002 May 31 294(1) 63-70"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Mouse",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Induction of murine H-rev107 gene expression by growth arrest and histone acetylation",
              "metadata": {
                "id": "524b3521d3fbfd4c340621bf",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(SFAM:\"HDAC Family\") actsIn cat(p(SFAM:\"HDAC Family\"))",
              "citation": {
                "type": "PubMed",
                "id": "12975471",
                "name": "J Clin Invest 2003 Sep 112(6) 863-71"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Mouse",
                "tissue": "",
                "cell": "cardiomyocyte"
              },
              "summary_text": "Hence, the predominant effect of nonspecific HDAC inhibition on cultured myocytes and in our transgenic and isoproterenol-treated mice is to prevent cardiac hypertrophy",
              "metadata": {
                "id": "524b3521d3fbfd4c34061fa0",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(SFAM:\"HDAC Family\") actsIn cat(p(SFAM:\"HDAC Family\"))",
              "citation": {
                "type": "PubMed",
                "id": "10521394",
                "name": "Genes Dev 1999 Oct 1 13(19) 2490-501"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Mouse",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "We report that trichostatin A (TSA), an inhibitor of histone deacetylases (HDACs), abrogates the ability of p53 to repress the transcription of two genes that it negatively regulates, Map4 and stathmin.",
              "metadata": {
                "id": "524b3521d3fbfd4c3406212f",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(SFAM:\"HDAC Family\") actsIn cat(p(SFAM:\"HDAC Family\"))",
              "citation": {
                "type": "PubMed",
                "id": "12097386",
                "name": "J Immunol 2002 Jul 15 169(2) 829-36"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Ariadne: Thus, Bcl6 binds to the IL-4 silencer region in Th1  cells and may deacetylate histones of the chromosomal region to repress  expression of those cytokine genes by recruiting the SMRT and histone  deacetylase complex.",
              "metadata": {
                "id": "524b3521d3fbfd4c340621e5",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(SFAM:\"HDAC Family\") actsIn cat(p(SFAM:\"HDAC Family\"))",
              "citation": {
                "type": "PubMed",
                "id": "17147010",
                "name": "COPD 2005 Dec 2(4) 445-55"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "In biopsies from asthmatic subjects there is an increase in HAT activity and some reduction in HDAC activity.",
              "metadata": {
                "id": "524b3521d3fbfd4c3406203e",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(SFAM:\"HDAC Family\") actsIn cat(p(SFAM:\"HDAC Family\"))",
              "citation": {
                "type": "PubMed",
                "id": "9917496",
                "name": "Int J Oncol 1999 Feb 14(2) 225-32"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "We studied the roles of butyrate and galectin-1 in the induction of differentiation and apoptosis in the prostate cancer cell line LNCaP. Treatment of LNCaP cells with butyrate resulted in induction of galectin-1 expression in a time- and dose-dependent manner.",
              "metadata": {
                "id": "524b3521d3fbfd4c34061fa8",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(SFAM:\"HDAC Family\") actsIn cat(p(SFAM:\"HDAC Family\"))",
              "citation": {
                "type": "PubMed",
                "id": "14695887",
                "name": "Proc Natl Acad Sci U S A 2004 Jan 13 101(2) 540-5"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "tumor",
                "cell": ""
              },
              "summary_text": "HDAC inhibition induces differentiation and/or apoptosis in transformed cells. We recently showed that HDAC inhibitors, such as suberoylanilide hydroxamic acid (SAHA), potently induce apoptosis",
              "metadata": {
                "id": "524b3521d3fbfd4c3406215d",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(SFAM:\"HDAC Family\") actsIn cat(p(SFAM:\"HDAC Family\"))",
              "citation": {
                "type": "PubMed",
                "id": "15123634",
                "name": "J Biol Chem 2004 Jul 16 279(29) 30358-68"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "inhibitors of histone deacetylase (HDAC) activity, butyrate, trichostatin A, and suberoylanilide hydroxamic acid, prevented IFNgamma-induced JAK1 activation, STAT1 phosphorylation, its nuclear translocation, and STAT1-dependent gene activation.",
              "metadata": {
                "id": "524b3521d3fbfd4c34061f8f",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(SFAM:\"HDAC Family\") actsIn cat(p(SFAM:\"HDAC Family\"))",
              "citation": {
                "type": "PubMed",
                "id": "14674679",
                "name": "Mol Cell Biochem 2003 Dec 254(1-2) 21-36"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": "colon epithelium"
              },
              "summary_text": "Numerous reports suggest that butyrate alters gene expression by reversibly inhibiting histone deacetylase (HDAC) causing hyperacetylation of histones leading to selective changes in gene expression [12, 23, 24].",
              "metadata": {
                "id": "524b3521d3fbfd4c3406217a",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(SFAM:\"HDAC Family\") actsIn cat(p(SFAM:\"HDAC Family\"))",
              "citation": {
                "type": "PubMed",
                "id": "9917496",
                "name": "Int J Oncol 1999 Feb 14(2) 225-32"
              },
              "experiment_context": {
                "disease": "Neoplasms",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Sodium butyrate is an established differentiation-inducing agent and has been shown to increase galectin-1 expression in colon carcinoma cells.",
              "metadata": {
                "id": "524b3521d3fbfd4c34062270",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(SFAM:\"HDAC Family\") actsIn cat(p(SFAM:\"HDAC Family\"))",
              "citation": {
                "type": "PubMed",
                "id": "15169878",
                "name": "Mol Cell Biol 2004 Jun 24(12) 5106-18"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Mouse",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Histone deacetylase (HDAC) inhibitors inhibit the proliferation of transformed cells in vitro, restrain tumor growth in animals",
              "metadata": {
                "id": "524b3521d3fbfd4c3406211e",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(SFAM:\"HDAC Family\") actsIn cat(p(SFAM:\"HDAC Family\"))",
              "citation": {
                "type": "PubMed",
                "id": "16357148",
                "name": "Cancer Res 2005 Dec 15 65(24) 11400-10"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Trichostatin A treatment inhibits histone deacetylase",
              "metadata": {
                "id": "524b3521d3fbfd4c340621d3",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(SFAM:\"HDAC Family\") actsIn cat(p(SFAM:\"HDAC Family\"))",
              "citation": {
                "type": "PubMed",
                "id": "15123634",
                "name": "J Biol Chem 2004 Jul 16 279(29) 30358-68"
              },
              "experiment_context": {
                "disease": "Neoplasms",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "inhibitors of deacetylase activity sensitized colon cancer cells to IFNgamma-induced apoptosis through cooperative negative regulation of Bcl-x expression",
              "metadata": {
                "id": "524b3521d3fbfd4c34061f2e",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(SFAM:\"HDAC Family\") actsIn cat(p(SFAM:\"HDAC Family\"))",
              "citation": {
                "type": "PubMed",
                "id": "11135429",
                "name": "Genes Chromosomes Cancer 2001 Feb 30(2) 123-35"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "K23 mRNA was highly induced by NaBu in different pancreatic cancer cells. Trichostatin A (TSA), a potent and specific inhibitor of histone deacetylase, similarly induced K23 mRNA expression.",
              "metadata": {
                "id": "524b3521d3fbfd4c340620c6",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(SFAM:\"HDAC Family\") actsIn cat(p(SFAM:\"HDAC Family\"))",
              "citation": {
                "type": "PubMed",
                "id": "15456740",
                "name": "FASEB J 2004 Dec 18(15) 1897-9"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "H2O2 and CSC decrease HDAC activity and histone deacetylase 2 levels",
              "metadata": {
                "id": "524b3521d3fbfd4c34061f22",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(SFAM:\"HDAC Family\") actsIn cat(p(SFAM:\"HDAC Family\"))",
              "citation": {
                "type": "PubMed",
                "id": "11533238",
                "name": "Mol Cell Biol 2001 Oct 21(19) 6495-506"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "treatment of these Rb-defective tumor cell lines with histone deacetylase, HDAC, inhibitors rescued IFN-gamma-inducible HLA-DRA and -DRB mRNA and cell surface protein expression, demonstrating repression of these genes by endogenous cellular HDAC activity",
              "metadata": {
                "id": "524b3521d3fbfd4c34061fbf",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(SFAM:\"HDAC Family\") actsIn cat(p(SFAM:\"HDAC Family\"))",
              "citation": {
                "type": "PubMed",
                "id": "15138260",
                "name": "J Biol Chem 2004 Jul 9 279(28) 29409-17"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "The extent of the acetylation is up-regulated by the transforming growth factor-beta signaling pathway and down-regulated by histone deacetylase activities.",
              "metadata": {
                "id": "524b3521d3fbfd4c34062024",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(SFAM:\"HDAC Family\") actsIn cat(p(SFAM:\"HDAC Family\"))",
              "citation": {
                "type": "PubMed",
                "id": "15602009",
                "name": "Pharmacol Rev 2004 Dec 56(4) 515-48"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": "Macrophages"
              },
              "summary_text": "The reduction of HDAC activity in macrophages is correlated with increased secretion of cytokines like TNF and IL8 ",
              "metadata": {
                "id": "524b3521d3fbfd4c3406202d",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(SFAM:\"HDAC Family\") actsIn cat(p(SFAM:\"HDAC Family\"))",
              "citation": {
                "type": "PubMed",
                "id": "14695212",
                "name": "Cancer Res 2003 Dec 15 63(24) 8948-54"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "However, as revealed by terminal deoxynucleotidyl transferase-mediated nick end labeling staining, only those KATO-III cells transfected with K320R p53 or K373R p53 became insensitive to the HDAC inhibitor, suggesting that these two residues of p53 may be essential for HDAC inhibitor-induced apoptosis, whereas others such as K382R p53 may not. ",
              "metadata": {
                "id": "524b3521d3fbfd4c34062016",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(SFAM:\"HDAC Family\") actsIn cat(p(SFAM:\"HDAC Family\"))",
              "citation": {
                "type": "PubMed",
                "id": "14654692",
                "name": "Nucleic Acids Res 2003 Dec 15 31(24) 7165-74"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Inhibition of histone deacetylase (HDAC) activity with HDAC inhibitors relieved this repression",
              "metadata": {
                "id": "524b3521d3fbfd4c34061fb7",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(SFAM:\"HDAC Family\") actsIn cat(p(SFAM:\"HDAC Family\"))",
              "citation": {
                "type": "PubMed",
                "id": "15452378",
                "name": "Oncology 2004 66(6) 481-91"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "HDAC inhibitor, trichostatin A (TSA)",
              "metadata": {
                "id": "524b3521d3fbfd4c34061f19",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(SFAM:\"HDAC Family\") actsIn cat(p(SFAM:\"HDAC Family\"))",
              "citation": {
                "type": "PubMed",
                "id": "16830229",
                "name": "Apoptosis 2006 Aug 11(8) 1349-57"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "carcinoma",
                "cell": ""
              },
              "summary_text": "siRNA-mediated knockdown of Bmf transcripts strongly inhibited its augmentation of IR-induced cell death, disruption of mitochondrial membrane potential and DNA fragmentation.",
              "metadata": {
                "id": "524b3521d3fbfd4c3406220d",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(SFAM:\"HDAC Family\") actsIn cat(p(SFAM:\"HDAC Family\"))",
              "citation": {
                "type": "PubMed",
                "id": "15130492",
                "name": "Dev Cell 2004 May 6(5) 673-84"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Mouse",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "We focused on follistatin since it is one of the most highly upregulated transcripts (28fold, Supplemental Table S1) and because of its reported role in muscle development (Lee and McPherron, 2001; Matzuk et al., 1995). In the absence of TSA, follistatin transcription was initiated after 4 to 12 hr of culture in differentiation medium and steadily increased over the next 48 hr (Figure 2G, Control). While being consistently elevated in every sample of TSA-treated cells, the follistatin transcripts displayed two peaks at 4 and 48 hr (Figure 2G, TSA). The transcriptional profile of follistatin was independently analyzed by RT-PCR and found to be concordant with that observed using microarray analysis (Figure 2G, lower panel). VPA and sodium butyrate, another HDAC inhibitor, also increased follistatin expression (Figure 2H). To investigate whether HDAC inhibitors induce follistatin expression in a cell type-spe-cific manner, mouse primary keratinocytes, C2C12 cells (Figures 3A and 3B), and mouse primary myoblasts (Figures 3C and 3D) were exposed to either TSA, sodium butyrate, or VPA for 18 hr and induced to differentiate. HDAC inhibitors increased follistatin levels in C2C12 and primary myoblasts but not in keratinocytes, which also failed to upregulate follistatin during differentiation (Figures 3A to 3D). Similarly, HDAC inhibitors could not augment follistatin expression in C3H10T1/2 and NIH3T3 mouse fibroblasts, as well as in the adipogenic 3T3-L1 and the osteogenic MC3T3-E1 cell lines (Figures 3E and 3F).",
              "metadata": {
                "id": "524b3521d3fbfd4c34061ff5",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(SFAM:\"HDAC Family\") actsIn cat(p(SFAM:\"HDAC Family\"))",
              "citation": {
                "type": "PubMed",
                "id": "11897684",
                "name": "Endocrinology 2002 Apr 143(4) 1280-90"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Ariadne: Moreover, PSF recruits the corepressor mSin3A to the hCYP17 promoter, resulting in repression, which is then alleviated upon cAMP stimulation and subsequent activation of SF-1",
              "metadata": {
                "id": "524b3521d3fbfd4c3406205f",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(SFAM:\"HDAC Family\") actsIn cat(p(SFAM:\"HDAC Family\"))",
              "citation": {
                "type": "PubMed",
                "id": "10640276",
                "name": "Genes Dev 2000 Jan 1 14(1) 55-66"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "The transcriptional corepressor SMRT functions by mediating the repressive effect of transcription factors involved in diverse signaling pathways. Taken together, our results provide the first evidence that SMRT-mediated repression is promoted by class I and class II histone deacetylases and that SMRT can recruit class II histone deacetylases",
              "metadata": {
                "id": "524b3521d3fbfd4c34062041",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(SFAM:\"HDAC Family\") actsIn cat(p(SFAM:\"HDAC Family\"))",
              "citation": {
                "type": "PubMed",
                "id": "15225871",
                "name": "Gene 2004 Jul 7 336(1) 1-13"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Mouse",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "The interaction of RB and E2F transcription factors represents a functional interaction that has been the predominant focus in the field. RB and the related family members p107 and p130 can each bind E2F to repress genes that are otherwise important for progression from G1 to S phase. The binding of RB, p107, or p130 has two simultaneous consequences: (1) binding prevents E2F from interacting with transcriptional co-activators (e.g., p300); and (2) binding recruits chromatin-modifying enzymes [e.g., histone deacetylases (HDACs)] to silence transcription. E2F itself is a family of transcription factors that include six E2F and three DP proteins, which together form the heterodimeric complex that comprises E2F transcriptional activity (reviewed in Trimarchi and Lees, 2002 and Yee and Wang, 2003). While there is considerable complexity, gene repression in G1 phase utilizes RB and E2Fs 1, 2, 3, and 4, while gene repression in G0 utilizes primarily p130 and E2Fs 4 and 5. binding prevents E2F from interacting with transcriptional co-activators (e.g., p300); and",
              "metadata": {
                "id": "524b3521d3fbfd4c34062039",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(SFAM:\"HDAC Family\") actsIn cat(p(SFAM:\"HDAC Family\"))",
              "citation": {
                "type": "PubMed",
                "id": "11295287",
                "name": "Cancer Lett 2001 May 10 166(1) 55-64"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Exposure of the NF-Y immunoprecipitates from TSA-treated cells to a phosphatase resulted in enhanced HAT activity. We have also shown that the mRNA levels of several genes, cyclin B1 and cyclin A, are downregulated by TSA; these effects do not require protein synthesis and the downregulation of cyclin B1 by TSA occurs through transcription.",
              "metadata": {
                "id": "524b3521d3fbfd4c34062030",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(SFAM:\"HDAC Family\") actsIn cat(p(SFAM:\"HDAC Family\"))",
              "citation": {
                "type": "PubMed",
                "id": "14583596",
                "name": "Physiol Genomics 2004 Jan 15 16(2) 204-11"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "4-Phenylbutyrate (PBA) is a histone deacetylase inhibitor",
              "metadata": {
                "id": "524b3521d3fbfd4c34061fe4",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(SFAM:\"HDAC Family\") actsIn cat(p(SFAM:\"HDAC Family\"))",
              "citation": {
                "type": "PubMed",
                "id": "15292521",
                "name": "Sci STKE 2004 Aug 3 2004(244) re11"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "exposure of cultured skeletal muscle cells to HDAC inhibitors results in the formation of myotubes with increased diameter, increased number of myonuclei and enhanced abundance of muscle structural proteins such as myosins",
              "metadata": {
                "id": "524b3521d3fbfd4c34061fde",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(SFAM:\"HDAC Family\") actsIn cat(p(SFAM:\"HDAC Family\"))",
              "citation": {
                "type": "PubMed",
                "id": "11292684",
                "name": "FASEB J 2001 Apr 15(6) 1110-2"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Trichostatin A (TSA, 10 ng/ml) reduced HDAC activity (165  16 versus 10.4  5.4 dpm/10 ?g protein) and inhibited the ability of dexamethasone (1 ?M) to reduce GM-CSF release (96% inhibition vs. 49% inhibition).",
              "metadata": {
                "id": "524b3521d3fbfd4c34061fdd",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(SFAM:\"HDAC Family\") actsIn cat(p(SFAM:\"HDAC Family\"))",
              "citation": {
                "type": "PubMed",
                "id": "23121078",
                "name": "Allergy 2013 Jan 68(1) 64-73"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": "Endothelial Cells"
              },
              "summary_text": " Cigarette smoke extract 5 percent inhibited HDAC activity and increased HAT activity generating glucocorticoid insensitivity.",
              "metadata": {
                "id": "524b3521d3fbfd4c34061fce",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(SFAM:\"HDAC Family\") actsIn cat(p(SFAM:\"HDAC Family\"))",
              "citation": {
                "type": "PubMed",
                "id": "14523559",
                "name": "Cell Mol Life Sci 2003 Sep 60(9) 1990-7"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Chemically different types of HDAC inhibitors, such as TSA, apicidin, SAHA, M344 and n-butyrate induced remarkably similar responses in SIRT1-7 mRNA expression patterns",
              "metadata": {
                "id": "524b3521d3fbfd4c34061fca",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(SFAM:\"HDAC Family\") actsIn cat(p(SFAM:\"HDAC Family\"))",
              "citation": {
                "type": "PubMed",
                "id": "12032081",
                "name": "EMBO J 2002 Jun 3 21(11) 2682-91"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Previous work by our laboratory and others (Seeler and Dejean, 2001 and references therein) prompted us to investigate further the possible role of sumoylation in transcriptional repression mechanisms. Here we show that the class II histone deacetylase HDAC4 undergoes SUMO-1 modification at a single lysine residue (K559) and that this process is regulated by CaMK signalling. We show that the NPC RanBP2 protein functions as an E3 ligase for HDAC4, suggesting that sumoylation and nuclear import are coordinated events. An HDAC4 mutant, defective for SUMO-1 conjugation, exhibits lower transcriptional repressing and histone deacetylase activities, indicating that sumoylation might be important for full biological activity of HDAC4-containing complexes. Finally, we provide in vitro evidence that other HDACs and HDAC-related proteins are modified similarly by SUMO.",
              "metadata": {
                "id": "524b3521d3fbfd4c34061fb5",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(SFAM:\"HDAC Family\") actsIn cat(p(SFAM:\"HDAC Family\"))",
              "citation": {
                "type": "PubMed",
                "id": "16537920",
                "name": "Mol Cell Biol 2006 Apr 26(7) 2782-90"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Here we found that an inhibitor of HDAC, depsipeptide (FR901228), but not trichostatin A (TSA), induces p21(Waf1/Cip1) expression through both p53 and Sp1/Sp3 pathways in A549 cells (which retain wild-type p53). ",
              "metadata": {
                "id": "524b3521d3fbfd4c34061f75",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(SFAM:\"HDAC Family\") actsIn cat(p(SFAM:\"HDAC Family\"))",
              "citation": {
                "type": "PubMed",
                "id": "17615396",
                "name": "Physiol Rev 2007 Jul 87(3) 1047-82"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": "Macrophages, Alveolar"
              },
              "summary_text": "Aqueous CSE reduced HDAC activity and HDAC proteins in MonoMac6 cell and human type II alveolar epithelial cell A549 cell (221, 361).",
              "metadata": {
                "id": "524b3521d3fbfd4c34061f50",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(SFAM:\"HDAC Family\") actsIn cat(p(SFAM:\"HDAC Family\"))",
              "citation": {
                "type": "PubMed",
                "id": "16516406",
                "name": "Gene 2006 Jun 7 374 128-33"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Histone deacetylase inhibitors (HDIs) induced expression of the B-ind1 protein that is a component of Rac-1-signaling pathways leading to the modulation of gene expression.",
              "metadata": {
                "id": "524b3521d3fbfd4c34061ef3",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(SFAM:\"HDAC Family\") actsIn cat(p(SFAM:\"HDAC Family\"))",
              "citation": {
                "type": "PubMed",
                "id": "15292521",
                "name": "Sci STKE 2004 Aug 3 2004(244) re11"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "Muscle, Skeletal",
                "cell": ""
              },
              "summary_text": "follistatin gene expression is activated by exposure of skeletal muscle cells to deacetylase inhibitors",
              "metadata": {
                "id": "524b3521d3fbfd4c34061eea",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(SFAM:\"HDAC Family\") actsIn cat(p(SFAM:\"HDAC Family\"))",
              "citation": {
                "type": "PubMed",
                "id": "12529387",
                "name": "Mol Cell Biol 2003 Feb 23(3) 815-25"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Mouse",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "The histone deacetylase inhibitor trichostatin A increases expression of the murine GHR gene, enhances association of acetyl-H3 at L2C1, inhibits formation of the repressosome complex, and decreases NF-Y's association with L2C1.",
              "metadata": {
                "id": "524b3521d3fbfd4c34061ee7",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(SFAM:\"HDAC Family\") actsIn cat(p(SFAM:\"HDAC Family\"))",
              "citation": {
                "type": "PubMed",
                "id": "11335099",
                "name": "Biochim Biophys Acta 2001 Apr 30 1536(1) 1-12"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "We also demonstrate that sodium butyrate, an inducer of differentiation, downregulated the expression of AF and gp96 mRNAs, supporting in part our pathological observation.",
              "metadata": {
                "id": "524b3521d3fbfd4c340622b1",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(SFAM:\"HDAC Family\") actsIn cat(p(SFAM:\"HDAC Family\"))",
              "citation": {
                "type": "PubMed",
                "id": "11872158",
                "name": "J Biochem (Tokyo) 2002 Mar 131(3) 307-11"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Mouse",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "A part of the N-terminal region of DPE2 (comprising amino acids 85-250) was found to be responsible for the interaction with SAP18. The interaction induced repression of transcription in reporter plasmid assays, which was inhibited by trichostatin A. These results indicate that DPE2 may recruit histone deacetylase (HDAC) to the replication fork to modify the chromatin structure.",
              "metadata": {
                "id": "524b3521d3fbfd4c34062291",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(SFAM:\"HDAC Family\") actsIn cat(p(SFAM:\"HDAC Family\"))",
              "citation": {
                "type": "PubMed",
                "id": "17615396",
                "name": "Physiol Rev 2007 Jul 87(3) 1047-82"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Lung tissues from patients with COPD had lower HDAC activity, HDAC(s) 2, 5, and 8 mRNA levels, and expression of HDAC2 protein in a disease severity-dependent manner, while histone-4 acetylation at the IL-8 promoter and IL-8 mRNA were increased in these patients (135).",
              "metadata": {
                "id": "524b3521d3fbfd4c34062280",
                "created_by": "selventa"
              }
            },
            {
              "bel_statement": "p(SFAM:\"HDAC Family\") actsIn cat(p(SFAM:\"HDAC Family\"))",
              "citation": {
                "type": "PubMed",
                "id": "12417732",
                "name": "Mol Cell Biol 2002 Dec 22(23) 8302-19"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Mouse",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Treatment of these cells with HDAC inhibitors also increased expression of the MTF-1 (metal transcription factor-1) gene as well as its DNA binding activity.",
              "metadata": {
                "id": "524b3521d3fbfd4c3406225b",
                "created_by": "selventa"
              }
            }
          ]
        }
      },
      {
        "source": "p(SFAM:\"HDAC Family\")",
        "target": "p(HGNC:HDAC8)",
        "relation": "hasMember",
        "directed": true,
        "label": "p(SFAM:\"HDAC Family\") hasMember p(HGNC:HDAC8)",
        "metadata": {
          "edgeId": null,
          "createdBy": null,
          "casual": null,
          "evidences": [

          ]
        }
      },
      {
        "source": "p(SFAM:\"HDAC Family\")",
        "target": "p(HGNC:HDAC10)",
        "relation": "hasMember",
        "directed": true,
        "label": "p(SFAM:\"HDAC Family\") hasMember p(HGNC:HDAC10)",
        "metadata": {
          "edgeId": null,
          "createdBy": null,
          "casual": null,
          "evidences": [

          ]
        }
      },
      {
        "source": "p(SFAM:\"HDAC Family\")",
        "target": "p(HGNC:HDAC5)",
        "relation": "hasMember",
        "directed": true,
        "label": "p(SFAM:\"HDAC Family\") hasMember p(HGNC:HDAC5)",
        "metadata": {
          "edgeId": null,
          "createdBy": null,
          "casual": null,
          "evidences": [

          ]
        }
      },
      {
        "source": "g(HGNC:GATA4)",
        "target": "path(MESHD:\"Pulmonary Disease, Chronic Obstructive\")",
        "relation": "association",
        "directed": true,
        "label": "g(HGNC:GATA4) association path(MESHD:\"Pulmonary Disease, Chronic Obstructive\")",
        "metadata": {
          "edgeId": null,
          "createdBy": null,
          "casual": null,
          "evidences": [
            {
              "bel_statement": "g(HGNC:GATA4) association path(MESHD:\"Pulmonary Disease, Chronic Obstructive\")",
              "citation": {
                "type": "PubMed",
                "id": "24973415",
                "name": ""
              },
              "experiment_context": {
                "disease": "COPD",
                "species_common_name": "human",
                "tissue": "sputum",
                "cell": ""
              },
              "summary_text": "It has previously been shown that methylation of the GATA-4 gene promoter region in sputum DNA is associated with low lung function and increased odds of chronic obstructive pulmonary disease (COPD) among smokers. ",
              "metadata": {
                "id": "",
                "created_by": ""
              }
            }
          ]
        }
      },
      {
        "source": "path(MESHD:\"Pulmonary Disease, Chronic Obstructive\")",
        "target": "bp(GOBP:\"DNA methylation\")",
        "relation": "association",
        "directed": true,
        "label": "path(MESHD:\"Pulmonary Disease, Chronic Obstructive\") association bp(GOBP:\"DNA methylation\")",
        "metadata": {
          "edgeId": "547ee11d89e36213f015981d",
          "createdBy": "swapna30",
          "casual": false,
          "evidences": [
            {
              "bel_statement": "path(MESHD:\"Pulmonary Disease, Chronic Obstructive\") association bp(GOBP:\"DNA methylation\")",
              "citation": {
                "type": "PubMed",
                "id": "25569234",
                "name": ""
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "When DNA methylation levels of methyl probes in CpG islands for COPD were compared with those of CTRL samples, the COPD samples were predominantly hypermethylated (S1A Fig.). Results based on probe-by-probe comparison also showed that CpG islands were more likely to be hypermethylated than hypomethylated in lung tissues of COPD patients (S4 Table). However, when comparing non-CpG island methyl probes, the pattern was very different and the numbers of hyper- and hypo- methylated probes were evenly distributed (S1B Fig. and S4 Table). This different pattern suggested there was no global methylation level difference between COPD and CTRL samples. The main difference between them was methylation levels of CpG islands, suggesting biological importance of methylation of CpG islands in transcription regulation.",
              "metadata": {
                "id": "552581fb89e36205c4a0976f",
                "created_by": "susana.martinez.arbas"
              }
            },
            {
              "bel_statement": "path(MESHD:\"Pulmonary Disease, Chronic Obstructive\") association bp(GOBP:\"DNA methylation\")",
              "citation": {
                "type": "PubMed",
                "id": "25807439",
                "name": "Epigenetic mechanisms in chronic obstructive pulmonary disease."
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Epigenetic modification may affect the expression of multiple inflammatory genes in lungs of patients with chronic obstructive pulmonary disease (COPD). Major epigenetic events include DNA methylation and various post-translational modifications of histones, such as histone methylation, acetylation, phosphorylation, ubiquitination, and sumoylation.",
              "metadata": {
                "id": "55245cbd89e36205c46d3d60",
                "created_by": "amian96"
              }
            },
            {
              "bel_statement": "path(MESHD:\"Pulmonary Disease, Chronic Obstructive\") association bp(GOBP:\"DNA methylation\")",
              "citation": {
                "type": "PubMed",
                "id": "22161163",
                "name": ""
              },
              "experiment_context": {
                "disease": "copd",
                "species_common_name": "human",
                "tissue": "white blood cells",
                "cell": "patient blood"
              },
              "summary_text": "This large-scale analysis suggests that DNA methylation may be a biomarker of COPD and may highlight new pathways of COPD pathogenesis.",
              "metadata": {
                "id": "547ee45789e3620d84a172eb",
                "created_by": "swapna30"
              }
            },
            {
              "bel_statement": "path(MESHD:\"Pulmonary Disease, Chronic Obstructive\") association bp(GOBP:\"DNA methylation\")",
              "citation": {
                "type": "PubMed",
                "id": "24298892",
                "name": ""
              },
              "experiment_context": {
                "disease": "COPD",
                "species_common_name": "human",
                "tissue": "small airway epithelia",
                "cell": "sampled by bronchoscopy"
              },
              "summary_text": "DNA methylation is globally disrupted and associated with expression changes in chronic obstructive pulmonary disease small airways.",
              "metadata": {
                "id": "547ee11d89e36213f01597ba",
                "created_by": "swapna30"
              }
            }
          ]
        }
      },
      {
        "source": "path(MESHD:\"Pulmonary Disease, Chronic Obstructive\")",
        "target": "p(HGNC:CDKN2A)",
        "relation": "association",
        "directed": true,
        "label": "path(MESHD:\"Pulmonary Disease, Chronic Obstructive\") association p(HGNC:CDKN2A)",
        "metadata": {
          "edgeId": "5529224a89e3620d90b1b3c1",
          "createdBy": "shaman.qn",
          "casual": false,
          "evidences": [
            {
              "bel_statement": "path(MESHD:\"Pulmonary Disease, Chronic Obstructive\") association p(HGNC:CDKN2A)",
              "citation": {
                "type": "PubMed",
                "id": "25807439",
                "name": ""
              },
              "experiment_context": {
                "disease": "COPD",
                "species_common_name": "human",
                "tissue": "sputum",
                "cell": ""
              },
              "summary_text": "Guzmn et al31\nfound a high percentage of CDKN2A and\nMGMT promoter methylation in induced sputum\nfrom COPD patients compared with healthy sub-\njects, and they are strongly associated with heavy\nsmoking",
              "metadata": {
                "id": "5529224a89e3620d90b1b313",
                "created_by": "shaman.qn"
              }
            }
          ]
        }
      },
      {
        "source": "path(MESHD:\"Pulmonary Disease, Chronic Obstructive\")",
        "target": "p(HGNC:HDAC2)",
        "relation": "decreases",
        "directed": true,
        "label": "path(MESHD:\"Pulmonary Disease, Chronic Obstructive\") decreases p(HGNC:HDAC2)",
        "metadata": {
          "edgeId": "552933d189e3620d90bab124",
          "createdBy": "dheeraj.bobbili",
          "casual": false,
          "evidences": [
            {
              "bel_statement": "path(MESHD:\"Pulmonary Disease, Chronic Obstructive\") decreases p(HGNC:HDAC2)",
              "citation": {
                "type": "PubMed",
                "id": "15888697",
                "name": ""
              },
              "experiment_context": {
                "disease": "COPD",
                "species_common_name": "human",
                "tissue": "Lungs",
                "cell": ""
              },
              "summary_text": "Specimens of lung tissue obtained from patients with increasing clinical stages of COPD had graded reductions in HDAC activity and increases in interleukin-8 messenger RNA (mRNA) and histone-4 acetylation at the interleukin-8 promoter. The mRNA expression of HDAC2, HDAC5, and HDAC8 and expression of the HDAC2 protein were also lower in patients with increasing severity of disease",
              "metadata": {
                "id": "552933d189e3620d90bab05e",
                "created_by": "dheeraj.bobbili"
              }
            }
          ]
        }
      },
      {
        "source": "path(MESHD:\"Pulmonary Disease, Chronic Obstructive\")",
        "target": "r(HGNC:HDAC8)",
        "relation": "negativeCorrelation",
        "directed": true,
        "label": "path(MESHD:\"Pulmonary Disease, Chronic Obstructive\") negativeCorrelation r(HGNC:HDAC8)",
        "metadata": {
          "edgeId": "5529332a89e3620d90ba825e",
          "createdBy": "dheeraj.bobbili",
          "casual": false,
          "evidences": [
            {
              "bel_statement": "path(MESHD:\"Pulmonary Disease, Chronic Obstructive\") negativeCorrelation r(HGNC:HDAC8)",
              "citation": {
                "type": "PubMed",
                "id": "15888697",
                "name": ""
              },
              "experiment_context": {
                "disease": "COPD",
                "species_common_name": "human",
                "tissue": "Lungs",
                "cell": ""
              },
              "summary_text": "Specimens of lung tissue obtained from patients with increasing clinical stages of COPD had graded reductions in HDAC activity and increases in interleukin-8 messenger RNA (mRNA) and histone-4 acetylation at the interleukin-8 promoter. The mRNA expression of HDAC2, HDAC5, and HDAC8 and expression of the HDAC2 protein were also lower in patients with increasing severity of disease",
              "metadata": {
                "id": "5529332a89e3620d90ba819a",
                "created_by": "dheeraj.bobbili"
              }
            }
          ]
        }
      },
      {
        "source": "path(MESHD:\"Pulmonary Disease, Chronic Obstructive\")",
        "target": "r(HGNC:HDAC10)",
        "relation": "negativeCorrelation",
        "directed": true,
        "label": "path(MESHD:\"Pulmonary Disease, Chronic Obstructive\") negativeCorrelation r(HGNC:HDAC10)",
        "metadata": {
          "edgeId": "552ad73989e3620a30dda6fd",
          "createdBy": "susana.martinez.arbas",
          "casual": false,
          "evidences": [
            {
              "bel_statement": "path(MESHD:\"Pulmonary Disease, Chronic Obstructive\") negativeCorrelation r(HGNC:HDAC10)",
              "citation": {
                "type": "PubMed",
                "id": "25834810",
                "name": "Int J Genomics. 2015;2015:206937. doi: 10.1155/2015/206937. Epub 2015 Mar 5.\nComprehensive Analysis of Transcriptome Sequencing Data in the Lung Tissues of COPD Subjects.\nKim WJ1, Lim JH2, Lee JS3, Lee SD3, Kim JH2, Oh YM3."
              },
              "experiment_context": {
                "disease": "COPD",
                "species_common_name": "human",
                "tissue": "lung",
                "cell": ""
              },
              "summary_text": "The expression of HDAC10 was decreased in the lung tissue of COPD subjects.",
              "metadata": {
                "id": "552ad73989e3620a30dda615",
                "created_by": "susana.martinez.arbas"
              }
            }
          ]
        }
      },
      {
        "source": "path(MESHD:\"Pulmonary Disease, Chronic Obstructive\")",
        "target": "r(HGNC:HDAC5)",
        "relation": "negativeCorrelation",
        "directed": true,
        "label": "path(MESHD:\"Pulmonary Disease, Chronic Obstructive\") negativeCorrelation r(HGNC:HDAC5)",
        "metadata": {
          "edgeId": "552932a889e3620d90ba4494",
          "createdBy": "dheeraj.bobbili",
          "casual": false,
          "evidences": [
            {
              "bel_statement": "path(MESHD:\"Pulmonary Disease, Chronic Obstructive\") negativeCorrelation r(HGNC:HDAC5)",
              "citation": {
                "type": "PubMed",
                "id": "15888697",
                "name": ""
              },
              "experiment_context": {
                "disease": "COPD",
                "species_common_name": "human",
                "tissue": "Lungs",
                "cell": ""
              },
              "summary_text": "Specimens of lung tissue obtained from patients with increasing clinical stages of COPD had graded reductions in HDAC activity and increases in interleukin-8 messenger RNA (mRNA) and histone-4 acetylation at the interleukin-8 promoter. The mRNA expression of HDAC2, HDAC5, and HDAC8 and expression of the HDAC2 protein were also lower in patients with increasing severity of disease",
              "metadata": {
                "id": "552932a789e3620d90ba43d2",
                "created_by": "dheeraj.bobbili"
              }
            }
          ]
        }
      },
      {
        "source": "path(MESHD:\"Pulmonary Disease, Chronic Obstructive\")",
        "target": "cat(p(SFAM:\"HDAC Family\"))",
        "relation": "negativeCorrelation",
        "directed": true,
        "label": "path(MESHD:\"Pulmonary Disease, Chronic Obstructive\") negativeCorrelation cat(p(SFAM:\"HDAC Family\"))",
        "metadata": {
          "edgeId": "5529355989e3620d90bb8751",
          "createdBy": "dheeraj.bobbili",
          "casual": false,
          "evidences": [
            {
              "bel_statement": "path(MESHD:\"Pulmonary Disease, Chronic Obstructive\") negativeCorrelation cat(p(SFAM:\"HDAC Family\"))",
              "citation": {
                "type": "PubMed",
                "id": "15888697",
                "name": ""
              },
              "experiment_context": {
                "disease": "COPD",
                "species_common_name": "human",
                "tissue": "macrophages and lung biopsy",
                "cell": ""
              },
              "summary_text": "HDAC activity was decreased in patients with COPD, as compared with normal subjects, in both the macrophages and biopsy specimens",
              "metadata": {
                "id": "5529355989e3620d90bb8689",
                "created_by": "dheeraj.bobbili"
              }
            }
          ]
        }
      },
      {
        "source": "path(MESHD:\"Pulmonary Disease, Chronic Obstructive\")",
        "target": "r(HGNC:KMT2A)",
        "relation": "positiveCorrelation",
        "directed": true,
        "label": "path(MESHD:\"Pulmonary Disease, Chronic Obstructive\") positiveCorrelation r(HGNC:KMT2A)",
        "metadata": {
          "edgeId": "552ad59189e3620a30dd999e",
          "createdBy": "susana.martinez.arbas",
          "casual": false,
          "evidences": [
            {
              "bel_statement": "path(MESHD:\"Pulmonary Disease, Chronic Obstructive\") positiveCorrelation r(HGNC:KMT2A)",
              "citation": {
                "type": "PubMed",
                "id": "25834810",
                "name": "Int J Genomics. 2015;2015:206937. doi: 10.1155/2015/206937. Epub 2015 Mar 5.\nComprehensive Analysis of Transcriptome Sequencing Data in the Lung Tissues of COPD Subjects.\nKim WJ1, Lim JH2, Lee JS3, Lee SD3, Kim JH2, Oh YM3."
              },
              "experiment_context": {
                "disease": "COPD",
                "species_common_name": "human",
                "tissue": "lung",
                "cell": ""
              },
              "summary_text": "In the current study, the expression of MLL, which plays an important role in H3K4 methylation [32], and CHD, which is important for chromatin modification and opening of chromatin to allow transcription [33], was increased in COPD subjects.",
              "metadata": {
                "id": "552ad59189e3620a30dd98b8",
                "created_by": "susana.martinez.arbas"
              }
            }
          ]
        }
      },
      {
        "source": "path(MESHD:\"Pulmonary Disease, Chronic Obstructive\")",
        "target": "r(HGNC:CARM1)",
        "relation": "positiveCorrelation",
        "directed": true,
        "label": "path(MESHD:\"Pulmonary Disease, Chronic Obstructive\") positiveCorrelation r(HGNC:CARM1)",
        "metadata": {
          "edgeId": "552c260c89e36208d47c9db2",
          "createdBy": "shaman.qn",
          "casual": false,
          "evidences": [
            {
              "bel_statement": "path(MESHD:\"Pulmonary Disease, Chronic Obstructive\") positiveCorrelation r(HGNC:CARM1)",
              "citation": {
                "type": "PubMed",
                "id": "25807439",
                "name": ""
              },
              "experiment_context": {
                "disease": "COPD",
                "species_common_name": "human",
                "tissue": "lung",
                "cell": ""
              },
              "summary_text": "Some\nresearch has shown that the mRNA expression\nlevels of PRMT4, 5, 6, 9, and 10 were up-regu-\nlated in COPD lung tissue specimen",
              "metadata": {
                "id": "552c260c89e36208d47c9cda",
                "created_by": "shaman.qn"
              }
            }
          ]
        }
      },
      {
        "source": "path(MESHD:\"Pulmonary Disease, Chronic Obstructive\")",
        "target": "r(HGNC:PRMT6)",
        "relation": "positiveCorrelation",
        "directed": true,
        "label": "path(MESHD:\"Pulmonary Disease, Chronic Obstructive\") positiveCorrelation r(HGNC:PRMT6)",
        "metadata": {
          "edgeId": "552c2a9189e36208d47d743a",
          "createdBy": "shaman.qn",
          "casual": false,
          "evidences": [
            {
              "bel_statement": "path(MESHD:\"Pulmonary Disease, Chronic Obstructive\") positiveCorrelation r(HGNC:PRMT6)",
              "citation": {
                "type": "PubMed",
                "id": "25807439",
                "name": ""
              },
              "experiment_context": {
                "disease": "COPD",
                "species_common_name": "human",
                "tissue": "lung",
                "cell": ""
              },
              "summary_text": "Some\nresearch has shown that the mRNA expression\nlevels of PRMT4, 5, 6, 9, and 10 were up-regu-\nlated in COPD lung tissue specimen",
              "metadata": {
                "id": "552c2a9189e36208d47d735c",
                "created_by": "shaman.qn"
              }
            }
          ]
        }
      },
      {
        "source": "path(MESHD:\"Pulmonary Disease, Chronic Obstructive\")",
        "target": "r(HGNC:PRMT9)",
        "relation": "positiveCorrelation",
        "directed": true,
        "label": "path(MESHD:\"Pulmonary Disease, Chronic Obstructive\") positiveCorrelation r(HGNC:PRMT9)",
        "metadata": {
          "edgeId": "552c2c3d89e36208d47dfb09",
          "createdBy": "shaman.qn",
          "casual": false,
          "evidences": [
            {
              "bel_statement": "path(MESHD:\"Pulmonary Disease, Chronic Obstructive\") positiveCorrelation r(HGNC:PRMT9)",
              "citation": {
                "type": "PubMed",
                "id": "25807439",
                "name": ""
              },
              "experiment_context": {
                "disease": "COPD",
                "species_common_name": "human",
                "tissue": "lung",
                "cell": ""
              },
              "summary_text": "Some\nresearch has shown that the mRNA expression\nlevels of PRMT4, 5, 6, 9, and 10 were up-regu-\nlated in COPD lung tissue specimen",
              "metadata": {
                "id": "552c2c3d89e36208d47dfa29",
                "created_by": "shaman.qn"
              }
            }
          ]
        }
      },
      {
        "source": "path(MESHD:\"Pulmonary Disease, Chronic Obstructive\")",
        "target": "r(HGNC:PRMT5)",
        "relation": "positiveCorrelation",
        "directed": true,
        "label": "path(MESHD:\"Pulmonary Disease, Chronic Obstructive\") positiveCorrelation r(HGNC:PRMT5)",
        "metadata": {
          "edgeId": "552c28c889e36208d47d3caa",
          "createdBy": "shaman.qn",
          "casual": false,
          "evidences": [
            {
              "bel_statement": "path(MESHD:\"Pulmonary Disease, Chronic Obstructive\") positiveCorrelation r(HGNC:PRMT5)",
              "citation": {
                "type": "PubMed",
                "id": "25807439",
                "name": ""
              },
              "experiment_context": {
                "disease": "COPD",
                "species_common_name": "human",
                "tissue": "lung",
                "cell": ""
              },
              "summary_text": "Some\nresearch has shown that the mRNA expression\nlevels of PRMT4, 5, 6, 9, and 10 were up-regu-\nlated in COPD lung tissue specimen",
              "metadata": {
                "id": "552c28c789e36208d47d3bce",
                "created_by": "shaman.qn"
              }
            }
          ]
        }
      },
      {
        "source": "path(MESHD:\"Pulmonary Disease, Chronic Obstructive\")",
        "target": "bp(GOBP:\"histone methylation\")",
        "relation": "association",
        "directed": true,
        "label": "path(MESHD:\"Pulmonary Disease, Chronic Obstructive\") association bp(GOBP:\"histone methylation\")",
        "metadata": {
          "edgeId": "552c4ebf89e36208d49ba63e",
          "createdBy": "sean.sapcariu",
          "casual": false,
          "evidences": [
            {
              "bel_statement": "path(MESHD:\"Pulmonary Disease, Chronic Obstructive\") association bp(GOBP:\"histone methylation\")",
              "citation": {
                "type": "PubMed",
                "id": "25807439",
                "name": ""
              },
              "experiment_context": {
                "disease": "COPD",
                "species_common_name": "human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Epigenetic modification may affect the expression of multiple inflammatory genes in lungs of patients with chronic obstructive pulmonary disease (COPD). Major epigenetic events include DNA methylation and various post-translational modifications of histones, such as histone methylation",
              "metadata": {
                "id": "552c4ebf89e36208d49ba566",
                "created_by": "sean.sapcariu"
              }
            }
          ]
        }
      },
      {
        "source": "a(SCHEM:\"Smoke, cigarette\")",
        "target": "g(HGNC:AHRR)",
        "relation": "association",
        "directed": true,
        "label": "a(SCHEM:\"Smoke, cigarette\") association g(HGNC:AHRR)",
        "metadata": {
          "edgeId": "547eeb5589e3620d84a19a98",
          "createdBy": "swapna30",
          "casual": false,
          "evidences": [
            {
              "bel_statement": "a(SCHEM:\"Smoke, cigarette\") association g(HGNC:AHRR)",
              "citation": {
                "type": "PubMed",
                "id": "22232023",
                "name": ""
              },
              "experiment_context": {
                "disease": "smoker no disease",
                "species_common_name": "human",
                "tissue": "bronchoalveolar lavage",
                "cell": "alveolar macrophages"
              },
              "summary_text": "Coordinated Changes in AHRR Methylation in Lymphoblasts and Pulmonary Macrophages from Smokers",
              "metadata": {
                "id": "547eebc289e3620d84a19d19",
                "created_by": "swapna30"
              }
            },
            {
              "bel_statement": "a(SCHEM:\"Smoke, cigarette\") association g(HGNC:AHRR)",
              "citation": {
                "type": "PubMed",
                "id": "22232023",
                "name": ""
              },
              "experiment_context": {
                "disease": "smoker no disease",
                "species_common_name": "human",
                "tissue": "lymphoblast",
                "cell": "ebv transformed patient cell line"
              },
              "summary_text": "Coordinated Changes in AHRR Methylation in Lymphoblasts and Pulmonary Macrophages from Smokers\n\nSmoking is associated with a wide variety of adverse health outcomes including cancer, chronic obstructive pulmonary disease, diabetes, depression, and heart disease. Unfortunately, the molecular mechanisms through which these effects are conveyed are not clearly understood. To examine the potential role of epigenetic factors in these processes, we examined the relationship of smoking to genome wide methylation and gene expression using biomaterial from two independent samples, lymphoblast DNA and RNA (n = 119) and lung alveolar macrophage DNA (n = 19). We found that in both samples current smoking status was associated with significant changes in DNA methylation, in particular at the aryl hydrocarbon receptor repressor (AHRR), a known tumor suppressor.",
              "metadata": {
                "id": "54e12d6a89e362035c315930",
                "created_by": "davidgaralf"
              }
            },
            {
              "bel_statement": "a(SCHEM:\"Smoke, cigarette\") association g(HGNC:AHRR)",
              "citation": {
                "type": "PubMed",
                "id": "22232023",
                "name": ""
              },
              "experiment_context": {
                "disease": "smoker no disease",
                "species_common_name": "human",
                "tissue": "lymphoblast",
                "cell": "EBV transformed patient cell line"
              },
              "summary_text": "Coordinated Changes in AHRR Methylation in Lymphoblasts and Pulmonary Macrophages from Smokers",
              "metadata": {
                "id": "547eeb5589e3620d84a19a32",
                "created_by": "swapna30"
              }
            }
          ]
        }
      },
      {
        "source": "a(SCHEM:\"Smoke, cigarette\")",
        "target": "p(HGNC:HDAC2)",
        "relation": "decreases",
        "directed": true,
        "label": "a(SCHEM:\"Smoke, cigarette\") decreases p(HGNC:HDAC2)",
        "metadata": {
          "edgeId": "54fe0d2889e3621524a8d9e9",
          "createdBy": "susana.martinez.arbas",
          "casual": false,
          "evidences": [
            {
              "bel_statement": "a(SCHEM:\"Smoke, cigarette\") decreases p(HGNC:HDAC2)",
              "citation": {
                "type": "PubMed",
                "id": "18927347",
                "name": ""
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "human",
                "tissue": "",
                "cell": "Lung epithelial cells"
              },
              "summary_text": "Cigarette smoke (CS)-induced lung inflammation involves the reduction of histone deacetylase 2 (HDAC2) abundance.",
              "metadata": {
                "id": "54fe0d2889e3621524a8d972",
                "created_by": "susana.martinez.arbas"
              }
            },
            {
              "bel_statement": "a(SCHEM:\"Smoke, cigarette\") decreases p(HGNC:HDAC2)",
              "citation": {
                "type": "PubMed",
                "id": "15456740",
                "name": "Moodie, F. M., J. A. Marwick, C. S. Anderson, P. Szulakowski, S. K. Biswas, M. R. Bauter, I. Kilty, and I. Rahman. 2004. \"Oxidative stress and cigarette smoke alter chromatin remodeling but differentially regulate NF-kappaB activation and proinflammatory cytokine release in alveolar epithelial cells.\" Faseb j no. 18 (15):1897-9. doi: 10.1096/fj.04-1506fje."
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "human",
                "tissue": "",
                "cell": "human type ii alveolar epithelial cell line a 549"
              },
              "summary_text": "In results, read the section called \"H202\nand CSC decrease HDAC activity and histone deacetylase 2 levels\"",
              "metadata": {
                "id": "54ff2c8e89e3621524ba0fdb",
                "created_by": "pirxtrurl"
              }
            }
          ]
        }
      },
      {
        "source": "a(SCHEM:\"Smoke, cigarette\")",
        "target": "bp(GOBP:\"DNA methylation\")",
        "relation": "increases",
        "directed": true,
        "label": "a(SCHEM:\"Smoke, cigarette\") increases bp(GOBP:\"DNA methylation\")",
        "metadata": {
          "edgeId": "5524178b89e36205c45da90e",
          "createdBy": "aishwarya.alex",
          "casual": false,
          "evidences": [
            {
              "bel_statement": "a(SCHEM:\"Smoke, cigarette\") increases bp(GOBP:\"DNA methylation\")",
              "citation": {
                "type": "PubMed",
                "id": "25807439",
                "name": ""
              },
              "experiment_context": {
                "disease": "COPD",
                "species_common_name": "human",
                "tissue": "",
                "cell": "white blood cell"
              },
              "summary_text": "Thus,\nwe may concluded that cigarette smoking can in-\ncrease the level of DNA methylation, which is in-\nvolved in the local and systematic inflammation\nof COPD",
              "metadata": {
                "id": "5524178b89e36205c45da86d",
                "created_by": "aishwarya.alex"
              }
            }
          ]
        }
      },
      {
        "source": "a(SCHEM:\"Smoke, cigarette\")",
        "target": "bp(GOBP:\"histone modification\")",
        "relation": "association",
        "directed": true,
        "label": "a(SCHEM:\"Smoke, cigarette\") association bp(GOBP:\"histone modification\")",
        "metadata": {
          "edgeId": "547eeed489e3620d84a1ba55",
          "createdBy": "swapna30",
          "casual": false,
          "evidences": [
            {
              "bel_statement": "a(SCHEM:\"Smoke, cigarette\") association bp(GOBP:\"histone modification\")",
              "citation": {
                "type": "PubMed",
                "id": "18927347",
                "name": ""
              },
              "experiment_context": {
                "disease": "copd",
                "species_common_name": "human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Cigarette smoke alone is a powerful modulator of histone post-translational modifications because it reduces HDAC activity and reduces HDAC expression, highlighting the importance for indicating whether samples were obtained from smokers or non-smokers.",
              "metadata": {
                "id": "54fe0bf989e3621524a8d52d",
                "created_by": "susana.martinez.arbas"
              }
            },
            {
              "bel_statement": "a(SCHEM:\"Smoke, cigarette\") association bp(GOBP:\"histone modification\")",
              "citation": {
                "type": "PubMed",
                "id": "25448041",
                "name": ""
              },
              "experiment_context": {
                "disease": "copd",
                "species_common_name": "human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "As with histone modifications as DNA methylation, cigarette smoke has profound effects on miRNA expression by directly affecting the expression of enzymes that regulate the levels of the epigenetic modifiers.",
              "metadata": {
                "id": "54fe0add89e3621524a8c250",
                "created_by": "susana.martinez.arbas"
              }
            },
            {
              "bel_statement": "a(SCHEM:\"Smoke, cigarette\") association bp(GOBP:\"histone modification\")",
              "citation": {
                "type": "PubMed",
                "id": "15456740",
                "name": "Moodie, F. M., J. A. Marwick, C. S. Anderson, P. Szulakowski, S. K. Biswas, M. R. Bauter, I. Kilty, and I. Rahman. 2004. \"Oxidative stress and cigarette smoke alter chromatin remodeling but differentially regulate NF-kappaB activation and proinflammatory cytokine release in alveolar epithelial cells.\" Faseb j no. 18 (15):1897-9. doi: 10.1096/fj.04-1506fje."
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "human",
                "tissue": "",
                "cell": "human type ii alveolar epithelial cell line a 549"
              },
              "summary_text": "\"...Our\nfindings show that both H202\nand CSC cause an increase in\nhistone acetylation as assessed by\nHAT activity and immunocytochemistry using a\nhistone H4 specific an\ntibody in A549 alveolar\nepithelial cells,,,\"",
              "metadata": {
                "id": "54ff25a389e3621524b7c5ac",
                "created_by": "pirxtrurl"
              }
            },
            {
              "bel_statement": "a(SCHEM:\"Smoke, cigarette\") association bp(GOBP:\"histone modification\")",
              "citation": {
                "type": "PubMed",
                "id": "24283195",
                "name": ""
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "human",
                "tissue": "bronchial epithelial cells",
                "cell": "H292"
              },
              "summary_text": "We found that CS-induced distinct posttranslational histone modification patterns in histone H3 and histone H4 in lung cells, which may be considered as usable biomarkers for CS-induced chronic lung diseases.",
              "metadata": {
                "id": "547eeed489e3620d84a1b9ed",
                "created_by": "swapna30"
              }
            },
            {
              "bel_statement": "a(SCHEM:\"Smoke, cigarette\") association bp(GOBP:\"histone modification\")",
              "citation": {
                "type": "PubMed",
                "id": "24283195",
                "name": ""
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "mouse",
                "tissue": "lung",
                "cell": "whole lung"
              },
              "summary_text": "We found that CS-induced distinct posttranslational histone modification patterns in histone H3 and histone H4 in lung cells, which may be considered as usable biomarkers for CS-induced chronic lung diseases.",
              "metadata": {
                "id": "547eef1a89e3620d84a1bca5",
                "created_by": "swapna30"
              }
            }
          ]
        }
      },
      {
        "source": "a(SCHEM:\"Smoke, cigarette\")",
        "target": "deg(p(HGNC:HDAC2))",
        "relation": "increases",
        "directed": true,
        "label": "a(SCHEM:\"Smoke, cigarette\") increases deg(p(HGNC:HDAC2))",
        "metadata": {
          "edgeId": "55284ccb89e362084468e3d4",
          "createdBy": "susana.martinez.arbas",
          "casual": false,
          "evidences": [
            {
              "bel_statement": "a(SCHEM:\"Smoke, cigarette\") increases deg(p(HGNC:HDAC2))",
              "citation": {
                "type": "PubMed",
                "id": "18927347",
                "name": "Am J Respir Cell Mol Biol. 2009 Apr;40(4):464-73. doi: 10.1165/rcmb.2008-0255OC. Epub 2008 Oct 16.\nHistone deacetylase 2 is phosphorylated, ubiquitinated, and degraded by cigarette smoke.\nAdenuga D1, Yao H, March TH, Seagrave J, Rahman I."
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "human",
                "tissue": "",
                "cell": "monocyte-macrophage, bronchial epithelial and primary small airway ephitelial cells."
              },
              "summary_text": "Cigarette smoke extract (CSE) exposure in MonoMac6 and in bronchial and airway epithelial cells led to phosphorylation of HDAC2 on serine/threonine residues by a protein kinase CK2-mediated mechanism, decreased HDAC2 activity, and increased ubiquitin-proteasomedependent HDAC2 degradation....",
              "metadata": {
                "id": "55284ccb89e362084468e316",
                "created_by": "susana.martinez.arbas"
              }
            }
          ]
        }
      },
      {
        "source": "a(SCHEM:\"Smoke, cigarette\")",
        "target": "p(HGNC:HDAC1)",
        "relation": "decreases",
        "directed": true,
        "label": "a(SCHEM:\"Smoke, cigarette\") decreases p(HGNC:HDAC1)",
        "metadata": {
          "edgeId": "55299d3f89e3620d90eadd2c",
          "createdBy": "susana.martinez.arbas",
          "casual": false,
          "evidences": [
            {
              "bel_statement": "a(SCHEM:\"Smoke, cigarette\") decreases p(HGNC:HDAC1)",
              "citation": {
                "type": "PubMed",
                "id": "16473865",
                "name": "Am J Physiol Lung Cell Mol Physiol. 2006 Jul;291(1):L46-57. Epub 2006 Feb 10. Cigarette smoke induces proinflammatory cytokine release by activation of NF-kappaB and posttranslational modifications of histone deacetylase in macrophages. Yang SR1, Chida AS, Bauter MR, Shafiq N, Seweryniak K, Maggirwar SB, Kilty I, Rahman I."
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "human",
                "tissue": "",
                "cell": "monocytes"
              },
              "summary_text": "We investigated whether protein modification is involved in the observed reduction in HDAC1, HDAC2, and HDAC3 levels....There was a significant increase in the tyrosine nitration and 4-HNE modification of HDAC1, -2, and -3 after 24 h of cigarette smoke exposure compared with untreated cells (Fig. 9). This supports the concept that the decrease in HDAC1, -2, and -3 levels by cigarette smoke exposure was in part due to the covalent modification of HDAC proteins by components of cigarette smoke.",
              "metadata": {
                "id": "55299d3f89e3620d90eadc4e",
                "created_by": "susana.martinez.arbas"
              }
            }
          ]
        }
      },
      {
        "source": "a(SCHEM:\"Smoke, cigarette\")",
        "target": "cat(p(SFAM:\"HDAC Family\"))",
        "relation": "decreases",
        "directed": true,
        "label": "a(SCHEM:\"Smoke, cigarette\") decreases cat(p(SFAM:\"HDAC Family\"))",
        "metadata": {
          "edgeId": "5529918889e3620d90e5fd08",
          "createdBy": "susana.martinez.arbas",
          "casual": false,
          "evidences": [
            {
              "bel_statement": "a(SCHEM:\"Smoke, cigarette\") decreases cat(p(SFAM:\"HDAC Family\"))",
              "citation": {
                "type": "PubMed",
                "id": "16473865",
                "name": "Am J Physiol Lung Cell Mol Physiol. 2006 Jul;291(1):L46-57. Epub 2006 Feb 10.\nCigarette smoke induces proinflammatory cytokine release by activation of NF-kappaB and posttranslational modifications of histone deacetylase in macrophages.\nYang SR1, Chida AS, Bauter MR, Shafiq N, Seweryniak K, Maggirwar SB, Kilty I, Rahman I."
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "human",
                "tissue": "",
                "cell": "monocytes"
              },
              "summary_text": "CSE decreases HDAC activity and HDAC1, HDAC2, and HDAC3 levels.....CSE (1%,, 2.5% and 5%) significantly decreased HDAC activity (Fig. 6), which was associated with the decreased levels of HDAC1, HDAC2, and HDAC3 protein levels at 4 and 24 h (Figs. 7 and 8).",
              "metadata": {
                "id": "5529918889e3620d90e5fc2b",
                "created_by": "susana.martinez.arbas"
              }
            }
          ]
        }
      },
      {
        "source": "a(SCHEM:\"Smoke, cigarette\")",
        "target": "p(HGNC:HDAC3)",
        "relation": "decreases",
        "directed": true,
        "label": "a(SCHEM:\"Smoke, cigarette\") decreases p(HGNC:HDAC3)",
        "metadata": {
          "edgeId": "55299e6f89e3620d90eb7253",
          "createdBy": "susana.martinez.arbas",
          "casual": false,
          "evidences": [
            {
              "bel_statement": "a(SCHEM:\"Smoke, cigarette\") decreases p(HGNC:HDAC3)",
              "citation": {
                "type": "PubMed",
                "id": "16473865",
                "name": "Am J Physiol Lung Cell Mol Physiol. 2006 Jul;291(1):L46-57. Epub 2006 Feb 10. Cigarette smoke induces proinflammatory cytokine release by activation of NF-kappaB and posttranslational modifications of histone deacetylase in macrophages. Yang SR1, Chida AS, Bauter MR, Shafiq N, Seweryniak K, Maggirwar SB, Kilty I, Rahman I."
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "human",
                "tissue": "",
                "cell": "monocytes"
              },
              "summary_text": "We investigated whether protein modification is involved in the observed reduction in HDAC1, HDAC2, and HDAC3 levels....There was a significant increase in the tyrosine nitration and 4-HNE modification of HDAC1, -2, and -3 after 24 h of cigarette smoke exposure compared with untreated cells (Fig. 9). This supports the concept that the decrease in HDAC1, -2, and -3 levels by cigarette smoke exposure was in part due to the covalent modification of HDAC proteins by components of cigarette smoke.",
              "metadata": {
                "id": "55299e6f89e3620d90eb7173",
                "created_by": "susana.martinez.arbas"
              }
            }
          ]
        }
      },
      {
        "source": "a(SCHEM:\"Smoke, cigarette\")",
        "target": "a(CHEBI:\"N(omega),N'(omega)-dimethyl-L-arginine\")",
        "relation": "association",
        "directed": true,
        "label": "a(SCHEM:\"Smoke, cigarette\") association a(CHEBI:\"N(omega),N'(omega)-dimethyl-L-arginine\")",
        "metadata": {
          "edgeId": "552c307589e36208d47f9946",
          "createdBy": "pranjul.shah_1",
          "casual": false,
          "evidences": [
            {
              "bel_statement": "a(SCHEM:\"Smoke, cigarette\") association a(CHEBI:\"N(omega),N'(omega)-dimethyl-L-arginine\")",
              "citation": {
                "type": "PubMed",
                "id": "25807439",
                "name": ""
              },
              "experiment_context": {
                "disease": "COPD",
                "species_common_name": "human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Some studies have found an decrease\nEpigenetic mechanisms in chronic obstructive pulmonary disease\nlevel of ADMA in smokers as compared to non-smokers, while others have detected increased amounts of ADMA in cigarette smoking\nsubjects",
              "metadata": {
                "id": "552c307589e36208d47f9876",
                "created_by": "pranjul.shah_1"
              }
            }
          ]
        }
      },
      {
        "source": "a(SCHEM:\"Smoke, cigarette\")",
        "target": "g(HGNC:F2RL3)",
        "relation": "association",
        "directed": true,
        "label": "a(SCHEM:\"Smoke, cigarette\") association g(HGNC:F2RL3)",
        "metadata": {
          "edgeId": null,
          "createdBy": null,
          "casual": null,
          "evidences": [
            {
              "bel_statement": "a(SCHEM:\"Smoke, cigarette\") association g(HGNC:F2RL3)",
              "citation": {
                "type": "PubMed",
                "id": "24273234",
                "name": "Environ Health Perspect. 2014 Feb;122(2):131-7."
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "human",
                "tissue": "blood",
                "cell": ""
              },
              "summary_text": "F2RL3 methylation intensity showed a strong association with smoking status (p < 0.0001), which persisted after controlling for potential confounding factors. Clear inverse dose-response relationships with F2RL3 methylation intensity were seen for both current intensity and lifetime pack-years of smoking. ",
              "metadata": {
                "id": "",
                "created_by": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(GOCC:\"ESC/E(Z) complex\")",
        "target": "p(HGNC:SUZ12)",
        "relation": "hasComponent",
        "directed": true,
        "label": "complex(GOCC:\"ESC/E(Z) complex\") hasComponent p(HGNC:SUZ12)",
        "metadata": {
          "edgeId": "5502e64d89e36209cc4e1bce",
          "createdBy": "susana.martinez.arbas",
          "casual": false,
          "evidences": [
            {
              "bel_statement": "complex(GOCC:\"ESC/E(Z) complex\") hasComponent p(HGNC:SUZ12)",
              "citation": {
                "type": "PubMed",
                "id": "24652950",
                "name": ""
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "The enhancer of zeste homolog 2 (EZH2) is the catalytic subunit of the polycomb repressive complex 2 (PRC2), which also includes the suppressor of zeste 12 protein, embryonic ectoderm development (EED) protein, and EED-associated HDAC1 and HDAC2.",
              "metadata": {
                "id": "5502e64d89e36209cc4e1b40",
                "created_by": "susana.martinez.arbas"
              }
            }
          ]
        }
      },
      {
        "source": "complex(GOCC:\"ESC/E(Z) complex\")",
        "target": "p(HGNC:EZH2)",
        "relation": "hasComponent",
        "directed": true,
        "label": "complex(GOCC:\"ESC/E(Z) complex\") hasComponent p(HGNC:EZH2)",
        "metadata": {
          "edgeId": "5500868789e3621814f3bbbd",
          "createdBy": "susana.martinez.arbas",
          "casual": false,
          "evidences": [
            {
              "bel_statement": "complex(GOCC:\"ESC/E(Z) complex\") hasComponent p(HGNC:EZH2)",
              "citation": {
                "type": "PubMed",
                "id": "24652950",
                "name": ""
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "The enhancer of zeste homolog 2 (EZH2) is the catalytic subunit of the polycomb repressive complex 2 (PRC2), which also includes the suppressor of zeste 12 protein, embryonic ectoderm development (EED) protein, and EED-associated HDAC1 and HDAC2.",
              "metadata": {
                "id": "5500868789e3621814f3bb33",
                "created_by": "susana.martinez.arbas"
              }
            }
          ]
        }
      },
      {
        "source": "complex(GOCC:\"ESC/E(Z) complex\")",
        "target": "p(HGNC:EED)",
        "relation": "hasComponent",
        "directed": true,
        "label": "complex(GOCC:\"ESC/E(Z) complex\") hasComponent p(HGNC:EED)",
        "metadata": {
          "edgeId": "550085d489e3621814f3b75e",
          "createdBy": "susana.martinez.arbas",
          "casual": false,
          "evidences": [
            {
              "bel_statement": "complex(GOCC:\"ESC/E(Z) complex\") hasComponent p(HGNC:EED)",
              "citation": {
                "type": "PubMed",
                "id": "24652950",
                "name": ""
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "The enhancer of zeste homolog 2 (EZH2) is the catalytic subunit of the polycomb repressive complex 2 (PRC2), which also includes the suppressor of zeste 12 protein, embryonic ectoderm development (EED) protein, and EED-associated HDAC1 and HDAC2.",
              "metadata": {
                "id": "550085d489e3621814f3b6da",
                "created_by": "susana.martinez.arbas"
              }
            }
          ]
        }
      },
      {
        "source": "complex(GOCC:\"ESC/E(Z) complex\")",
        "target": "bp(GOBP:\"DNA methylation\")",
        "relation": "association",
        "directed": true,
        "label": "complex(GOCC:\"ESC/E(Z) complex\") association bp(GOBP:\"DNA methylation\")",
        "metadata": {
          "edgeId": "5500895289e3621814f3c6a2",
          "createdBy": "susana.martinez.arbas",
          "casual": false,
          "evidences": [
            {
              "bel_statement": "complex(GOCC:\"ESC/E(Z) complex\") association bp(GOBP:\"DNA methylation\")",
              "citation": {
                "type": "PubMed",
                "id": "24652950",
                "name": ""
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "The enhancer of zeste homolog 2 (EZH2) is the catalytic subunit of the polycomb repressive complex 2 (PRC2)...EZH2 acts as a lysine-specific HMT that mediates H3K27me3...A large percentage of PRC2 target genes contain CpG islands and therefore are likely to undergo DNA methylation as a means to ensure a stable repressive state.",
              "metadata": {
                "id": "5500895289e3621814f3c616",
                "created_by": "susana.martinez.arbas"
              }
            },
            {
              "bel_statement": "complex(GOCC:\"ESC/E(Z) complex\") association bp(GOBP:\"DNA methylation\")",
              "citation": {
                "type": "PubMed",
                "id": "25806038",
                "name": "Evolution and function of epigenetic processes in the endosperm."
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "The Polycomb Repressive Complex 2 (PRC2) is particularly targeted to DNA hypomethylated regions, possibly alleviating the negative effects associated with loss of DNA methylation in the endosperm.",
              "metadata": {
                "id": "55245dc789e36205c46d995a",
                "created_by": "amian96"
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:EZH2)",
        "target": "bp(GOBP:\"histone methylation\")",
        "relation": "directlyIncreases",
        "directed": true,
        "label": "p(HGNC:EZH2) directlyIncreases bp(GOBP:\"histone methylation\")",
        "metadata": {
          "edgeId": "5522e68189e36208f8fe7b17",
          "createdBy": "susana.martinez.arbas",
          "casual": false,
          "evidences": [
            {
              "bel_statement": "p(HGNC:EZH2) directlyIncreases bp(GOBP:\"histone methylation\")",
              "citation": {
                "type": "PubMed",
                "id": "24652950",
                "name": ""
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "human",
                "tissue": "lung",
                "cell": "fibroblasts"
              },
              "summary_text": "EZH2 acts as a lysine-specific HMT that mediates H3K27me3.",
              "metadata": {
                "id": "5522e68189e36208f8fe7a73",
                "created_by": "susana.martinez.arbas"
              }
            }
          ]
        }
      },
      {
        "source": "a(CHEBI:\"hydrogen peroxide\")",
        "target": "p(HGNC:HDAC2)",
        "relation": "decreases",
        "directed": true,
        "label": "a(CHEBI:\"hydrogen peroxide\") decreases p(HGNC:HDAC2)",
        "metadata": {
          "edgeId": "550743f089e3620b944ee66a",
          "createdBy": "pirxtrurl",
          "casual": false,
          "evidences": [
            {
              "bel_statement": "a(CHEBI:\"hydrogen peroxide\") decreases p(HGNC:HDAC2)",
              "citation": {
                "type": "PubMed",
                "id": "15456740",
                "name": "Moodie, F. M., J. A. Marwick, C. S. Anderson, P. Szulakowski, S. K. Biswas, M. R. Bauter, I. Kilty, and I. Rahman. 2004. \"Oxidative stress and cigarette smoke alter chromatin remodeling but differentially regulate NF-kappaB activation and proinflammatory cytokine release in alveolar epithelial cells.\" Faseb j no. 18 (15):1897-9. doi: 10.1096/fj.04-1506fje."
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "human",
                "tissue": "",
                "cell": "human type II alveolar epithelial cell line A549"
              },
              "summary_text": "In results, read the section \"H2O2 and CSC decrease HDAC activity and histone deacetylase 2 levels\". See the figure 3 and 4.",
              "metadata": {
                "id": "550743f089e3620b944ee5ea",
                "created_by": "pirxtrurl"
              }
            }
          ]
        }
      },
      {
        "source": "g(HGNC:F2RL3)",
        "target": "bp(GOBP:\"hypomethylation of CpG island\")",
        "relation": "positiveCorrelation",
        "directed": true,
        "label": "g(HGNC:F2RL3) positiveCorrelation bp(GOBP:\"hypomethylation of CpG island\")",
        "metadata": {
          "edgeId": "55114c8889e3620b9c5b2625",
          "createdBy": "susana.martinez.arbas",
          "casual": false,
          "evidences": [
            {
              "bel_statement": "g(HGNC:F2RL3) positiveCorrelation bp(GOBP:\"hypomethylation of CpG island\")",
              "citation": {
                "type": "PubMed",
                "id": "21457905",
                "name": ""
              },
              "experiment_context": {
                "disease": "Smoking",
                "species_common_name": "human",
                "tissue": "Peripheral-blood",
                "cell": ""
              },
              "summary_text": "Assessment of Methylation extents in peripheral-blood DNA from 177 current smokers, former smokers, and those who had never smoked revealed a single locus, cg03636183, located in F2RL3, with genome-wide significance for lower methylation in smokers. (Adapted from the original document)",
              "metadata": {
                "id": "55114c8789e3620b9c5b258c",
                "created_by": "susana.martinez.arbas"
              }
            }
          ]
        }
      },
      {
        "source": "bp(GOBP:\"hypomethylation of CpG island\")",
        "target": "g(HGNC:SERPINA1)",
        "relation": "positiveCorrelation",
        "directed": true,
        "label": "bp(GOBP:\"hypomethylation of CpG island\") positiveCorrelation g(HGNC:SERPINA1)",
        "metadata": {
          "edgeId": "55257b0b89e36205c49dc26c",
          "createdBy": "susana.martinez.arbas",
          "casual": false,
          "evidences": [
            {
              "bel_statement": "bp(GOBP:\"hypomethylation of CpG island\") positiveCorrelation g(HGNC:SERPINA1)",
              "citation": {
                "type": "PubMed",
                "id": "22161163",
                "name": ""
              },
              "experiment_context": {
                "disease": "COPD",
                "species_common_name": "human",
                "tissue": "",
                "cell": "white blood cells"
              },
              "summary_text": "Our observations include significant, replicable associations between SERPINA1 hypomethylation and COPD and lower average lung function phenotypes (combined P values: COPD, 1.5  10(-23); FEV(1)/FVC, 1.5  10(-35); FEV(1), 2.2  10(-40)).",
              "metadata": {
                "id": "55257b0b89e36205c49dc1bd",
                "created_by": "susana.martinez.arbas"
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:HDAC1)",
        "target": "p(HGNC:DEFB1)",
        "relation": "decreases",
        "directed": true,
        "label": "p(HGNC:HDAC1) decreases p(HGNC:DEFB1)",
        "metadata": {
          "edgeId": "55258f4989e36205c4a4a393",
          "createdBy": "susana.martinez.arbas",
          "casual": false,
          "evidences": [
            {
              "bel_statement": "p(HGNC:HDAC1) decreases p(HGNC:DEFB1)",
              "citation": {
                "type": "PubMed",
                "id": "23185513",
                "name": ""
              },
              "experiment_context": {
                "disease": "COPD",
                "species_common_name": "human",
                "tissue": "lung",
                "cell": "epithelial cells (A549)"
              },
              "summary_text": "From full text, section \"Knockdown of HDAC1, but not HDAC2 or HDAC3, Increases DEFB1 Gene Expression in A549 Cells\"...These data showed that only HDAC1, but not HDAC2 or HDAC3, was involved in the transcriptional repression of DEFB1 in A549 cells.",
              "metadata": {
                "id": "55258f4989e36205c4a4a2df",
                "created_by": "susana.martinez.arbas"
              }
            }
          ]
        }
      },
      {
        "source": "bp(GOBP:\"histone methylation\")",
        "target": "bp(GOBP:\"histone modification\")",
        "relation": "isA",
        "directed": true,
        "label": "bp(GOBP:\"histone methylation\") isA bp(GOBP:\"histone modification\")",
        "metadata": {
          "edgeId": null,
          "createdBy": null,
          "casual": null,
          "evidences": [
            {
              "bel_statement": "bp(GOBP:\"histone methylation\") isA bp(GOBP:\"histone modification\")",
              "citation": {
                "type": "Online Resource",
                "id": "http://geneontology.org/",
                "name": "The Gene Ontology"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "accessed 2015-07-29",
              "metadata": {
                "id": "",
                "created_by": ""
              }
            }
          ]
        }
      },
      {
        "source": "bp(GOBP:\"histone acetylation\")",
        "target": "bp(GOBP:\"histone modification\")",
        "relation": "isA",
        "directed": true,
        "label": "bp(GOBP:\"histone acetylation\") isA bp(GOBP:\"histone modification\")",
        "metadata": {
          "edgeId": null,
          "createdBy": null,
          "casual": null,
          "evidences": [
            {
              "bel_statement": "bp(GOBP:\"histone acetylation\") isA bp(GOBP:\"histone modification\")",
              "citation": {
                "type": "Online Resource",
                "id": "http://geneontology.org/",
                "name": "The Gene Ontology"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "accessed 2015-07-29",
              "metadata": {
                "id": "",
                "created_by": ""
              }
            }
          ]
        }
      },
      {
        "source": "bp(GOBP:\"response to oxidative stress\")",
        "target": "cat(p(HGNC:DNMT1))",
        "relation": "increases",
        "directed": true,
        "label": "bp(GOBP:\"response to oxidative stress\") increases cat(p(HGNC:DNMT1))",
        "metadata": {
          "edgeId": "5525548589e36205c48cf0c3",
          "createdBy": "aishwarya.alex",
          "casual": false,
          "evidences": [
            {
              "bel_statement": "bp(GOBP:\"response to oxidative stress\") increases cat(p(HGNC:DNMT1))",
              "citation": {
                "type": "PubMed",
                "id": "25807439",
                "name": ""
              },
              "experiment_context": {
                "disease": "COPD",
                "species_common_name": "human",
                "tissue": "Lung",
                "cell": ""
              },
              "summary_text": "Oxidative stress can up-regulate the\nexpression and activity of DNA methyltransferase 1 (DNMT1) and induce DNA promoter methylation, in turn, affect the expression of the\ngenes",
              "metadata": {
                "id": "5525548589e36205c48cf01d",
                "created_by": "aishwarya.alex"
              }
            }
          ]
        }
      },
      {
        "source": "cat(p(HGNC:DNMT1))",
        "target": "bp(GOBP:\"DNA methylation\")",
        "relation": "directlyIncreases",
        "directed": true,
        "label": "cat(p(HGNC:DNMT1)) directlyIncreases bp(GOBP:\"DNA methylation\")",
        "metadata": {
          "edgeId": null,
          "createdBy": null,
          "casual": null,
          "evidences": [
            {
              "bel_statement": "cat(p(HGNC:DNMT1)) directlyIncreases bp(GOBP:\"DNA methylation\")",
              "citation": {
                "type": "PubMed",
                "id": "25807439",
                "name": "Eur Rev Med Pharmacol Sci. 2015;19(5):844-56."
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "human",
                "tissue": "lung",
                "cell": ""
              },
              "summary_text": "Oxidative stress can up-regulate the\nexpression and activity of DNA methyltransferase 1 (DNMT1) and induce DNA promoter methylation, in turn, affect the expression of the\ngenes",
              "metadata": {
                "id": "",
                "created_by": ""
              }
            }
          ]
        }
      },
      {
        "source": "g(HGNC:SERPINA1)",
        "target": "path(MESHD:\"Pulmonary Disease, Chronic Obstructive\")",
        "relation": "association",
        "directed": true,
        "label": "g(HGNC:SERPINA1) association path(MESHD:\"Pulmonary Disease, Chronic Obstructive\")",
        "metadata": {
          "edgeId": "553a470f89e36209b4f0d888",
          "createdBy": "ganna.androsova",
          "casual": false,
          "evidences": [
            {
              "bel_statement": "g(HGNC:SERPINA1) association path(MESHD:\"Pulmonary Disease, Chronic Obstructive\")",
              "citation": {
                "type": "PubMed",
                "id": "22161163",
                "name": "Am J Respir Crit Care Med. 2012 Feb 15;185(4):373-81. doi: 10.1164/rccm.201108-1382OC. Epub 2011 Dec 8.\nVariable DNA methylation is associated with chronic obstructive pulmonary disease and lung function.\nQiu W1, Baccarelli A, Carey VJ, Boutaoui N, Bacherman H, Klanderman B, Rennard S, Agusti A, Anderson W, Lomas DA, DeMeo DL."
              },
              "experiment_context": {
                "disease": "copd",
                "species_common_name": "human",
                "tissue": "",
                "cell": "white blood cells"
              },
              "summary_text": "Our observations include significant, replicable associations between SERPINA1 hypomethylation and COPD and lower average lung function phenotypes (combined P values: COPD, 1.5  10(-23); FEV(1)/FVC, 1.5  10(-35); FEV(1), 2.2  10(-40)).",
              "metadata": {
                "id": "5541386a89e36209e88928f7",
                "created_by": "susana.martinez.arbas"
              }
            }
          ]
        }
      },
      {
        "source": "g(HGNC:FUT7)",
        "target": "bp(GOBP:\"hypomethylation of CpG island\")",
        "relation": "positiveCorrelation",
        "directed": true,
        "label": "g(HGNC:FUT7) positiveCorrelation bp(GOBP:\"hypomethylation of CpG island\")",
        "metadata": {
          "edgeId": "55257cb989e36205c49e4181",
          "createdBy": "susana.martinez.arbas",
          "casual": false,
          "evidences": [
            {
              "bel_statement": "g(HGNC:FUT7) positiveCorrelation bp(GOBP:\"hypomethylation of CpG island\")",
              "citation": {
                "type": "PubMed",
                "id": "22161163",
                "name": ""
              },
              "experiment_context": {
                "disease": "COPD",
                "species_common_name": "human",
                "tissue": "",
                "cell": "white blood cells"
              },
              "summary_text": "One of the top five associated CpG sites for all three phenotypes in both cohorts was with a CpG in the fucosyltransferase-7 (FUT7) gene (OMIM 602030), which was relatively hypomethylated in the presence of COPD and lower lung function.",
              "metadata": {
                "id": "55257cb989e36205c49e40d0",
                "created_by": "susana.martinez.arbas"
              }
            }
          ]
        }
      },
      {
        "source": "g(HGNC:FUT7)",
        "target": "path(MESHD:\"Pulmonary Disease, Chronic Obstructive\")",
        "relation": "association",
        "directed": true,
        "label": "g(HGNC:FUT7) association path(MESHD:\"Pulmonary Disease, Chronic Obstructive\")",
        "metadata": {
          "edgeId": null,
          "createdBy": null,
          "casual": null,
          "evidences": [
            {
              "bel_statement": "g(HGNC:FUT7) association path(MESHD:\"Pulmonary Disease, Chronic Obstructive\")",
              "citation": {
                "type": "PubMed",
                "id": "22161163",
                "name": "Am J Respir Crit Care Med. 2012 Feb 15;185(4):373-81. "
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "One of the top five associated CpG sites for all three phenotypes in both cohorts was with a CpG in the fucosyltransferase-7 (FUT7) gene (OMIM 602030), which was relatively hypomethylated in the presence of COPD and lower lung function.\n",
              "metadata": {
                "id": "",
                "created_by": ""
              }
            }
          ]
        }
      },
      {
        "source": "deg(p(HGNC:HDAC2))",
        "target": "p(HGNC:HDAC2)",
        "relation": "directlyDecreases",
        "directed": true,
        "label": "deg(p(HGNC:HDAC2)) directlyDecreases p(HGNC:HDAC2)",
        "metadata": {
          "edgeId": null,
          "createdBy": null,
          "casual": null,
          "evidences": [

          ]
        }
      },
      {
        "source": "a(CHEBI:corticosteroid)",
        "target": "bp(GOBP:\"inflammatory response\")",
        "relation": "decreases",
        "directed": true,
        "label": "a(CHEBI:corticosteroid) decreases bp(GOBP:\"inflammatory response\")",
        "metadata": {
          "edgeId": "552910a689e3620d90a892d2",
          "createdBy": "aishwarya.alex",
          "casual": false,
          "evidences": [
            {
              "bel_statement": "a(CHEBI:corticosteroid) decreases bp(GOBP:\"inflammatory response\")",
              "citation": {
                "type": "PubMed",
                "id": "25807439",
                "name": ""
              },
              "experiment_context": {
                "disease": "COPD",
                "species_common_name": "human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Corticosteroids appear to sup-\npress inflammation by switching off the inflam-\nmatory genes by targeting these transcription fac-\ntors and their ability to induce histone modifica-\ntions and chromatin remodeling",
              "metadata": {
                "id": "552910a589e3620d90a88fca",
                "created_by": "aishwarya.alex"
              }
            }
          ]
        }
      },
      {
        "source": "a(CHEBI:corticosteroid)",
        "target": "bp(GOBP:\"histone modification\")",
        "relation": "decreases",
        "directed": true,
        "label": "a(CHEBI:corticosteroid) decreases bp(GOBP:\"histone modification\")",
        "metadata": {
          "edgeId": "5529114b89e3620d90a9e27d",
          "createdBy": "aishwarya.alex",
          "casual": false,
          "evidences": [
            {
              "bel_statement": "a(CHEBI:corticosteroid) decreases bp(GOBP:\"histone modification\")",
              "citation": {
                "type": "PubMed",
                "id": "25807439",
                "name": ""
              },
              "experiment_context": {
                "disease": "COPD",
                "species_common_name": "human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Corticosteroids appear to sup-\npress inflammation by switching off the inflam-\nmatory genes by targeting these transcription fac-\ntors and their ability to induce histone modifica-\ntions and chromatin remodeling",
              "metadata": {
                "id": "5529114b89e3620d90a9e1c5",
                "created_by": "aishwarya.alex"
              }
            }
          ]
        }
      },
      {
        "source": "a(CHEBI:corticosteroid)",
        "target": "bp(GOBP:\"chromatin remodeling\")",
        "relation": "decreases",
        "directed": true,
        "label": "a(CHEBI:corticosteroid) decreases bp(GOBP:\"chromatin remodeling\")",
        "metadata": {
          "edgeId": "55291c3489e3620d90ae0c26",
          "createdBy": "aishwarya.alex",
          "casual": false,
          "evidences": [
            {
              "bel_statement": "a(CHEBI:corticosteroid) decreases bp(GOBP:\"chromatin remodeling\")",
              "citation": {
                "type": "PubMed",
                "id": "25807439",
                "name": ""
              },
              "experiment_context": {
                "disease": "COPD",
                "species_common_name": "human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Corticosteroids appear to sup-\npress inflammation by switching off the inflam-\nmatory genes by targeting these transcription fac-\ntors and their ability to induce histone modifica-\ntions and chromatin remodeling",
              "metadata": {
                "id": "55291c3489e3620d90ae0b6a",
                "created_by": "aishwarya.alex"
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:HDAC2)",
        "target": "bp(GOBP:\"cellular response to DNA damage stimulus\")",
        "relation": "association",
        "directed": true,
        "label": "p(HGNC:HDAC2) association bp(GOBP:\"cellular response to DNA damage stimulus\")",
        "metadata": {
          "edgeId": "5526fe9189e36201cca7ccf7",
          "createdBy": "susana.martinez.arbas",
          "casual": false,
          "evidences": [
            {
              "bel_statement": "p(HGNC:HDAC2) association bp(GOBP:\"cellular response to DNA damage stimulus\")",
              "citation": {
                "type": "PubMed",
                "id": "22842217",
                "name": ""
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "HDAC2 regulates chromatin plasticity and enhances DNA vulnerability, suggesting that HDAC2 inhibition can lead to DNA damage (76). This may be due to HDAC2-mediated transcriptional repression, which prevents transcription from interfering with the repair process. Another possibility is that HDAC2 recruitment influences the ability of DNA repair factors (e.g., Ku70/Ku80) to bind the damaged DNA or to function effectively (82) (Fig. 2).",
              "metadata": {
                "id": "5526fe9189e36201cca7cc3b",
                "created_by": "susana.martinez.arbas"
              }
            }
          ]
        }
      },
      {
        "source": "r(HGNC:HDAC5)",
        "target": "p(HGNC:HDAC5)",
        "relation": "translatedTo",
        "directed": true,
        "label": "r(HGNC:HDAC5) translatedTo p(HGNC:HDAC5)",
        "metadata": {
          "edgeId": null,
          "createdBy": null,
          "casual": null,
          "evidences": [

          ]
        }
      },
      {
        "source": "r(HGNC:HDAC8)",
        "target": "p(HGNC:HDAC8)",
        "relation": "translatedTo",
        "directed": true,
        "label": "r(HGNC:HDAC8) translatedTo p(HGNC:HDAC8)",
        "metadata": {
          "edgeId": null,
          "createdBy": null,
          "casual": null,
          "evidences": [

          ]
        }
      },
      {
        "source": "cat(p(SFAM:\"HDAC Family\"))",
        "target": "tscript(p(HGNC:EGR1))",
        "relation": "increases",
        "directed": true,
        "label": "cat(p(SFAM:\"HDAC Family\")) increases tscript(p(HGNC:EGR1))",
        "metadata": {
          "edgeId": "524b3517d3fbfd4c34051974",
          "createdBy": "selventa",
          "casual": true,
          "evidences": [
            {
              "bel_statement": "cat(p(SFAM:\"HDAC Family\")) increases tscript(p(HGNC:EGR1))",
              "citation": {
                "type": "PubMed",
                "id": "18830406",
                "name": "PLoS One 2008 3(10) e3316"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "In human pulmonary epithelial cells, exposure to CSE or histone deacetylase (HDAC) inhibitor rapidly induced autophagy. CSE decreased HDAC activity, resulting in increased binding of early growth response-1 (Egr-1) and E2F factors to the autophagy gene LC3B promoter, and increased LC3B expression. Knockdown of E2F-4 or Egr-1 inhibited CSE-induced LC3B expression. Knockdown of Egr-1 also inhibited the expression of Atg4B, a critical factor for LC3B conversion. Inhibition of autophagy by LC3B-knockdown protected epithelial cells from CSE-induced apoptosis. Egr-1(-/-) mice, which displayed basal airspace enlargement, resisted cigarette-smoke induced autophagy, apoptosis, and emphysema.",
              "metadata": {
                "id": "524b3521d3fbfd4c34061eec",
                "created_by": "selventa"
              }
            }
          ]
        }
      },
      {
        "source": "cat(p(SFAM:\"HDAC Family\"))",
        "target": "tscript(p(HGNC:GLI1))",
        "relation": "decreases",
        "directed": true,
        "label": "cat(p(SFAM:\"HDAC Family\")) decreases tscript(p(HGNC:GLI1))",
        "metadata": {
          "edgeId": "524b3517d3fbfd4c34051975",
          "createdBy": "selventa",
          "casual": true,
          "evidences": [
            {
              "bel_statement": "cat(p(SFAM:\"HDAC Family\")) decreases tscript(p(HGNC:GLI1))",
              "citation": {
                "type": "PubMed",
                "id": "11960000",
                "name": "Proc Natl Acad Sci U S A 2002 Apr 16 99(8) 5442-7"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Mouse",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Here we report that the mouse homolog of Su(fu) [mSu(fu)] specifically interacts with SAP18, a component of the mSin3 and histone deacetylase complex. In addition, we demonstrate that mSu(fu) functionally cooperates with SAP18 to repress transcription by recruiting the SAP18-mSin3 complex to promoters containing the Gli-binding element.",
              "metadata": {
                "id": "524b3521d3fbfd4c34061f73",
                "created_by": "selventa"
              }
            }
          ]
        }
      },
      {
        "source": "cat(p(SFAM:\"HDAC Family\"))",
        "target": "tscript(p(HGNC:E2F4))",
        "relation": "increases",
        "directed": true,
        "label": "cat(p(SFAM:\"HDAC Family\")) increases tscript(p(HGNC:E2F4))",
        "metadata": {
          "edgeId": "524b3517d3fbfd4c34051976",
          "createdBy": "selventa",
          "casual": true,
          "evidences": [
            {
              "bel_statement": "cat(p(SFAM:\"HDAC Family\")) increases tscript(p(HGNC:E2F4))",
              "citation": {
                "type": "PubMed",
                "id": "0",
                "name": ""
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "metadata": {
                "id": "524b3521d3fbfd4c3406214b",
                "created_by": "selventa"
              }
            }
          ]
        }
      },
      {
        "source": "cat(p(SFAM:\"HDAC Family\"))",
        "target": "p(HGNC:CCNB1)",
        "relation": "decreases",
        "directed": true,
        "label": "cat(p(SFAM:\"HDAC Family\")) decreases p(HGNC:CCNB1)",
        "metadata": {
          "edgeId": "524b3517d3fbfd4c34051977",
          "createdBy": "selventa",
          "casual": true,
          "evidences": [
            {
              "bel_statement": "cat(p(SFAM:\"HDAC Family\")) decreases p(HGNC:CCNB1)",
              "citation": {
                "type": "PubMed",
                "id": "0",
                "name": ""
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "Human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "metadata": {
                "id": "524b3521d3fbfd4c340621e4",
                "created_by": "selventa"
              }
            }
          ]
        }
      },
      {
        "source": "cat(p(SFAM:\"HDAC Family\"))",
        "target": "bp(GPBP:\"histone deacetylation\")",
        "relation": "directlyIncreases",
        "directed": true,
        "label": "cat(p(SFAM:\"HDAC Family\")) directlyIncreases bp(GPBP:\"histone deacetylation\")",
        "metadata": {
          "edgeId": null,
          "createdBy": null,
          "casual": null,
          "evidences": [

          ]
        }
      },
      {
        "source": "p(HGNC:HDAC3)",
        "target": "p(HGNC:GDF11)",
        "relation": "decreases",
        "directed": true,
        "label": "p(HGNC:HDAC3) decreases p(HGNC:GDF11)",
        "metadata": {
          "edgeId": "55293dac89e3620d90c1d3ab",
          "createdBy": "susana.martinez.arbas",
          "casual": false,
          "evidences": [
            {
              "bel_statement": "p(HGNC:HDAC3) decreases p(HGNC:GDF11)",
              "citation": {
                "type": "PubMed",
                "id": "15169878",
                "name": "Mol Cell Biol. 2004 Jun;24(12):5106-18.\nActivation of the growth-differentiation factor 11 gene by the histone deacetylase (HDAC) inhibitor trichostatin A and repression by HDAC3.\nZhang X1, Wharton W, Yuan Z, Tsai SC, Olashaw N, Seto E."
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Here we show that activation of gdf11 results from the inhibition of HDAC3 activity on the gdf11 promoter..... overexpression of HDAC3 caused a significant (10-fold) repression of the gdf11 promoter. Similar to HDAC1 and HDAC2, overexpression of class II HDACs (HDAC4, -5, -6, -7, -9, or -10) and HDAC11 resulted in either an insignificant repression or a mild activation of the gdf11 promoter (Fig. (Fig.4B).4B). These results suggest that HDAC3 is chiefly responsible for the repression of the gdf11 promoter.",
              "metadata": {
                "id": "55293dab89e3620d90c1d2d1",
                "created_by": "susana.martinez.arbas"
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:KMT2A)",
        "target": "bp(GOBP:\"histone methylation\")",
        "relation": "directlyIncreases",
        "directed": true,
        "label": "p(HGNC:KMT2A) directlyIncreases bp(GOBP:\"histone methylation\")",
        "metadata": {
          "edgeId": "552ad49389e3620a30dd9015",
          "createdBy": "susana.martinez.arbas",
          "casual": null,
          "evidences": [
            {
              "bel_statement": "p(HGNC:KMT2A) directlyIncreases bp(GOBP:\"histone methylation\")",
              "citation": {
                "type": "PubMed",
                "id": "25834810",
                "name": "Int J Genomics. 2015;2015:206937."
              },
              "experiment_context": {
                "disease": "COPD",
                "species_common_name": "human",
                "tissue": "lung",
                "cell": ""
              },
              "summary_text": "In the current study, the expression of MLL, which plays an important role in H3K4 methylation [32], and CHD, which is important for chromatin modification and opening of chromatin to allow transcription [33], was increased in COPD subjects. T",
              "metadata": {
                "id": "",
                "created_by": ""
              }
            }
          ]
        }
      },
      {
        "source": "r(HGNC:KMT2A)",
        "target": "p(HGNC:KMT2A)",
        "relation": "translatedTo",
        "directed": true,
        "label": "r(HGNC:KMT2A) translatedTo p(HGNC:KMT2A)",
        "metadata": {
          "edgeId": null,
          "createdBy": null,
          "casual": null,
          "evidences": [

          ]
        }
      },
      {
        "source": "r(HGNC:HDAC10)",
        "target": "p(HGNC:HDAC10)",
        "relation": "translatedTo",
        "directed": true,
        "label": "r(HGNC:HDAC10) translatedTo p(HGNC:HDAC10)",
        "metadata": {
          "edgeId": null,
          "createdBy": null,
          "casual": null,
          "evidences": [

          ]
        }
      },
      {
        "source": "r(HGNC:CARM1)",
        "target": "p(HGNC:CARM1)",
        "relation": "translatedTo",
        "directed": true,
        "label": "r(HGNC:CARM1) translatedTo p(HGNC:CARM1)",
        "metadata": {
          "edgeId": null,
          "createdBy": null,
          "casual": null,
          "evidences": [

          ]
        }
      },
      {
        "source": "r(HGNC:PRMT5)",
        "target": "p(HGNC:PRMT5)",
        "relation": "translatedTo",
        "directed": true,
        "label": "r(HGNC:PRMT5) translatedTo p(HGNC:PRMT5)",
        "metadata": {
          "edgeId": null,
          "createdBy": null,
          "casual": null,
          "evidences": [

          ]
        }
      },
      {
        "source": "r(HGNC:PRMT6)",
        "target": "p(HGNC:PRMT6)",
        "relation": "translatedTo",
        "directed": true,
        "label": "r(HGNC:PRMT6) translatedTo p(HGNC:PRMT6)",
        "metadata": {
          "edgeId": null,
          "createdBy": null,
          "casual": null,
          "evidences": [

          ]
        }
      },
      {
        "source": "r(HGNC:PRMT9)",
        "target": "p(HGNC:PRMT9)",
        "relation": "translatedTo",
        "directed": true,
        "label": "r(HGNC:PRMT9) translatedTo p(HGNC:PRMT9)",
        "metadata": {
          "edgeId": null,
          "createdBy": null,
          "casual": null,
          "evidences": [

          ]
        }
      },
      {
        "source": "a(SCHEM:\"Diesel exhaust particles\")",
        "target": "path(MESHD:\"Pulmonary Disease, Chronic Obstructive\")",
        "relation": "increases",
        "directed": true,
        "label": "a(SCHEM:\"Diesel exhaust particles\") increases path(MESHD:\"Pulmonary Disease, Chronic Obstructive\")",
        "metadata": {
          "edgeId": "552c363489e36208d4857c32",
          "createdBy": "pranjul.shah_1",
          "casual": false,
          "evidences": [
            {
              "bel_statement": "a(SCHEM:\"Diesel exhaust particles\") increases path(MESHD:\"Pulmonary Disease, Chronic Obstructive\")",
              "citation": {
                "type": "PubMed",
                "id": "25807439",
                "name": ""
              },
              "experiment_context": {
                "disease": "COPD",
                "species_common_name": "human",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "Diesel exhaust particles (DEP)\nhas been associated with numerous adverse respiratory health outcomes including COPD",
              "metadata": {
                "id": "552c363489e36208d4857b5e",
                "created_by": "pranjul.shah_1"
              }
            }
          ]
        }
      },
      {
        "source": "bp(GPBP:\"histone deacetylation\")",
        "target": "bp(GOBP:\"histone modification\")",
        "relation": "isA",
        "directed": true,
        "label": "bp(GPBP:\"histone deacetylation\") isA bp(GOBP:\"histone modification\")",
        "metadata": {
          "edgeId": null,
          "createdBy": null,
          "casual": null,
          "evidences": [
            {
              "bel_statement": "bp(GPBP:\"histone deacetylation\") isA bp(GOBP:\"histone modification\")",
              "citation": {
                "type": "Online Resource",
                "id": "http://geneontology.org/",
                "name": "The Gene Ontology"
              },
              "experiment_context": {
                "disease": "",
                "species_common_name": "",
                "tissue": "",
                "cell": ""
              },
              "summary_text": "accessed 2015-07-29",
              "metadata": {
                "id": "",
                "created_by": ""
              }
            }
          ]
        }
      }
    ],
    "metadata": {
      "boundary_conditions": "The human model sets were built to represent healthy processes and were then enhanced with COPD data to represent early COPD (GOLD stage I and II) processes. If supporting literature from early COPD studies were not available, stage-independent COPD studies were used. For a mechanism predicted from COPD data it was incorporated into a network with an edge based on COPD studies if available, and if not healthy context was used to incorporate these COPD mechanisms. Literature describing processes active in acute exacerbation in COPD patients was excluded from supporting edges of the network models. We prioritized data collected from studies of lung and COPD-relevant cell types, but excluded literature related to asthma or bronchitis. We excluded cancer, idiopathic pulmonary fibrosis, cystic fibrosis, all virus infections, all bacterial infections, septic pneumonitis, acute respiratory distress syndrome (ARDS), allergic responses/asthma, pneumoconiosis, and COPD exacerbations. We also excluded animal inhalation studies with solid particles (titanium dioxide, quartz, asbestos, carbon black, diesel exhaust etc). For the in vitro-specific exclusion criteria we excluded tumor-derived cell lines, immortalized cell lines, neuronal cells, and cell types that cannot be found in the respiratory/vascular system. There were some exceptions where we included immortalized cell lines and non-lung cell types for canonical mechanisms where there was evidence that the relationship was not tissue-specific but could also take place in the lung. Human-specific connections were preferred, but rat and mouse were also included where human data was not available.",
      "BELJGF Version": "2.0",
      "description": "The Epigenetics network describes epigenetic changes reported to be associated with COPD, as well as epigenetic modulators reported to be affected by COPD or smoking including the histone deacetylase (HDAC) family and DNA methyltransferase (DMT) family member DNMT1, as well as connections from these epigenetic mediators to the core cell cycle components (e.g. CCND1, CDKN2A). Reviewed during Jamboree2015",
      "species_common_name": "Human",
      "version": "2.0"
    }
  }
}
